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SUMMARY
C
_
Introduction: X mactivation (Xi) randomly mactivates a single X chromosome (maternai or
patemai) in female somatic ceils. In a significant proportion of females however, Xi is flot random,
a phenomenon termed skewed Xi [arbitrarily defmed as preferentiai inactivation (75%) of the
maternai (Xm) or patemal X (Xp)]. The proportion ofXp inactivated relative to Xm is termed the X
inactivation ratio (XIR). The study of Xi in humans is hampered by two unrelated phenotypes. i)
The primary Xi trait. Initiated during early embryogenesis, in a developmental context, it induces a
similar Xi pattern, which can vary ftom random to skewed, among varions tissues. A resulting
skewed Xi paffem, tenned primary skewing (PS), may resuit from a small number of stem ceils
present when Xi is initiated However, other possibilities include genetic influences, such as
heterozygosity for the X-linked Xce locus, as observed in certain mice hybrids. That 9% of human
female neonates demonstrate a skewed Xi pattem in cord blood supports a PS trait in humans. ii)
the secondwy skewing trait, usualIy associated with a skewed Xi pattem in a tissue-specific mariner,
occurs after the initiation of Xi. Secondary skewing often resuits from a growth competition
between X-linked alleles, such as in female carriers of various X-linked immunodeflciency disease
alleles. Flowever, X-linked disease alleles are rare and do not explain the high prevalence of
skewing (38%) as observed in peripheral blood (PB) of ‘healthy’ females 60 years of age and older.
The latter trait, termed acquired skewing (AS), lias been assigned varlous etiologies. Recent data
support an X-linked genetic component influencing hematopoietic stem ceil (HSC) growtWsurvival
kinetics. Clinically, skewed Xi lias been associated with varlous biomarkers (breast cancer and
recurrent spontaneous abortion for example). In light of this data, a study was undertaken to resolve
the etiologies and biological / ciinical associations of Xi traits in liuman femaies. Methods: French
Canadian nuclear families (females oniy) were recruited for study analysis. Two biological tissues
were obtained: PB for analysis of the AS trait and buccal cetis (BC) for analysis of the primary Xi
trait. PB was fractionated and cell-sorted to obtain pure-ceil populations. The XIR was determined
by the HUMARA clonaiity assay. Xi phenotypes included. i) The )UR derived from BC for analysis
of the primary Xi trait. ii) The XW of PB for analysis of the AS trait and iii) the relative value of
AS obtained by quantitating deviation from the primary )UR (i.e., difference between the BC and
P13 )UR). Qualitative analyses included a skewed Xi pattem (25% deviation from random Xi for
the )UR and an AS value 0,25 for the relative AS trait). Subject data included a medical
questionnaire and blood counts, which were analyzed as a function of Xi phenotypes. Genetic
effects were determined by heritability studies. Resuits and Conclusion: 1144 females derived from
193 nuclear families were recruited. Age ranged from 3$-96 years, with a mean of 63,3 years.
90,8% of females were informative for the HIJMARA assay. findings related to the BC XIR were
four-fold: I) the incidence of Xi skewing in BC was low (12,4% - similar to that reported in
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neonatal cord blood, i.e. 8,6%); ii) the incidence of Xi skewing was relatively stable with advancing
age (p=O,21); iii) the BC )UR was modestly correlated with that of PB lineages (O,46<r<O,56) and
iv) heritabiÎity analysis revealed a genetic (piausibly X-linked) component (p<O,0001; h2O,30).
These findings are similar to the Xce-influenced primary Xi trait in mice, supporting evidence for
an XCE-Iike primary Xi trait in humans. further, this fmding suggests that the primary Xi trait in
humans is flot strictly a stochastic process as previously suggested. Clinically, the BC and blood
)UR was associated with asthma. Among hematopoietïc lineages, the incidence of skewed Xi was
higher versus BC: granulocytes (PMN) 36%; monocytes 36,6%; T cells 20,1% and B cells 26,5%.
The incidence of relative AS was 22,7; 27,2; 11,4 and 16,3%, respectively. With the exception of T
ceils, signilhcant correlation of AS values among B ceils and myeloid lineages (0,73<r<0,$5) was
consistent with a FISC origin of AS. The incidence of AS (relative and absolute) increased
significantly with age, particularly for myeloid lineages. Lack of T celis contribution may be
attributed to long-lived memory T cells. Heritability estimates attributed 20-39% of the variance of
AS values to genetic effects (plausibly X-Iinked), supporting linkage studies to map the trait(s).
Clinically, increasing AS values were associated with a decreased eosinophil count. Because
eosinophïl count is a predictor of ail-cause mortaiity, the finding suggests AS may 5e associated
with increased longevity. In effect, that the AS trait demonstrated a different biological profile
versus the PS trait (i.e., late versus early-onset, increased incidence of skewing with age versus
stable, different incidence of skewing, and a different clinical profile) is convincing evidence for
two distinct traits.
Key words: X chromosome, acquired skewing, primary skewing, HUMARA, heritability,
hematopoietic stem ceNs, buccal ceils, human, females, Québec, hematopoietic lineages, association
studies, clinical data, complete blood counts, age
VRÉSUMÉ
C .Introduction: Dans les cellules somatiques de femmes, I mactivation du chromosome X (iX)
inactive, de façon aléatoire, l’un des deux chromosome X (maternel ou paternel). Cependant, dans
une certaine proportion de femmes, l’inactivation n’est pas aléatoire, un phénomène appelé IX
biaisé [arbitrairement défmi comme étant une inactivation préférentielle (?75%) du X maternel
(Xm) ou paternel (Xp)J. La proportion de Xp inactivé relatif au Xm est appelé le ratio d’ inactivation
du X (RIX). Chez l’humain, l’étude de iX est entravée par deux phénotypes non reliés: i) Le LX
primaire. Amorcé tôt durant l’embryogenèse, dans un contexte de développement donné, induit un
RIX similaire dans divers tissus, soit aléatoire ou biaisé, ce dernier est appelé le biaisé primaire
(BP). Le BP peut provenir d’un petit nombre de cellules souches présentent lors de l’initiation du
IX. D’autres causes incluant les influences génétiques, comme l’hétérozygocité du locus Xce lié au
X, observée dans certaines hybrides de souris. Le fait que chez 9% des nouveau-nés de sexe féminin
on observe l’IX biaisé dans le sang du cordon suggère un phénotype BP chez l’humain, ii) Le
phénotype biaisé secondaire, habituellement associé avec l’iX biaisé dans un tissu spécifique, a lieu
après l’initiation de IX. Le biais est le résultat d’un désavantage de croissance conféré par des
allèles mutant liés au X. Les exemples incluent des porteuses de différents allè]es de maladies
immunodéficientes liées au X. Malgré cela, ces allèles sont rares et n’expliquent pas la haute
fréquence (3 8%) de ce biais observé dans le sang périphérique ($P) chez des femmes âgées de 60
(au plus) et en santé. Ce phénotype, appelé biais acquis (BA), a été associé à diverses causes. De
récentes données indiquent une composante génétique liée au X qui influence la cinétique des
cellules souches hématopofétiques (CSH). Cliniquement, le phénotype iX biaisé a été associé à
différents marqueurs biologiques comme le cancer du sein et l’avortement spontané répétitif À la
lumière de ces données, une étude a été entreprise pour élucider les causes et les associations
biologiques des deux phénotypes iX chez les femmes. Méthodes: Des familles Canadiennes
Françaises (femmes seulement) ont été recrutées pour participer à l’étude. Deux tissus biologiques
ont été recueillis pour analyse: le sang périphérique (SP) pour l’analyse du phénotype BA et des
cellules buccales (CB) pour l’analyse du phénotype iX primaire. Le SP a été fractionné, et ses
cellules classées pour obtenir des populations de cellules pures. Le RIX a été déterminé par la
méthode de HUMARA. Les phénotypes de iX inclus sont: i) Le RIX obtenu des CB, représentatif
du phénotype IX primaire. ii) La valeur absolue du RIX pour ]‘analyze du phénotype BA et iii) la
valeur BA relatif calculé selon la différence entre les RIX primaires des CB et du SP. Pour les
analyses qualitatives, le RIX biaisé (25%) et la valeur BA relatif (0,25) ont été utilisé. Les
données cliniques incluant un questionnaire médicale et les analyse sanguines, ont été analysées en
relation avec le lUX. Une composante génétiquelfamiliale des phénotypes a été évaluée par une
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étude familiale. Résultats et conclusion: Parmi 193 familles, 1144 femmes ont été recrutées. Ces
(E dernières étaient âgées entre 3$ et 96 ans, pour une moyenne de 63,3 ans. Les résultats obtenus pour
le phénotype DC primaire sont de quatre ordres : i) la fréquence du DC biaisé dans les CB était faible
(12,4%-similaire au résultat obtenu dans les cordons de nouveau-nés (8,6%)), ii) le RIX des CB
était relativement stable avec l’âge (p=O.2l), iii) le RIX des CB corrélait signilitivement avec celui
des types cellulaires du SP (O,46<r<O,56) et iv) l’héritabilité des RIX des CB suggère une
composante génétique (p<O,000I; h2=O,30). Ces propriétés sont en lien direct avec un phénotype iX
primaire, possiblement en relation avec un locus Xce lié au X. Ceci suggère que le IX primaire chez
l’humain n’est pas un processus strictement stochastique comme suggéré précédemment.
Cliniquement, les RIX ont été associé à une augmentation des cas d’asthme. Parmi les types
hématopoïétiques, l’incidence du DC biaisé était plus élevée par rapport au CB: granulocytes (PMN)
36%, monocytes 36,6%; lymphocytes T 20,1% et lymphocytes B 26,5%. En utilisant la valeur BA
relatil l’incidence du BA (valeur 0,25) était 22,7; 27,2; 11,4 et 16%, respectivement. À
l’exception des cellules T, chez un individu les RIX entre les différentes cellules hématopoïétiques
corrèlent d’un façon significative (O,73<r<O,85), ce qui supporte une d’origine CSH. L’incidence de
BA augmentent significativement avec l’âge, particulièrement pour les types myéloïdes. Une
incidence du BA moins fréquente chez les lymphocytes T pourrait être attribuée à une plus grande
(E longévité. Les études d’héritabilité ont attribué 20 à 39% de la variance des valeurs de BA aux
effets génétiques, ce qui supportent les études de liaisons génétiques pour localiser les phénotypes.
Cliniquement, l’augmentation des valeurs de BA était associée à une diminution du nombre
d’éosinophiles. Puisque le compte d’éosinophiles est associé à la mortalité, une association négative
suggère que le BA est associé à la longévité. En conséquence, le fait que le phénotype BA ait
démontré un profil biologique différent de celui du phénotype BP (i.e. : l’apparition acquise versus
primaire, l’incidence de iX biaisé differentes et les profils cliniques differentes) suggère fortement
deux phénotypes distincts.
Mots clés: chromosome X, biaisé acquise, biaisé primaire, HUMARA, héritabilité, cellules souches
hématopoïétiques, cellules buccales, humain, femme, Québec, lignées hématopolétiques, études
d’association, donnée clinique, analys&sanguines, l’âge
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oChapter I
INTRODUCTION AND LITERATURE REVIEW
2I THE X CHROMOSOME
(
1.1 Basic principles
‘flic term “X chromosome”, used to denote the sex chromosome that determines the development of
the homogametic female sex, lias been adopted in honor of Henking’s observation of a densely
stained body that appeared in haif of secondary spermatocytes of the heteropteran insect,
Pyrrhocoris apterus. 11e was uncertain of the clear nature of die body so lie labeled it “X” for
unknown, years later identified as the sex chromosome. The X is an exceptional chromosome as it
can undergo inactivation or reactivation - dependant on chromosome company, developmental
pathway (soma versus germiine) and stage of development. Among eutherian mammals, with few
exceptions, it is conserved in size and compromises roiighly 5% of the haploid genome (01mo,
1967). Moreover, as the X chromosome Iacks a pairing partner in males (aside from the PAR
regions that recombine with the Y), 01mo hypothesized that h is relatively protected from
rearrangements thus conserving gene linkage to the X chromosome across various eutherian
species.
Among mammalian species, X-Jinked gene dosage equivalence between XX females and XY males
is accomplished by a fundamental mechanism of gene regulation: X chromosome inactivation. By
the same mechanism, aneuploidy of the X chromosome (extra copies or monosomy) is well
tolerated. X inactivation (Xi) is initiated during eariy female development and is a fundamental
requirement for normal development. Failure to do so has been associated with severe
developmental defccts and embryonic lethality (Migeon et al., 1993). In partïcular, ectodermal ceil
death and absence of mesodermal formation lias been observed in mouse embryos bearing two
active Xs (Takagi and Abe, 1990). To achieve gene dosage equivalence with the autosomes, gene
expression from the single active X is upregulated approximately 2-fold, as demonstrated in
different mice strains where a particular bous was X-linked in one but autosomal in another (Adier
et al., 1997), consistent with Ohno’s hypothesis for an evolutionary requirement for high level gene
expression from the single active X chromosome (01mo, 1967).
1.2 Lyon’s Hypothesis
The X chromosome inactivation hypothesis, first proposed by Mary Lyon (Lyon, 1961), states that:
(ï) one of the two X chromosomes in mammalian female ceils îs genetically inactivated; (ii) the
inactive X could be maternai or patemal in origin; (iii) inactivation occurs early in embryonic
development and remains flxed in progeny celis. The latter is consistent with clonai inheritance of
3X inactivation patterns (Davidson et al., 1963). In other words, “X chromosome inactivation is the
transcriptional silenchig of a randomly selected X chromosome initiated in early female
development”. As a resuit, females are functional mosaics for X-linked polymorphisms, with two
distinct ceil lines/populations. Lyon based lier hypothesis on summation of the following
observations: i) the Barr body (then referred to as the X-chromatin body) was formed by
condensation of a single X chromosome (01mo et al., 1959); ii) the asynchronous labeling of the X
chromosomes (Gilbert et al., 1962); iii) mice with an X0 genotype were normal fertile femafes,
suggesting a single X is required for development (Welshons and Russell, 1959); and iv) mice
heterozygous for an X-linked coat color gene (moftled, brindled, tortoise-sheli, or tabby - most of
which are lethal in the hemizygous state) present a variegated coat phenotype (Welshons and
Russefi, 1959) (Lyon, 1960). In fact, in the heterozygous state, these genes give rise to a random
patchy, somewhat linear, distribution of abnormal and wild type coat colors (Lyon, 1962). Dosage
compensation by X inactivation lias been tested and extended to humans (Gartier et al., 1992).
Indeed, very similar patterns can be seen in female carriers ofvarious X-lïnked skin disease alleles.
1.3 Anatomical human X-m osaicism
In humans, the unes of Blashko, a nonrandom developmental pattem of the skin, manifest in the
heterozygous state of various X-linked gene defects, with mutant gene expression covering affected
areas and wiid-type gene expression constituting normal skin. Examples of X-linked skin disorders
with clinical manifestations foflowing the Blashko unes are focal dermal hypoplasia,
chondrodyspiasia punctata, and hypohidrotic ectodermal dyspiasia (Happle, 1985). The nature and
origins of the unes of Blashko may be best explained by the visible consequences of Lyonization
(Flappie, 1985), possibly reflecting the stream or trend of embryonic tissue growth. They describe a
V-shape over the spine, on the abdomen they frequently form whorls and on the limbs they mn in a
more or less perpendicular linear direction. When compared to mosaic defects of human skin, the
banding observed in mice is usually much more coarse, vaguely resembling the distribution of
Biashko’s unes.
Although the linear skin lesions are likely to reflect cional prolïferation of two functionaily different
ccli populations, analysis of smaH skin specimens (3-6mm) from normal individuals lias found
similar X inactivation paffems UP) in different regions of the same individual, suggesting skin
growth is characterized by considerable ccii mixing (Fiaikow, 1973). Similar findings were reported
for uterine tissue (Linder and Gartler, 1965) and hair roots (Gartier et aI., 1969). Moreover, in
human skin sampies composed of approximately 35 basai keratinocytes, a fme mosaic of tiles was
observed, with the maternai or paternal X chromosome inactivated in each tue (Asplund et al.,
42001). It appears therefore that the distribution paftern of skin ceils may be influenced by X-liiilced
genetic factors: in healthy females, a fme mosaic of tues; in carrier’s of certain X-Iinked skin
disease alleles on the other hand, a linear pattem may be observed.
1.4 Timing of X inactivation: concurrent with tissue d!fferentialion
Aftbough the process and mechanism of Xi bas been investigated in several species, a prime model
is the mouse as it is experimentafly amenable and a plethora of information is available. The
following is an outiine.
Pre-fertitizution
During early female development, oogenesis is characterized by reactivation of the inactive X,
occurring prior to the leptotene stage (Kratzer and Chapman, 1981), (Gartler et al., I 9$0), ensuing
in two active X chromosomes (Epstein, 1972). During mate gametogenesis on the other hand, the
active X chromosome is progressively inactivated around fffst meiotic prophase (Lifschytz and
Lindsley, 1972), ensuing in formation of the XY body. Akin to the female soma, the inactive X is
relatively condensedlheterochromatic. In contrast however, althougb transcriptionally inactive
(Richier et aI., 1992), flic CpG islands ofhouse keeping genes are relatively unmethylated (Driscoli
and Migeon, 1990).
Post-fertilization
Key observations of Xi occurring post-fertilization have been documented in vivo using harvested
mouse preimplantation embryos and in embryonic stem (ES) ceils. In both systems, initiation of Xi
has been tightly regulated to tissue differentiation - sec figure 1 (page 6) . Upon fertilization, the
zygote and early blastocyst (prior to implantation) embodies two active X chromosomes (Gartier et
al., 1972). Reactivation of the sperm-derived inactive X chromosome however has not been well
characterized. Upon dïfferentiation, one X is inevitably selected for inactivation (Epstein et al.,
197$), (Kratzer and Gartier, 197$), (Monk and Kathuria, 1977), (Monk and Harper, 1979), (Penny
et al., 1996). In ceits destined to form extraembiyonic lineages (trophectoderm and primitive
endoderm), the patemal X bears a putative imprÏnt marking the chromosome for early inactivation,
wherein Xi is initiated 4,0-5,0 days post-coitum (dpc), shortly around or after the time of
implantation (Takagi and Sasaki, 1975), (West et al., 1977), (Takagi et aL, 197$), (Monk and
Harper, 1979), (Costanzi et al., 2000). After implantation (5,5 — 6,5 dpc), a genome-wide
demethylation event is believed responsible for erasure of the parental imprint(s) (Rastan, I 9$2a)
(Monk et al., 1987), ensuing in random inactivation of parental X chromosomes in cells ofthe inner
ceti mass (Gardner and Lyon, 1971).
5furthennore, aithougli preliminaiy data found that Xi occurs concurrently with tissue differentiation
(Monk aiid Harper, 1979), unequivocal evidence was derived from a mouse une transgenic for an
X-Iinked Lac Z transgene. The transgene, which was subject to inactivation, underwent inactivation
in a developmental context, gradually proceeding in sub-populations and Jineages, and was vfrtually
completed by 11,5 dpc (Tan et al., 1993; Tan et al., 2000). Thereafier, the inactive state of the
chromosome was clonally inherited in daughter celis. lii humans, Xi is speculated to occur
approximatety 16 dpc (Park, 1957).
2 MECHÀMSM 0f X INACTWATION
Xi is an intensely studied subject that involves several molecular mechanisms: counting and
choosing, initiation/propagation and maintenance. An introduction to the underlying principles,
properties and mechanisms of Xi wilJ be provided (for a comprehensive review see (Willard, 1996a;
Avner and Heard, 2001)). The X-inactivation center (Xic), spanning approximately 1MB, is a key
cis-regulator for the initiation of Xi. Several elements involved in the Xi process reside within the
Xic (Figure 2, page 7) (Table I, page 7).
2.1 The X inactivation center (XicIXIC)
The fïrst dues for an “initiator of X chromosome inactivation” came from genetic studies wherein
mutant X chromosomes lacking a particular region were unable to undergo inactivation. This
deleted region was thereafier called the X chromosome inactivation center (Xic). Evidence that the
Xic functions in cis lias been progressively defmed by the partial spreading of inactivation onto
autosomal segments in X-autosome transiocations containiiig the XicDUC (Russell, 1963), (Rastan,
1983), (Cattanach et al., 1991), (Jeppesen and Turner, 1993; Jeppesen and Turner, 1993).
Localization ofthe human )UC has been assigned to band Xq13 (Brown et al., 1991a), (Leppig et
al., 1993), (Lafreniere et al., 1993). There is no convincing evidence for more then a single XIC
(Wïllard, 1 996b). The corresponding syntenic region in mouse is somewhat smaller and the overali
organization ofthe XicDUC is poorly conserved between human and mouse (Debrand et al., 1998).
Three general processes have been attributed to the Xic/XIC: counting, choice and
initiatio&propagation.
6Figure 1. Timing and appearance of X inactivation during female mouse development. After
formation of the zygote, both Xs are relatively active. An imprinting pathway, where Xp (paternal
X chromosome) is preferentially inactivated, is operative in tissues destined to form extraembiyonic
structures. At around the time of implantation, random X inactivation begins in celis destined to
form epiblast-derived tissues.
Oocyte Sperm
Blastocyst
Implantation
celis destined to form extraembiyonic
tissue
- Xp marked (impnnted) for inactivation
inner celi mass
- both Xs active
Xp preferentially inactïvated
Random X inactivation
Zygote
uterine walI
Abbreviations: Xm, maternai X; X, paternal X; a, active; j, inactive
7figure 2. The Xic region and its defmed elements. The Xic, located at Xq13, bas been implicated in
three defined processes of X inactivation: ï) counting, ii) choice, and iii) initiationlpropagation.
Genetic elements identifïed within the Xic that play a rote in the X inactivation process are Xist,
Tsix and the Xce element. Distances between elements and the size of the genetic elements are
approximate.
Xic (Xq13)
_-
Xist gene expression Xce element
4
Tsix gene expression
Table L The Xic and its elements.
Xic: A master control region required for the initiation of X inactivation. As the Xic functions in
cis, X chromosomes void of an Xic fait to undergo inactivation. A counting, choosing and spreading
role bas been attributed to this locus. Effector elements residing within the Xic includeXist, Xce and
Tsix.
Xist: Localized to the Xic region, the X inactive specific transcript (Xist) is a non-protein coding
mRNA essential for the initiation of X inactivation in cis and appears to be the primary signal for
propagation of inactivation along the chromosome.
Tsix: Tsix is a mRNA species transcribed antisense to and approximatety 15 Kb downstream of the
Xist gene. In mice, the transcript spans the whole of the Xist gene while in humans a shorter
transcript has been identified. Targeted deletions in the 5’ region of Tsix Ieads to skewed X
inactivation and disrupts imprinted X inactivation in extraembryonic tissues, suggesting Tsix
influences X chromosome choice. A possibte role of Tsix may be regulating Xist activity in cis.
Xe: The apparent function of the cis-acting X-chromosome controlling element (Xce) is to
modulate the probability upon which a particular X chromosome is inactivated. In the mouse, a
gradient of alleles bas been demonstrated. In the heterozygous state, the X chromosome bearing a
stronger allele is preferentiatly setected to remain active versus the X with the weaker alfele,
resulting in primary nonrandom X inactivation. Xce activity resides 3’ to Xist.
$i) Counting: This step senses the number of X chromosomes in the celi and ensures that only a
single X chromosome remains active per diploid celi - ai] other X(s) are inactivated (Therman and
Patau, 1974) (Rastan, 1982a). The absolute requirement ofat Ieast two Xics is required for initiation
of X inactivation (Rastan and Robertson, 1 9$5), (Rastan, 1983). How a single X is selccted is flot
presently clear. It is speculated that a blocking factor produced in limited amounts binds to a single
Xic (reviewed in (Migeon, 1994). Alternatively, allelic methylatïon differences within a proposed
differential methylation region may be another (Chao et aI., 2002). Since the number of active X
chromosomes is dependant on the number of chromosomal sets (ploidy number of autosomes), as
there are one to two active X’s in XXX triploids (69 chromosomes) and two active X’s in X)OOC
tetraploids (92 chromosomes), an autosomal origin for the blocking factor lias been supported (Carr,
1971), (Jacobs and Migeon, 1989). In fact, recent findings identified the CTCf insulator /
transcription factor as ‘the’ or ‘one of’ several putative trans-acting “blocking facto?’. As several
CTCF binding sites were identified in the mouse TsixIDXPas34 region, the authors postulate that
Tsix and CTCF work together to designate the future active X by inhibiting Xist activity in cis
(Chao et al., 2002). for a review of plausible mechanisms, see (Percec and Bartolomei, 2002). Ihe
role for CTCF as the human “blocking factor” is presently unclear as the number of CTCf binding
sites in the syntenic human region has signiflcantly less CTCf binding sites.
ii) Choice. During the choice process, one X is seiected to remain active and the other to be
inactivated. Although believed to be a random process, with maternai and paternal X boasting equal
inactivation probabïlity, deviation from random inactivation has been noted. for example, in extra
embiyonic lineages of mouse, the patemal X is marked for preferential inactivation. In the embryo
proper ahernatively, the imprint is believed erased soon after implantation, ensuing in random X
inactivation. Nonetheless, in mice, allelic variants ofthe Xce locus (the nature of which is presently
unclear) can compromise choice, ensuing in primaiy nonrandom X inactivation pattems. A gradient
of Xce alleles lias been identified, each influencing the probability of inducing cis-ïnactivation
(Cattanach and Isaacson, 1967), (Cattanach et al., 1969), (Cattanacli and Perez, 1970). it is
specuiated that the Xce affects affinity for the trans-blocking factor. Additional elements recently
implicated in the choice step are Tsix (Lee and Lu, 1999), Xist (Marahrens et al., 1997), (Boumil
and Lee, 2001), (Newali et aI., 2001) andXite (Ogawa and Lee, 2003). Further, as CTCF may act in
concert with Tsix in designating the future active X, it may aiso play a rote in the choice step.
iii) Initiation I propagation: This step involves initiation and spreading of the inactivation signal
onto neighboring regions in a cis-mediated manrier (Rastan, 1983), (Lee et ai., 1996), (Willard,
I 996a). Given the cis-Iimited function of Xist, binding sites or nucleation centers (booster elements)
have been specutated (Gartier and Riggs, 1983), (Riggs, 1990). As a candidate booster element,
9Lyon (Lyon, 199$) proposed long interspersed repeat elements- 1 (Li), based on two observations.
i) The X chromosome is enriched for sucli elements, approximately two-fold versus the autosomes
(Bailey et al., 2000). ii) In the event of X-autosome transiocations, the extent of inactivation
spreading onto autosomal regions correlated with levels of LI elements. Moreover, X-linked
regions that contain genes that escape inactivation are sïgnïficantly reduced in Li content versus
chromosomal segments containing genes subject to inactivation (Bailey et aI., 2000).
Although Xist RNA coating of the inactive X chromosome may have a chromatin-remodeling role,
(Clemson et al., 199$), Xist expression per se may flot be required for ‘maintenance’ of inactivation
(Csankovszki et al., 1999) (Wutz and Jaenisch, 2000) as Ioss of the )UC in humans bas flot been
associated wïth instability ofthe inactive state (Brown and Willard, 1994), thus suggesting that once
silencing bas been achieved, it is frreversible and thereof independent of Xist. Moreover, when Xist
expression was reactivated from the active X or when ectopic Xist expression was induced,
inactivation could flot be initiated (Wutz and Jaenisch, 2000) (Clemson et aI., 1998), consistent with
a developmental context ofXist expression.
2.2 Genetic elements of the Xic: Xist gene
The Xist gene, for X inactivation specific transcript, is believed to play a primary role in the X
inactivation process: I) it is located within the Xic (Xq 13.2), ii) is transcribed specifically from the
inactive X chromosome in both human (Brown et al., 1991b) and mouse (Borsani et aI., 1991),
(Brockdorff et aI., 1991), iii) is transcribed prior to Xi (Kay et al., 1993), and iv) bas been shown to
be essential for cis-mediated Xi by loss-of-function experiments (Penny et al., 1996), (Marahreiis et
al., 1997), (Lee et al., 1996). Although necessary for Xi, the Xist gene is flot required for male
development since male mice bearing a Xist deletion are fertile and physiologically normal
(Marahrens et al., 1997).
The Xist/XIST gene encodes a large untranslated RNA (Brown et al., 1992; Lee et al., 1996),
(Brockdorff et al., 1992) localized to the nucleus (Brown et al., 1992; Clemson et al., 1996; Lee et
aL, 1996). Although both the mouse and human gene contain at least $ exons, the )U$T cDNA
spans a maximal 19.3 KB (Hong et al., 2000) whule Xist cDNA spans at least 17.4 KB, however
smaller isoforms have been produced (Hong et al., 1999). The mouse and human Xist/XI$T gene
exhibit moderate but significant conservation of sequence and gene structure (Nesterova et al.,
2001).
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2.2.1 Developmental regulation ofXist
Dynamic changes in Xist expression mark one of the earliest events of the Xi process (Figure I .3a).
In undifferentiated murine embryonic stem (ES) celis (both male and female), the X-chromosomes
are relatively active and marked by basal Xist expression (Hong et al., 1999; Tai et al., 1994),
(Beard et al., 1995), (Daniels et al., 1997a), (Panning and Jaenisch, 1996) (Panning et al., 1997),
(Panning et al., 1997), (Johnston et al., 199$). This RNA however accumulates at the site of
transcription and does flot localize across the chromosome. Upon differentiation however, Xist RNA
expression is upregulated (>1 5-fold) from the X destined for iriactivation and is downregulated on
the future active X (Panning and Jaenisch, 1996) (Panning and Jaenisch, 1996). Xist upregulation is
thought to resuit from an increased RNA haif-life (Panning et al., 1997), (Sheardown et al., 1997),
possibly owing to a switch in Xist promoter usage (Johnston et al., 199$). However, recent data
suggcst an altemate mechanism: Tsix gene interference (vide infra) (Warshawsky et al., 1999).
Nonetheless, Xist accumulation is rapid, coating the inactive X within one celi cycle (Wutz and
Jaenisch, 2000), (Panning et al., 1997). $everal thousand X-linked genes are transcriptionally
silenced shortly afler the accumulation ofXist RNA (Keohane et al., 1996).
2.3 Characteristics acquired with Xist upregulation
Acquisition of Xi involves several progressively acquired changes in structure and function,
including recruitment of regulatory / chromatin proteins, many ofwhich have been identified. Both
genetic and epigenetic modifications have been characterized, see Table II (page 12) for an outiine.
Cytologically, the inactive X assumes a condensed, compact appearance coïned the Barr body (Barr
and Bertram, 1949).
Methylation of CpG islands of Xi-linked genes
During the course of Xi, the CpG islands of Xi-linked genes are generally hypermethylated (Wolf
and Migeon, 1982; Wolf et aI., 1984) (Keith et aI., 1986) (Bird, 1986), erisuing in transcriptional
silencing.
Asynchronous replication of the inactive X
With respect to its’ active counterpart, the inactive X chromosome (and residing genes) replicate
Il
Figure 3. Xist, Tsix and X inactivation. a) Xis! and Tsix expression in undifferentiated versus
differentiated ES ceils. b) Xist and Tsix expression in extraembryonic (pre-implantation) versus
embiyonic tissues (post-implantation).
a) ES Ceils
undifferentiated
Tsix upregutated
(Xist downregulated)
Xist upregulated
(Tsix downregulated)
b) Embryo
pre-imptantation
- preferential (imprinted) inactivation of Xp in
extraembiyonic tissues
Xist Xist
Tsix Isix
Tsix Xist
(preferentially (preferentially
maternai in paternal in
origin) origin)
differentiated post-implantation
future future
XaX
Xist (future Xi) Xist (fiture Xi)
- erasure of imprint
- random X inactivation
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Table U. Genetic/epigenetic and morphological characteristics acquired with inactivation of the X
chromosome.
Genetic nwdjficatians
- Xist gene upregulation
- Tsix gene downregulation
- General shutdown of most X-Iinked genes
Epigenetic nwd,ficatwns
- Xist mRNA coating
- hypermethylation of CpG islands
- asynchronous replication (usually late-repticating)
- hypoacetylation ofhistones 113 and 114
- hypermethylation ofhistone H3
- high concentration of core histone macroll2A 1.2
- enrichment for BRCA1 mRNA
- condensed chromatin structure, coined the Barr body
C
asynchronously (reviewed in (fleard et al., 1997)), namely in late S phase, (Boggs and Chinault,
1994), (Schmidt and Migeon, 1990). Genes that eseape X inactivation on the other hand, replïcate
in synchronicity with its’ active X homologue (Boggs and Chinault, 1994).
Covalent modifications of X chromosome associated histones
Histone acetylation
The transcriptionally active X is charactenzed by hyper-acetylation ofNTI2-terminal lysine residues
of histone H3 and 114 (Jeppesen and Tumer, 1993), (Gilbert and Sharp, 1999), (Boggs et aI., 1996),
while those associated with promoters of transcriptionally inactive genes of the inactive X
chromosome are essentially hypoacetylated.
Historie methylation
During X chromosome inactivation, methylation of lysine 9 of histone 113 (H3-K9 methylation)
occurs within or shortly afier Xist accumulation (fleard et al., 2001), (Mermoud et aI., 2002).
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Enrichment of histone variants
The inactive X is further characterized by a high concentration of the core histone macrofl2Al .2
(Costanzi and Pehrson, 1998). Localization of macrofl2Al .2 to the inactive X may be mediated by
interaction with Xist mRNA, possibly by formation ofa ribonucleoprotein compiex (Csankovszki et
al., 1999).
Ennchment of mRNA species
Recent studies have demonstrated that BRCAI mRNA associates (possibly essential) with )UST
mRNA in female somatic celis, mediating chromatin stability of the inactive X (Ganesan et al.,
2002). Thereof in absence of functional BRCA1 (either by germiine mutations, LOil or RNA
interference), i) the chromatin state of the inactive X was destabilized, ii) enrichment for
macrofl2Al .2 was suppressed and iii) particular X inactivated genes (a GfP transgene for example)
were partially upregulated, thus suggesting BRCAI plays a pivotai roie in mediating Xi. Thus, the
gender-speciflcity upon which BRCAI mutations transcend to ovarian and breast cancer may be
expÏained by genomic instability of the inactive X chromosome. Supportive evidence was derived
from various BRCAI4 tumors, of which demonstrated defects in chromatin structure and over
expression of several genes linked to the inactive X (Jazaeri et al., 2002). One hypothesis may be
that derepression of Xi leads to a dosage imbalance of genes required for normal
function!development of breast and ovaries.
2.4 Stability of X inactivation
Once Xi has been achieved, the chromatin state is clonally inherited (Davidson et ai., 1963) and the
inactive state believed stably maintained for duration ofthe cell lifespan (Migeon, 1972). However,
exceptions have been noted. i) The inactive X is reactivated as a normal part of oogenesis. ii) Albeit
at a low ftequency (1 0 to I 0), in vitro cuitivation has been associated with reactivation of varions
Xi-linked genes (Dyer et al., 1989) (Mohandas et al., 1981), (Graves, 1982). In addition, there ïs
convincing evidence in mice that particular Xi-linked genes are partially reactivated with advancing
age (Wareham et al., 1987) (Brown and Rastan, 198$).
3 REGULATORY ELEMENTS 0F THE XIC
To identify regulatoiy regions within the Xic, deletion and transgenetic analyses in and adjacent to
the Xis! gene and their consequential effects on cis-mediated Xi were investigated.
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Initiation etement
Targeted deletion of the 5’ region ofXist (7-Kb, including 30 bp of the promoter region) abolished
initiationlpropagation (Penny et aI., 1996), delïmiting initiation of Xi to thïs region (Lee et al.,
1 999a).
Counting elements
The counting process was delImited to a 37-Kb region lying 3’ to Xist, but genetically separable
from Tsix promoter and Xite. Moreover, as the aberrant X was also inactivated in differentiating XY
ceils, sex-specific factors in the Initiation of Xi are putatively excluded.
Choice elements
The choice process appears influenced by various elements within the Xic. i) The elusive Xce tocus,
reputably associated with nonrandom Xi patterns (Caftanach and Papworth, 19$1), has been
delimited to a rather large region 3’ to the Tsix locus (reviewed in section 7.3.2.1). ii) Targeted
deletion of the Xist antisense transcript, i.e., Tsix, induces constitutive Xist expression and
nonrandom Xi of the aberrant X (Lee and Lu, 1999). iii) The recently identified Xite gene
(downstream from Tsix) also mediates choice as targeted deletion of the gene downregulated Isix
activity in cis, resulting in Xist upregulation and preferential inactivation of the aberrant X (Ogawa
and Lee, 2003). iv) In humans, a rare base-pair mutation in the XIST promoter region lias been
associated with preferential inactivation of the mutant X (Plenge et al., 1997), suggesting
mutation/polymorphisms in the Xist gene may influence Xi pattems. A plausible mechanism may be
increased Xist transcription, thus increased probability of undergoing Xi. y) lnduced chemical
mutagenesis of the mouse genome identified two autosomal bd (yet to be clearly identified) which
when mutated altered X chromosome choice (Percec et aÏ., 2002).
3.1 Further characterization of the Tsix gene
The Tsix gene, so dubbed as it is franscribed antisense to Xist, encodes a 40-Kb transcript
originating some 2$ Kb downstream ofXist in both liuman and mouse (Lee et al., 1999b), (Sado et
al., 2001), (Migeon et al., 2001). Although originally deflned as having no conserved ORF, recent
studies suggest it is partially processed, giving rise to a 2,7 and 4,3 Kb franscript (Sado et al., 2001).
It is found exclusivety in the nucleus, but unlike Xist, remains bocalized to the Xic (Lee et aL,
1999b).
Rote of Tsix in regulation ofXist
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Because Tsix is i) transcribed antisense to Xist, ii) is concurrent with early Xist expression and iii)
Tsix upregulation from the future Xa is associated with Xist downregulation (Panning and Jaeniscli,
1996), (Lee et al., 1999b), a role in regulating Xist activity bas been speculated. Avallable evidence
suggests high Jevel Tsix expression represses Xist Jikely thougli a franscriptional mechanism (Lee
and Lu, 1999), however other mechanisms are plausible (sec (Avner and Heard, 2001) for review).
Once Xi is estabuished, Tsix expression from Xa ïs downregulated to undetectable levels.
Similar to the munne homologue, human T$IX is expressed exclusively in epiblast derived ceils.
However, it is truncatcd at its 3’ end, ending approximately at exon 5 of the XÎST gene, deriving a
transcript of approximately 35 Kb (Migeon et al., 2001). Moreover, human T$IX lach the 5’ CpG
is]and putatively required for murine Tsix imprinting fimction (Sado et al., 2001), suggesting TSJX
may flot function like its murine counterpart (Migeon et al., 2001).
4 IMPRINTED X INACTWATION
Genomic imprinting is a process whereby gene function is affected in a parental origin-specific
manner and is manifested as a difference in expression of parental alleles. The effects of genomic
imprinting arise from differential epÏgenetïc modification of parental alleles during gametogenesis,
followed by additional epigenetic processes that may occur afier fertilization (Latham, 1999).
Genomic imprinting may limit the effects of growth factors in the embryo andlor in extra
embiyonic tissues, in which there is differentiai parental investment (flaig, 1993). Strong epigenetic
effect of parental iniprinting on the X inactivation proeess has been observed in mouse and weaker
evidence has been found in human.
4.1 Preferential inactivation of the paternal X in extraembryonic tissues
li mice, unlike embryonic tissues that exhibit random Xi, the patemal X is preferentially inactivated
in the first ceils to differentiate, the physiologicai consequence of which is presently not clear,
eventually giving rise to tissues destined for extra-embiyonic development (Takagi and Sasaki,
1975), (West et aÏ., 1977), (Harper et al., 1982), with $7-$$% oftrophoblasts possibly showing Xp
inactivation (Takagi and Sasaki, 1975), (West et al., 1977). Resistance of Xm from undergoing
inactivation lias been ascribed to acquisition of an imprint during oogenesis (Lyon and Rastan,
1984), (Tada et ai., 2000). flic Xist gene is thought to play a vital role in the imprinted pathway
since female mice inheriting a patemai Xist deletion bear 2 active Xs and die early in
embryogenesis. Mice inheriting a maternai Xist deletion on the other hand, are normal and exhibit
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exclusive paternai Xi (Marahrens et al., 1997). In humans however, there is no evidence for
parental-specific preference of Xist expression (Daniels et al., 1997b) (Ray et al., 1997).
Interestïngly however, preferential inactivation of Xp in extra-embryonic tissues may flot be related
to imprinting at ail. Alternatively, relative to the active maternai X, the inactive X derived from
sperni may be more receptive to the inactivation signal (Monk and McLaren, 1981). Supporting
evidence was derived from elegant cloning experiments where the inactive X (maternai or paternal
in origin) of the donor-derived nucleus was preferentially inactivated in extra-embtyonic tissues of
the cioned embiyo (Eggan et aI., 2000), thus suggesting that the donor-derived inactive X, like in
sperm, is poised for early inactivation.
4.2 X-imprinting in humans
Unlike the mouse, evidence for preferential inactivation of Xp in extraembryonic tissues in humans
remains controversial. Although random Xi was observed in chorionic villi of eariy gestation
(Migeon and Do, 1979), (Migeon et al., 1985), (Mohandas et aL, 1989), (Bamforth et al., 1996),
preferentia! inactivation of Xp was observed by others (Harrison and Warburton, 1986), (ilarrison,
1989), (Goto et al., 1997) and partially supported by (Uehara et al., 2000). furthermore, whereas
trophoblasts from fuil-term placentas showed Jack of preferentiai inactivation of Xp (Looijenga et
al., 1999), Xp was preferentialiy inactivated in another study (Ropers et al., 197$). Discrepancies
may be explained by methodofogy used, tissue type andlor maternai ccli contamination.
5 ESCAPE FROM X INACTIVATION
An intriguing aspect of Xi is that certain genes escape inactivation, resulting in expression from
both X chromosomes. Approximately 30% of genes on the short arm of X and less than 5% of
genes on the long arm escape Xi, averaging over 10% of X-linked genes (Carrel et aI., 1999).
Relative to mice, humans are believed to have a larger number of genes that escape Xi (Disteche,
1999). These genes may be independent or clustered together, the latter found in or near the
pseudoautosomal region (PAR) (Lyon, 1962), (Miller and Willard, 199$), suggesting a
chromosomai domain model of regulation. It is unclear whether genes are initiaily inactivated and
then re-activated, or simply remain active. it was hypothesized that genes escape Xi to compensate
for functionai Y homologues in males. However, many genes that escape Xi do flot have an Y
homologue, suggesting dosage imbalance between the sexes. Interestingly, several genes display
variable escape from Xi, being expressed from the inactive X in some females but subject
to inactivation in others (Carre! and Willard, 1999), (Anderson and Brown, 1999). Escape
17
from Xi may be a significant factor for physiological and disease susceptibility differences
tE between the sexes (see (Brown and Robinson, 2000) for review).
6 CLINICAL APPLICATION 0F THE LYON’S HYPOTHESIS
Several methods have been developed to determine the clonai nature of a pathologicai tissue.
Originally these methods relied on specific gene defeets associated with particular cancers
(reviewed in (Gilliland et al., 199 la)). For example (I) immunoglobulin and T ceil receptor gene
rearrangements in iymphomas, (ii) cytogenetic and fluorescence in situ hybridization analysis of
genetic aberrations (transiocations, deletions, duplications and inversions) in acute myeloid
leukemia, chronic myeloid leukemia and myeloproliferative disorders, (iii) point mutations in
criticai genes such as proto-oncogenes and tumor suppressor genes in hematological and
gastrointestinal cancers, and (iv) viral integration in vfral-associated lymphomas. However, not ail
tumors exhibit particular tumor-specific markers or the specific abnormalities are flot known.
6.1 X inactivation-based clonality assays
Xi based clonaiity assays were developed on precepts of the Xi hypothesis (Linder and Gartier,
1965). These assays, winch do not rely on the presence of tumor-specific markers, have the
advantage of detecting clonai derivation of ceils in any informative female. The finding that a
pathological tissue is monoclonal is consistent with a neopiastic process (i.e., that a tumor bas arisen
from acquired somatic mutation(s) in a single progenitor celi (Nowell and Hungerford, 1960))
whereas normal and reactive celi populations (inflammatory tissues) are typically polyclonal in
origin. Application of these assays is central to many aspects of our understanding of the normal
biology of hematopoiesis as weil as the pathogenesis of hematologic malignancies ((Busque and
Gilliland, 199$) for review). For example, the stem ceil origin of differentiated hematopoietic
lineages (Gartler et al., 1969), the clonai origin of numerous hematological and non-hematological
maiignancies (Linder and Gartler, 1965), and the stem celi origin of various hematologic
malignancies. In addition, these assays can be utilized for detection status of female carriers of
various X-linked disease alleles (reviewed in (Puck and Willard, 199$)).
6.2 Principles ofX-inactivation based clonatity assays
Xi-based ctonality assays, reÏy on two basic prerequisites. The first is to differentiate parental origin
ofthe chromosomes: Xp from Xm. The second is to distinguish the active X (aX) from the inactive
1$
X (iX). A limitation to these assays is exclusion of male (XY) samples. Table III (page 1$) provides
(E a list of informative Xi-based assays.
6.2.1 Distinguish Xp from Xm
The ability to distinguish Xp from Xm is based on polymorphisms that exist in the general
population at different loci on the X chromosome (reviewed in (Busque and Gilliland, 199$)).
These DNA polymorphisms are typically of a single base-pair variation or variation in tength of a
simple repeat sequence (SRS). Both PCR and Southern-blot based techniques are utilized, but PCR
is more efficient and does not requ ire large quantities of DNA starting material (pico- to nanogram
quantitÏes acceptable). Expression-based assays have been developed, which may be transcript- or
protein-based. The informativeness of a polymorphism is directly related to the frequency and
number of alleles present in the population, which may vary among different ethnic groups.
6.2.2 Distinguish active X (aX) from inactive X (IX)
The iX chromosome, characterized by hypermethylation of CpG dinucleotides in promoter regions
and repression of gene activity, is amenable to both epigenetic and expression-based assays
respectively (see (Busque and Gilliland, 1998) and (Gale and Linch, 199$) for review). Absolute
( requwements of the epigenetic-based assay are ï) one allele be invariably metliylated and the
invariably unmethylated, and ii) DNA methylation patterns be stable with advancing age.
Expression-based assays rely on the principle that transcript/protein expression occur exclusively
from the active X chromosome. Moreover, expression-based assays have the advantage of
analyzing non-nucleated ceils such as platelets and RBC. A comprehensive list of informative (>
30% heterozygosity) X-linked clonality assays is provided in Table W (page 18).
6.3 Utility of Xi based clonality assays
To bu useful, a clonality assay should be highly informative and exhibit strict differential
methylation pattems. Although not a single X-linked clonality assay is informative in 100% of
females, the HUMARA assay was utilized for our analyses as it exhibits a high degree of
heterozygosity, results are reproducible, has been thoroughly validated, and is the most frequently
used assay to infer Xi status of normal and neoplastic specimens.
6.3.1 HUMARÀ assay
The HUMARA locus (DXS 1213; Xq li-12) consists of eight exons spanning more than 90 Kb of
DNA (Kuiper et al., 1989), (Steddens et al., 1992), (Lubahn et aL, 198$), (Chang et al., 198$). The
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first exon contains a highly polymorphic in-frame CAG trimeric repeat. In the general population, $
to 36 CAG repeat units have been observed, corresponding to a 2$ allele-spectrum (J)ersonal
observations). The alleles follow a Gaussian distribution which approaches a constitutional
heterozygosity value of 90%, as determined in several racial groups (Sleddens et al., 1992), (Allen
et aI., 1992), (Edwards et aI., 1992), (Busque et al., 1996), (Desmarais et al., 199$). Significant
repeat expansion (3$-66 repeats) lias been associated with spinal and bulbar muscular atrophy
(Kennedy disease), an X-linked motor neuron dïsease (La Spada et al., 1991). Proximal to the
repeats are four particular methylation sensitive restriction enzyme (RE) sites that meet obligate
methylation pafterns. The cytosine residues within these sites are sfrictly methylated on the iX but
unmethylated on the aX. Utilizing these key features, the PCR-based HUMARA clonality assay
was deveioped (Ai]en et aI., 1992). Since the polymorphism is in the coding region, an expression
based assay (mRNA) lias also been developed (Busque et al., 1994). figure 4 (page 22-23) depicts
the principles ofthe HUMARA clonality assay and sample resijits are shown.
Utitia’ ofthe HUMARA assay
Advantages of the HUMARA assay inciude PCR-based requiring littie DNA as starting material, a
high rate of heterozygosity, and preciselaccurate quantitation of alleles. Commonly used techniques
in the assessment of band intensities are visual evaluation, laser densitometry, and more recently,
fluorochrome and phosphor imaging technology. The technique has been validated by severai
investigators, establishing a reliabie and reproducibie assay to study the clonai origin of sample
specimens. In fact, it bas confirmed or refuted the monoclonal and/or clonai origin (consistent with
a neoplastic growth) of several diseases/disorders (see Table 1V, page 24-25, for a comprehensive
list). However, clonality does flot necessitate expansion of a mutant clone, since in certain instances,
large X inactivation patches, as observed on diffuse intimai thickening of coronaries, may mimic
clonalïty (Muny et al., 1997). furtlier, in presence of a large polyclonal background, the assay is
unable of detecting a clonai ceil population (Allen et aI., 1992), (Gilliland et ai., 1991b). Because of
the high heterozygosity rate, the HUMARA locus ïs frequently used as a genotype marker
applicable for forensic/paternity testing (Desmarais et al., 199$) and Iinkage analyses. Moreover, as
length of the repeat lias been correlated witli functional activity of the receptor, role of the AR gene
in prostate, breast cancer (Giguere et al., 2001) and a wide variety of otlier diseases and conditions
has been investigated (reviewed in (Yong et al., 2000)).
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Figure 4. HUMARA cionality assay (figures A - C).
A) Clonai ccli population. n this hypothetical example, the paternai X chromosome (bearing the
smaller HUMARA alleie) is inactive in ail ceils. The DNA is extracted and subjected to methylation
sensitive restriction enzyme digestion (i.e., Hpa If). As the paternal allele is methylated, it is
resistant to enzyme digestion, thus amenable to PCR amplification. Upon gel electrophoresis, a
single band is detected on autoradiographic film, reflecting amplification of the inactive allele,
signifying a monoclonal ccli population. A mock digest (without addition of Hpa II) is aiso
included, serving as an internai control (determines zygosity status and quantifies potential
preferential amplification of the smaller allele). In a non-pathological seffing, as in normal tissue
samples, such a pattern is referred to as a skewed or a nonrandom X inactivation pattern.
B) Polyclonal ccii population. A mixed population of ceils where Xp and Xm are equaily
inactivated. Afler DNA extraction and RE digestion with Hpa Ij, only the intactlmethylated aileles
are amenable to PCR amplification, in this case, both alleles. Upon gel electrophoresis, two bands
of similar intensity are detected on autoradiographic film, reflecting a polyclonat cdl population. In
a non-pathological setting, as in normal tissue sampies, such a pattera is referred to as a random X
inactivation pattera.
A) ClonaI ccli population B) Poiyclonal ccli population
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C) Sample HUMARA resuits of a clonai and polyclonat ccli population. Clonai ce!! population.
As two alleles are detected in the mock-digest lane, the sample is heterozygous thus informative for
clonality analysis. In the Hpa II digest lane, a single predominant band is observed, consistent with
clonai derivation (or a skewed X inactivation pattera if tissue was derived from a healthy female).
Polyclona! ce!! population. Two aileles are detected in the mock-digest lane, consistent with an
informative sample. In the Hpa II digest Jane, two aileles of approximate equal intensity are
detected, consistent with a polyclonai ceil population (known as a random X inactivation pattern if
tissue was derived from a healthy femaie).
Clonai ccli population Polyclonal ccli population
(skewed X inaclivation) (random X inactivaflon)
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6.4 flematological application of clonality assays
C
6.4.1 Clonai origin of hematologic malignancies
Several precepts 0f modem hematologic oncology rety on data obtairied by Xi-based ctonality
assays. The documentation of monoelonaÏ derivation of ceils in acute myeloid Jeukemia (Wiggans
et al., 197$), acute lymphocytic leukemia (Dow et aI., 1985), chronic myeloid leukemia (Fialkow et
al., 1967), myelodysplastic syndromes (MDS) (Raskind et al., 1984), myelofibrosis with myeloid
metaplasia (Kreipe et al., 1991), and in various other myeloproliferative disorders (MPDs) (Anger
et aL, 1990), (Fialkow et al., 19$ 1) has provided a monoclonallneoplastic origin for most
hematologic malignancies.
6.4.2 Stem ccli origin of hematologic malignancies
The demonstration of a skewed Xi pattemn in multiple hematopoietic lineages has invoked a
multipotent stem ccli origin for various MPDs (Adamson et aI., 1976), (Gaetam et al., 1982),
(Raskind et al., 1985), (Fialkow et al., 1981), (Jacobson et al., 197$). Other studies however have
cited heterogeneity in lineage involvement (Anger et al., 1990), (Asimakopoulos et al., 1996), (el
Kassar et aI., 1995), (Tsukamoto et al., 1994), (Gilliland et al., 1991b), (Janssen et aL., 1990). In
MUS subjcets furthermore, although some scientists have reported the involvement of T
lymphocytes in disease pathogenesis thus suggesting a pluripotent stem ccli involvement
(Tsukamoto et al., 1993), (Janssen et al., 1989), (Tefferi et al., 1990), others have excluded the
uniform involvement of T lymphocytes (Raskind et al., 1984), (Abrahamson et al., 1991),
(Lawrence et al., 1987), consistent with a more differentiated stem ceil origin. Disparity in fmdings
remains enigmatic.
6.4.3 Camer detection of X-linked disorders
As a consequence of random Xi, female carriers of X-linked mutant alleles are functional mosaics,
with one population of cel]s expressing the wild type allele and the other the mutant. Mthough the
wild type ceJis are generally sufficient to sparc females from the clinical defccts of recessive X
Iinked mutant alIdes, in the hematopoietic department, a unique capacity for cellular compensation
exists. For certain X-linked disease alleles, celis expressing the mutant allele fait to mature along a
specific developmental pathway, rendering lineage development to be derived from precursor ceils
expressing the wiid type allele. Examples include female carriers of various X-linked
immunodeficiencies such as X-linked severely combined immunodeficiency (X-SCID), X-linked
agammaglobulinemia (XLA), and Wîskott-Aldrich syndrome (WAS) (sec section 7.3.3 for further
analysis). As such, identification of a clonai (or skewed) Xi pattern in the pertinent ccli lineage(s)
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may be used as a diagnostic marker to identify female carriers of X-Iinked disease alleles (reviewed
in (Beimont, 1995)).
6.5 Limitation of X-inactivation based clonality assay
Aside from pathological conditions such as hematologic malignancies and female carriers’ of X
linked disease alleles, clonai origin of ceils has been observed at a phenomena]ly higli frequency in
the general female population. Clinically, it poses a potential limitation to Xi-based clonality assays
since it mimics clonai derivation of ceils but does not equate with malignancy. for fundamentai
purposes, recent efforts have aftempted to identify ami characterize (incidence, implicated celi
types, etiologies, biological associations and consequences) of this “ftequentlnon-pathological”
form ofcionaiity.
7 NONRANDOM X-INACTIVATION
7.1 Binomial distribution of X-inactivation ratios
Because of the random nature of Xi, the maternai or paternal X chromosome may be inactivated in
any given celI (Gartier and Riggs, 1983). In any given female tissue, the proportion of celis
inactivating Xp relative to Xm can be quantitated, deriving the X inactivation ratio (XIR). Upon
examination of a large number of healthy females, XWs tend to follow a binomial or beli-shaped
distribution (Fialkow, 1973), (GaIe et ai., 1991; GaIe et al., 1992; Gaie et ai., 1994) (Naumova et
al., 1996a) (Busque et al., 1996). )URs about the mean represent symmetrical or equal inactivation
of the materna] and paternal X chromosome, defined as a random Xi pattem. Extremes of the
distribution represent significant departure from equaiity of inactivation, which can occur in favor
of the maternai or patemal X chromosome, defmed as preferentiai Xi, skewed X inactivation or
nonrandom X inactivation (a clonai Xi pattem is used in a pathological setting). As skewed Xi was
observed in ‘healthy’ females, a benign/non-pathological origm was speculated.
7.2 Skewed X-inacfivatiou as a discrete trait
The threshold value commonly used to delineate a skewed Xi pattem was arbitrarily assigned to a
disproportion of 75%:25% (3:1) or greater between the number of celis that inactivate Xp versus
Xm, or vice-versa. The tenn skewed Xi simply denotes a bias in choice of parental X selected for
inactivation (no association with the preferentially active or inactive X is given, uniess otherwise
stated). This ratio is widely accepted in the literature to delineate clonai derivation of ceils (Gale et
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aI., 1991; GaIe et al., 1992), (GaIe et aI., 1994); (Vogelstein et al., 1987), (AIlen et al., 1994),
(Busque et al., 1996). Using this threshold criterion, samples can be arbitrarily categorized as
skewed or non-skewed. A more stringent criterion for a skewed Xi pattern, i.e., a ratio of l 0:1,
whïch corresponds to greater than 90% of celis inactivating the same X chromosome, bas also been
utllized (Gale et al., 1992), (Fey et al., 1994), (Busque et aI., 1996), (Plenge et aI., 1997). Using the
3:1 criterion, the incidence of skewed X inactivation in the general female population was found to
vary from 3.7 to 23% (fialkow, 1973), (Vogelstein et al., 1987), (Gale et al., 1991), (Gale et al.,
1992).
In the absence of methods to precisely quantify the Xi paffem (or )UR), the trait lias been
tmditionally limited to qualitative analyses, where the Xi pattern was dichotomized as skewed or
non-skewed. ilowever, with the advancement of reliable quantitative techniques, quantitative trait
analyses are amenable.
7.3 Etiologies of skewed X inactivation
The normal distribution of )URs observed in the general population implies a highly variable trait.
Two general and unrelated phenotypes of Xi have been reported. i) The primary Xi trait. Initiated
during early embryogenesis, it induces Xi in a developmental context, concurrent with tissue
differentiation. Anecdotal evidence suggests it induces a relatively similar Xi pattem among various
tissues within the individual (i.e., a body-wide Xi pattem). $kewed Xi as a resuit of the primary Xi
trait lias been aptly termed primary skewing (PS). $tochastic processes such as a small number of
stem celis present when Xi is initiated are believed responsible for this skewed Xi pattem.
However, more compatible with the developmental context of initiation of Xi are other etiologies.
for instance, genetic influences, such as heterozygosity for the X-Iïnked Xce locus, as observed in
certain strains of mice, can induce a similar phenotype. ii) The second phenotype, termed secondary
skewing, usually associated with a skewed Xi pattem in a celI lineage or tissue-specific manner,
occurs after the initiation of Xi. The most widely accepted etiology is presence of an X-linked
mutant allele. Examples include female carriers of various X-Iinked immunodeficiency disease
alleles. in particular, skewing is the resuit of a growth competition between X-linked wiid-type
versus mutant atieIe(s). However, another etiology includes clonai derivation of celis [see Table V
(page 30) and (Belmont, 1996) and (Migeon, 1998) for reviewj.
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Table V. Primay versus secondai-y etiologies of skewed Xi paffems. Primary skewing bas been
fundamentally associated with a biased event of X inactivation occurring during early
embryological development and associated multiple tissue skewing. n contiast, secondary skewing
ensues afler the initiation of X inactivation, is nonnally tissue-specific and may reflect clonai
derivation of cetis or reflect a growth competition between celis expressing genetic variants of an
X-linked gene.
Etiologies of Primary skewiug: embryological event
Stochastic (based on a - Small number of precursor ceils: unequal inactivation of parental
binomial probability of X X chromosomes
inactivation) - Twinning: reduced number of precursor ceils
- CPM: reduced number ofprecursor celis (trisomy rescue)
- Early X inactivation: reduced number of precursor celis
Genetic - Xce allele heterozygosity
- XJST, TSJX or possibly XJTE gene mutations
- Imprinting of extraembryonic tissues
- Timing of X mactivation gene, may influence number of ceil
______________________
present at initiation of X inactivation event
Etiologies ofsecondaiy skewing: occurs aller the initiation ofrandom X inactivation
Stochastic - clonai hematopoiesis (pre-neoplasia)
- clonai dominance secondary to stem ccli depletion
Genetic - growth advantage conferred by an X-linked aiieie (hemizygous
celi seiection). Examples inciude female carriers ofX-linked
disease alleles.
31
7.3.1 Etiology ofprimary skewing: Stochastic event
( As the choice of X selected for inactivation at the outset of Xi is speculated to be a random event,
the number of primordial celis present at such time will be a strong determinant of Xi ratios
(McLaren, 1972), (Fia&ow, 1973), (Luzzatto et al., 1979). As sucli, the variance in the distribution
of X[Rs will follow a binomial distribution where deviation from the mean is inversely proportional
to the number of celis present. It follows that if the number of cells is small, the probability of
unequal Xi is statistically large (for example, 3 7,5% if 4 cells are present). Likewise, if the number
of cells is large (e.g., n1 6), the probability of nonrandom Xi is small (4,90%). Therefore, by
assessing the incidence of skewing in the general female population, several studïes have deduced
the number of stem celis present at the onset of Xi. Assuming that i) Xi is random, ii) there is no
selection of X-linked alleles, and iii) that the variation XIRs is flot the consequence of early versus
late Xi, estimates for the progenitor ceil pool size, at least for the hematopoietic department, have
ranged from 4-20 cells (Gandini et al., 196$), (Fia&ow, 1973), (GaIe et al., 1991), (Puck et al.,
1992), (Prchal et al., 1996), (Gale et al., 1997), (Tonon et al., 199$). A progenÏtor pool size of
approximately n=1 6 cells has been deduced in felines (Abkowitz et al., 199$). Hypothetical
mechanisms that can possibly increase this variance, some of which may be genetically influenced,
are monozygous (MZ) twinning (Goodship et al., 1996), (Bamforth et al., 1996), confined placenta
mosaicism (CPM) (Lau et al., 1997), and earlïer X chromosome inactivation (lngerslev et al., 1 9$9).
A plausible mechanism may be a decrease in stem ceil precursor size, further increasing the
variance and probability of a skewed Xi pattem.
Originally, Xi was speculated to precede tissue differentiation (Nesbitt, 1971), (Nesbift and Gartier,
1971), implicating a common precursor celi pool from which ah tissues are derived, ensuing in
common XIRs among multiple tissues within the individual. That Xi patterns are relatively
consistent among various tissues within the individual, in both mice and human (vide infra: section
$.2) supports this model. However, more recent data suggests Xi occurs in a developmental context,
gradually proceeding in sub-populations and hineages (Monk and Harper, 1979), (Tan et al., 1993).
Consequently, according to this model, Xi pattems would be tissue-specific. However, that Xi
pafterns are body-wide argues in favor of alternative etiologies. For instance a genetic component to
acquisition ofthe primary Xi paffem.
7.3.2 Etiology of primary skewing: a hentable trait
Evidence for a genetic component to derivation of the primary Xi paftern is based on the following:
ï) the familial clustering of skewed Xi patterns in healthy familles (Luzzafto et al., 1979) (Naumova
et al., 1996b), and ii) the frequent concordance of a skewed Xi pattem in mother-daughter pairs
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(Harris et al., 1992), (Tihy et aI., 1994), (Rupert et al., 1995), (Azofeifa et aI., 1995), (Parolini et al.,
199$), (Orstavik et al., 1999) (and personal observations see Annex 1, page ii).
Genetic elements hitherto identïfied that may play a role in P$ reside within the Xic region. This
includes allelic variants of the Xce locus and genetic perturbations of the Xist/XIST gene. Imprinted
inactivation of Xp in extraembryonïc tissues bas been omitted from this section as it was previously
described (section 4.1).
7.3.2.1 Xce aÏlele heterozygosity: a skewedXipattern in multtpÏe tissues
In mice, the X chromosome-controlling element (Xce), which co-localizes to the Xic but a separate
genetic element from Xist (Simmier et aI., 1993), blases the choice of X chromosome selected for
inactivation (Cattanach and Isaacson, 1967; Cattanach and Perez, 1970). Although, the molecular
correlates responsible for Xce allelism have not been fully elucidated (Avner and Heard, 2001), Xce
allele strength bas been correlated with the methylation status of the DXPas34 Iocus (located 15 Kb
downstream of Xist). In fact, DXPas34 is hypermethylated on Xce alleles that are more Iikely to
remain active (Courtier et aI., 1995). However, methytation anatysis of this bous at different stages
of embiyogenesis has determined differential methylation to be a late event, making it an unlikely
candidate for Xce alletism (Prissette et al., 2001). More recently however, the Xite gene,
approximate]y 40-Kb downstream from Xist, was found to regulate Tsix activity in cis (Ogawa and
Lee, 2003). In fact, deletion ofXite downregulated Tsix activity, resulting in a skewed Xi pattem.
Further, as molecular / allelic variants ofXite were noted, a candidate element for Xce-allehsm was
speculated. Regardless, at least three Xce alletes (Xc?, Xceb, Xcec) and possibly a fourth (Xce’)
have been identified. Mice heterozygous for the bous are susceptible to skewing, the degree of
which dependent on the strength and combination of alleles (XIRs are essentially random in
homozygotes). The alleles are classified on a gradient of increasing tendency to remain active:
Xce”> Xc?> Xceb> Xce’ (Cattanach and Williams, 1972), (West and Chapman, 1978), (Johnston
and Cattanacli, 1981). For example, in the Xceal Xce heterozygote, the X chromosome bearing the
Xc? allele is more likely to remain activate versus the X bearing the Xcea allele, resulting in a
skewed Xi pattern. Albeit a Gaussian distribution about the mean (Plenge et al., 2000), thus
implying variability in phenotypic expression, the distortion induced by Xce aIIeIe skewing
normaUy resuits in an average skew of 20-30%. Xce allele strength was originally defined by
counting vibrissae number in mice heterozygous for the X-Iinked mutation Tabby (Cattanach et al.,
1969), but more recent assays have examined protein polymorphisms (West and Chapman, 197$),
gene expression profiles (Singer-Sam et al., 1992), (Buzin et al., 1994), (Penny et al., 1996),
(Plenge et aL, 2000) and DNA methylation pattems (Courtier et aL, 1995), (Avner et al., 199$).
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Cytological staining studies found that Xce X chromosome skewing resuits from a primary bias in
choice of X selected for inactivation rather then a consequence of secondaiy celi selection (Rastan,
1982b). The XIR induced by Xce allele skewing is relativety consistent among multiple tissues
(Johnston and Cattanach, 1981), (Nesbitt, 1971) (Krietsch et al., 1986), (Plenge et aI., 2000). In fact,
when six different tissues of 1$ mice were analyzed, there was ten times more variation between
animais then among tissues within any given mouse (Plenge et al., 2000). further, correlation
analyses of XIRs from two tissues in 74 Xce heterozygotes derived a correlation coefficient of 0,62.
These flndings suggest that the )UR, as a resuit ofXce ailele heterozygosity, is generally body-wide.
Consequently, due to the synteny between the mouse and human X chromosome and correlates of
X-linked loci implicated in the Xi process, we speculate an XCE-like locus may be operative in
humans, aithough none lias yet been clearly identified.
7.3.22 XIST/T$IX aberrations as u cause ofprimwy skewing
Mutations in and around the Xist/Tsix gene, as discussed in section 3 (choice element), have been
associated with a skewed Xi paffem in multiple tissues. 0f special interest, a more in-depth analysïs
of the Xist promoter mutation will be discussed here. In two unrelated families, female carrier’s
(n=9) of a XJST promoter mutation (C43G) were associated with preferential inactivation of the
mutated X in multiple tissues (Plenge et al., 1997). Paradoxically however, promoter construct
analysis found that the mutant promoter was consistently iess active versus the wild type promoter.
further, that the XJST mutation was detected in only one of 1166 aUdit ional X chromosomes
analyzed implies a rare mutation. In addition, the mutation was not detected in 32 DuchennelBecker
muscular dystrophy carriers nor in 34 normal control females exhibiting a skewed Xi pattem,
suggesting the mutation is not a common cause of skewing and/or the mutation by itself is
insufficient to induce skewing (Perefra and Zatz, 1999). Furthermore, that i) carriers of the mutation
exhibited variable skewing, ii) non-carrier famiiy members also exhibited a skewed Xi pattera, and
iii) that maies acquiring the mutation were healthy, suggests that the XI$T promoter mutation in of
itself is insufficient to induce skewing. If )UST polymorphisms are indeed implicated as a primary
cause ofskewing, they have yet to be identified.
7.3.3 Etiology of Secondaiy Skewing: selection against X-linked disease aIIeIe(s)
After random Xi is initiated, there is potential for natural selection pressures to influence the
balance of the two ceil populations (reviewed in (Belmont, 1995), (Belmont, 1996), (Puck and
Willard, 199$), (Migeon, 199$)). In the case of large X chromosome rearrangement, selection
favors the ‘)east disruptive’ gene-dosage event. Thus, cel)s bearing the normai X in the active state
are setectively eliminated (Disteche et al., 1981), (Russell and Cacheiro, 197$). Since negative
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selection occurs during embryogenesis, it is associated with multiple tissue skewing. In the event of
a deletion on the other hand, ceils with the deleted X in the active state are setectively eliminated.
Mutations in single genes have also been associated with a skewed Xi pattern, mostly in a
lineageltissue-specific manner, with ceils expressing the mutant allele failing to thrive along a
specific developmental pathway. Exampies ïnclude female carriers of X-linked immunodeficiency
alleles such as female carriers of the WA$P gene mutation whom exhibit a skewed )UP among
hematopoietic lineages (Prchal et al., 1980), (Fearon et al., 1988) but a random Xi pattern among
fibroblasts and oral epitheliai celis (Fearon et al., 198$), (Wengler et al., 1995); female carriers of
the X-linked agammaglobulinemia gene defect whom exhibit a skewed Xi pattem Iimited to B
lymphocyte (Conley et al., 1986); and carriers of the X-SCID gene mutation whom exhibit a skewed
Xi pattem limited to lymphocyte (Puck et al., 1987). Other diseases include female carriers of X
linked thrombocytopenia, whom have a skewed Xi pattern in lymphocytes (Saint-Basile et al.,
1991) and female carriers of the Lesch-Nyhan gene defect whom have a skewed Xi paffem in
erythroid celis (Nyhan et aI., 1970), (Albertini and DeMars, 1974). Less frequently however,
single-gene disorders may also resuit in a skewed XJP among multiple tissues, as seen in females
with X-linked Dyskeratosis Congenita. These subjects demonstrate a skewed Xi pattem in
peripheral blood and possibly in flbroblasts and buccal mucosa (Devriendt et al., 1997), (Vulliamy
et aI., 1997). Nonetheless, gross X chromosome aberrations and X-linked disease alleles are
relatively rare genetic events, therefore a negligibie cause for the high incidence of skewed Xi
patterns as observed in the general female population.
7.3.3.1 Suggestive evidence that secondary skewing may be incompletety penetrant
Selection against X-linked mutant alleles in female carriers of X-linked immunodeficiency
syndromes is usually greater than 95%. However, this may not be the case in “non
immunodeflciency” syndromes, as specutated by (Plenge et al., 1999). In a family originally
described for segregating a DDP gene mutation (Orstavik et al., 1996), of $ sibllngs, ail of whom
carried the mutation, 7 demonstrated a skewed Xi pattem. However, that one of the carriers
exhibited a random Xi pattem argues against secondaiy ccli selection as a cause of skewing.
Altematively, the authors speculated a primaly etiology of skewing. They hypothesize that the DPP
mutant allele was in linkage disequilibrium with an X chromosome skewing allele in 7/8 siblings. In
the non-skewed sibling however, a recombination event occurred between the two loci.
Altematively, (Plenge et al., 1999) argues in favor of a secondaiy etiology of skewing, wherein
selection against the mutant allele is not fiuiiy penetrant in some subjects. flowever, that the tissue
expression paftern of the DDP gene-product has not been ftilly evaluated, aside ftom high level
expression in fetal and aduit brain (Jin et al., 1996), selection against DDP mutant ailele as a cause
of secondary skewing in leukocytes warrants further investigation.
35
7.3.3.2 Nonhematopoietic tissues are generally robust to secondaiy skewing
Aithougli the hematopoietic department demonstrates a unique compensatory mechanism for
dealing with oeils expressing X-linked mutant alleles, anecdotal evidence suggests that
nonhematopoietic tissues (NHTs) are less subject to intrinsic factors of skewing such as X-Jinked
mutant allele(s). for example, females with Lesch-Nyhan syndrome, whom exhibit deficiency for
the X-linked enzyme hypoxanthine phosphoribosyl transferase (HPRT), exhibit normal NPRT
activity ïn both red blood ceils (RBC) and leukocytes but intermediate activity in skin specimens
(namely fibroblasts), suggesting that the mutant clone ïs selectively eliminated in the hematopoietic
department (i.e., negative selection occurring at the HSC level) but flot in skin (Nyhan et al., 1970).
In addition, selection in blood appears to be age-dependant, as the HPRT-deflcient clone was
detected at low leveis (5-10%) in young female heterozygotes (7-17 yo) (Aibertini and DeMars,
1974) but undetectable in aduit lymphocyte and erythrocyte lineages (McDonald and Kelley, 1972).
A similar foeding was made in mice: negative selection of the Hprt deficient clone was age
dependant and limited to the hematopoietic department as selection was not seen in N}ITs such as
skeletai muscle, kidney, liver, lung and brain (Anseli et aI., 1991), (Samuel et aI., 1993). further
findings were made in female carriers of class I glucose-6-phosphate dehydrogenase (G6PD)
mutations (Filosa et al., 1996), whom (n=4) demonstrated a skewed Xi pattera in several
hematopoietic lineages but a relativeiy random Xi pattem in NIITs (buccal mucosa oeils, urinary
tract ceils, and hait bulbs).
Lack of a secondaiy mechanism of skewing operatïng in NHTs may be explained by various
factors. i) NNTs, in contrast to hematopoietic lineages, may reflect lower metabolic/gene activity of
the X-Iinked gene of interest, therefore less proue to selection pressures. ii) Tissue-specific
differences (differentiated versus less differentiated) in timing of gene expression. for instance,
expression in NIITs may be occurring in more differentiated oeil types. As such, the stem ceil pool
would be unaffected, therefore a continuous source of mutant and wild-type celi types would be
provided.
Inasmuch as X-iinked mutant alleles are indeed capable of inducing skewed Xi in NIITs, they are
exceedingly rare in the population, therefore a negiigibie cause of NHT skewïng in the generai
female population.
7.4 Familial clustering of skewed Xi: Primary or secondary etiology?
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Familial clustering of skewed Xi was reported by several scientists (Ropers et al., 1977), (Orstavlk
et al., 1996), (Marcus et al., 1992), (Tihy et al., 1994), thus inferring a familial/genetic component.
Various examples are given beiow.
ï) In a famiiy segregating a paternally derived Fabry gene, (Ropers et al., 1977), leukocyte samples
from 4 siblings canying the mutation exhibited aipha-galactosidase activity 50% of normal (thus
speculative of a random Xi pattern). Mother four siblings aiso carrying the mutation cxhibited
enzyme activity levels 20% of normal (thus speculative of a skewed Xi pattem), suggesting 2
genetically heterogeneous subgroups. Since four heterozygotes had 50% of normal enzyme activity
and that the vast majorily of fabry heterozygotes have enzyme activity 30% of normal is
supportive evidence against negative selection as a general feature of Fabry carriers. further,
skewing as a resuit of a stochastic processes of Xi was argued against as this would service a
Gaussian distribution of enzyme activity among the siblings. Alternatively, that enzyme activity
was positively correlated in different tissues of the same individuai is consistent with a primary
etiology of Xi pattern derivation. Heterogeneity of enzyme activity among siblings (50% versus
20%) may be best explained by heterogeneity for a primary skewing gene (possibiy XCE-tike).
Accordingly, since the disease gene was paternaiiy derived and applying the ru les of Xce skewing,
pairing of the paternal X (assuming bearer of a sfrong XCE-iike aiieie) with a maternai X of weaker
XCE-like activity, preferential inactivation of the maternai X is speculated, resulting in low enzyme
activity, as seen among four siblings. On the other hand, if paired with a maternai ailele of equal
XCE-iike activity, a random Xi pattern is speculated, as seen with the remainiTlg siblings. 0f intcrest
however, that there was a high female-to-male ratio among the sibiings, one can speculate that the
mother may be transmitting a ‘more’ detrimentai X-llnked disease ailele (Migeon, 1993), causing
iethaiity in males and a skewed Xi pattem in favor of the ‘least’ disruptive allele in daughters (i.e.,
the patemal X).
ii) (Orstavik et al., 1996) studied the Xi pafterns of a famiiy segregating X-Iinked recessive dcafness
syndrome (Mohr-Tranebjaerg syndrome). Observed was a high incidence of skewed Xi in
ieukocytes of obligate female carriers. One however exhibited a random Xi pattem, a fmding
arguing against a secondaiy etiology of skewing. Alternativeiy, as described above, a primary
etiology of skewing was speculated.
iii) (Parolini et aL, 1998) identified a femaic carrier of a paternally derived denovo WASP gene
mutation whom had the majority of blood cells and oral epithelial ceils expressing the mutant atleie.
Normally however, ceils expressing a mutant WASP allele are selectively eliminated ftom
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circulation. As her mother aiso exhibited a skewed Xi paffem, with the maternai X preferentiaily
inactïvated in both mother and daughter, two etiologies of skewing were speculated: i) a pnmary
etiology of skewing genetically transmitted from mother to daughter or ii) selection against a ‘more’
detrimental X-iinked mutant allele (Migeon, 1993).
iv) Among a mothcr-daughter pair canying of a dystrophin gene deletion, the mother was
asymptotic while the daughter was affectcd with severe Becker muscular dystrophy (Tihy et al.,
1994). A probable cause for discordant phenotype was attributed to a discordant Xi pattern: mutant
X preferentially inactivated in the mother, while preferentiaily active in the daughter. Since the
DMD mutation is flot normally associated with negative ccli selection however, a primaiy etiology
of skewing was specuiated.
The clustering of skewed Xi paffems within these families and mother-daugbter pairs is sirong
evidence in favor of a familial/genetic component to derivation of Xi pattems. However, because
these familles also segregate X-iinked mutant alleles, the “true” cause of skewing (primaiy versus
secondary) was obscured (reviewed in (Migeon, 199$)). Therefore, to properly identify the formai
genetics and the putative bd that influence X chromosome choice, familles that do not segregate
X-Iinked mutant ailetes should be evaluated.
7.5 Randomty ascertained familles to identify the etiology of skewed Xi
In a preliminaiy study affempting to identify genetic control of X inactivation, Xi pattems of 36
randomiy ascertained families were analyzed (Naumova et ai., 1996a). One family demonstrated
significant aggregation of skewing, where ail 7 daugliters and the mother of the father exhibited a
skewed Xi pattem in lymphocyte samples. Preferential and consistent inactivation of the maternai X
among the daugbters argues against a nonnally distributed trait, but compliant with an X-Iinked
pattem of inheritance, plausibly transmitted from patemal grandmother to grandchildren. An XCE
Hke etiology of skewing was speculated. Smail famiiy size however limited genetic linkage studies.
Segregation analysis of FIUMARA and XIST alleles has excluded linkage to this region. Secondary
selection against a matemally derived X-linked mutant allele was excluded on basis of a random Xi
pattem in both mother and maternai grandmother. This study has provided pretiminary evidence in
favor of a genetic component to derivation of Xi patterns in humans.
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2 INCIDENCE 0F SKEWED Xi IN THE GENERAL FEMALE
POPULATION: variable
In the past 30 years, the incidence of skewed Xi in the human female population, as estimated by
different investigators, has been variable. for example, reanalysis of normal tissue samples
(granulocytes, skin, and muscle), as first descnbed by (Fialkow, 1973), but using a discrete criteria
of skewed Xi (>75:25), found 13% of samples to demonstrate a skewed Xi pattern. In a Jater study
(Vogelstein et aI., 1987), a lower incidence of skewing (3,7%) was reported for normal tissue
samples (colonic mucosa and lymphocytes). More recently, the prevalence of skewing in blood and
boue marrow samples ofhematologically normal females was figured at 22-23% (Gale et al., 1991)
(Gale et al., 1992). Similar fmdings have been reported in other studies (Brown and Browu, 1993),
(Barris et al., 1992), (Puck et al., 1992). The disparity in the reported incidence of skewing was
initially explained by the diversity of assays used, criteria used to delineate skewed Xi, and small
population sizes. However, a more plausible explanation came from studies that analyzed multiple
tissues from the same individual.
8.1 Righer incidence of skewed Xi in peripheral blood versus NIITs
C)
In contrast to Mils such as gastrointestinal mucosa and thyroid which demonstrated a Jow
incidence of skewed Xi (Fey et aI., 1992), an incidence of 33% was detected in blood leukocytes
(Fey et al., 1994). Similar findings were reported by (Gale et al., 1994), who observed a
significantly higher incidence of skewing in blood-derived ceils (40%) versus Ni-Ils such as skin
(20%), muscle (25%), and colon mucosa (12%). When tissues of different embiyonal origin were
analyzed (Azofeifa et al., 1996), a higher incidence of skewing was observed in leukocytes (70%)
versus NIITs such as muscle (20%), thyroid gland (30%) and suprarenal gland (40%). The tissue
specifïc incidence of skewing was thought to reflect differences in the timing of Xi (Tan et al.,
1993), together with tissue-specific differences in the number ofprogenitor celis present at the time
when Xi is initiated. The higher variance of skewing in blood implied a smaller progenitor pool
and/or earlier time of Xi.
8.2 Correlafion of XIRs among varlous tissues
A limited number of studies have investigated the correlation of XIRs among various tissues and
ceil types within an individual, which includes I) between the varions hematopoietic ceil lineages,
ii) behveen leukocytes and N}ITs, and iii) among varions N}ITs.
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8.2.1 Correlation ofXERs among blood ccli lineages: strong
Within the hematopoietic department, with the exception of red blood celis (RBC), )URs are well
correlated and relatively similar among the various hematopoietic lineages within the mdividual
(Table VI, page 40), with a correlation coefficient r ranging from 0,97 to 0,99 (GaIe et al., 1994),
similar to previous fmdings (Gandmi and Gartler, 1969). Strong correlation was an expected fmding
since these celis are derived from a common progenitor ccli (i.e., FISC). Correlation of RBC with
leukocytes was modestly weaker (r0,77 with granulocytes; r=0,66 with lymphocytes), possibly
refloeting the influence of extrinsic factors [dietary factors (e.g., won, fava beans) and akitudeJ on
polymorphic X-linked genetic determinants (G6PD for exampie) governing RBC kinetics.
8.2.2 Correlation of XIRs among MITs: moderate, evidencefor a body-wide XJR
Correlation ofXIRs among NIITs, with the exception of muscle-thyroid comparison (0,46<r<0,M),
reveaied a modest correlation coefficient (r), varying from 0,71 to 0,99 (sec Table VI, page 40).
With few exceptions, these findings suggest that within an individual, )URs are generally simïlar
ftom one tissue to the next (i.e., body-wide )UR), consistent with properties of the pnmary Xi
pattem. Similar findings were observed in mice (Nesbitt, 1971), (Johnston and Caftanach, 19$1),
(E (Krietsch et al., 1986), (Plenge et ai., 2000).
8.2.3 Correlation ofXIRs betweeu blood cdils and NUTs: tow
Among the various NIIT-blood cel] lineage comparisons, extreme variation in correlation was
observed: 0,19 <r <0,99. Weakest correlation was observed between thyroid tissue ami leukocytes
(0,1 9<r<0,24) and between skin and RBC (r=0,34) (fable VI, page 40). Lack of significant
correlation between RBCs ami a NHT (haw roots) was previously demonstrated (Gartier et al.,
1969), as weII as weak correlation between polymorphonuclear celis (PMN) and hair buIbs, r=0,3 I
(Tonon et aI., 1998). High variability in correlation may be explained by the higher incidence of
skewed Xi in PB (section 8.1).
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Table VI. Correlation of XIR of different tissues within the same individual
Note. Abbreviations: gran, granulocytes; mono, monocytes; lympho, lymphocytes; RBC, red blood
ceils; thyr, thyroid gland; supra, suprarenal gland; leuko, leukocytes
Comparison Investigator Summar
Gale (94) fialkow (73) Azofejfa (96)
gran - (mono/B oeils) gran - lympho 0.66 - 0.99
0,99 (n26) 0,97 (n20)
gran-Tcells gran-RBC
Blood - Blood 0,97 (n25) 0,77 (n42)
RBC - lympho
0,66 (n=20)
skin - muscle muscle-muscle 0,46 - 0,99
0,79 (n20) 0,8$
skin - colon muscie - thyr
0,71 (n=9) 0,46 - 0,64
muscle - colon muscle - supra
0,94 (n=9) 0,85 - 0,95
NHT-NNT thYf-thYr
0,89
thyr - supra
0,8$ - 0,99
supra - supra
0,94
skin-gran skin-gran muscie-leuko 0,19-0,99
0,74 (n20) 0,X8 (nl$) 0,6]- 0,73
muscle - gran muscle - gran thyr - leuko
0,63 (n20) 0,99 (n=5) 0,19 - 0,24
MIT - 310041 colon - gran skin - lympho supra - leuko
0,69 (n=9) 0,89 (n=i 1) 0,46-0,51
skin - RBC
0,34 (n=1$)
muscle - RBC
0,99 (n =5)
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Concordance ofXi patterns between bÏood and NHTs: evidence ofa body-wide Xi pattern
Skewing in a MUT was generally associated with a skewed Xi pattem in blood (i.e., 100%
concordance for muscle-granulocyte comparison) (Gale et al., 1994). A skewed Xi pattem in blood
on the other hand was Iess ofien associated with skewing in a NNTs (i.e., 45% concordance for
blood-muscle comparison). Similar results were observed with skin-blood and colon-blood
comparisons (Gale et al., 1994) and by other scientists (Fialkow, 1973), (Azofeifa et al., 1996),
(Buller et al., 1999). These findings suggest Xi patterns are generally body-wide, consistent with the
properties of the primary Xi pattem. The higher incidence of skewing may be unrelated to skewing
in NHTs.
8.3 Suggestive evidence for an XCE-Iike X chromosome skewing trait
Findings of a body-wide )URJXI pattern imply a common mechanism/etiology of Xi pattem
derivation among various tissues within an individual. Md although recent data suggests Xi
proceeds with different schedules in different tissues (Tan et al, 1993), strong correlation of XIRs
among multiple NIITs argues against a stochastic etiology of Xi paftern derivation as this would
foster tissue-specific )URs. A secondary etiology of skewing is also unlikely as X-linked mutant
alleles are exceedingly rare and do not generally induce skewing in NIITs (section 7.3.3.2). Rather,
j) that strong correlation of )URs among multiple tissues in mice corresponds to a primary etiology
of XTR derivation, i.e., Xce allellsm, and ii) due to synteny of Xi-related elements between human
and mouse (Xic, Xist, Tsix), we speculate that the Xi paffem of a human N}IT reflects zygosity for
an XCE-like locus. No conclusive evidence, albeit suggestive (Naumova et al., 199$), for a human
XCE-correlate lias been identified.
Identification of the genetic element(s) implicated in derivation of the primary Xi paffem may shed
light on the molecular elements implicated in the Xi pathway andlor the choice step of Xi. Further,
as PS resuits in preferentia] expression of a parental X chromosome (similar to imprinting), the
clinical consequences (fecundity, disease susceptibility) warrants investigation.
9 ANALYSIS 0F BLOOD Xi PATTERNS AS A FUNCTION 0F AGE
Unequivocal insight into the higher incidence of skewed Xi patterns in blood versus NUTs was
provided by the examination of )URs as a function of age. Preliminary data suggested a
significantly higher incidence of extremely skewed Xi pafterns in leukocytes of elderly females
(aged 75-96 years) versus healthy chiidren (aged 2-8 years) and younger females (aged 20-5$ years)
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(Fey et al., 1994). However, given the Jack of reliability and ambiguity in interpreting resuits based
on the M273 clonality assay (Fey et al., 1994), we conducted a similar study based on a larger
sample size utilizing a more reliable clonality assay, i.e., HtJMARA. This study comprised the core
of my Master’s research project entitled: Clonality Analysis of B]ood-Denved Ceils in Healthy
Females: Evidence for Age-Dependent Increase in Clonai Hematopoiesis. In total, 295 normai
females cross-sectioned into three different age groups were recruited. We found that the incidence
of skewed Xi increased significantly with advancing age: 8,6% in cord blood of neonates, 16,4% in
penpheral blood (PB) of 2$-32 year oids, and 37,9% in PB of females 60 years of age and oider
(Busque et al., 1996). The phenomenon (trait) was termed acquired skewing (AS) and represents
significant departure from random Xi in blood ceils with advancing age. Although the increased
incidence of skewing in the 2$-32 year old (yo) group was marked, it was flot significantly higher
versus neonates. The incidence of skewing in the elderly group (>60 yo) was significantly higher
versus neonates (p<O,000I) and the 2$-32 yo group (p=0,0064).
9.1 AS: confirmation studies
The increased incidence of skewed Xi with advancing age lias recently been confirmed. In one
study the incidence of skewed Xi in the polymorphonuclear (PMN) fraction of cord blood was 8.3%
(Tonon et al., 199$), whule in a second study 26% (GaIe et al., 1997). The discrepancy may be due
to the small sample size analyzed by Gale (n23) versus n=36 (Tonon et al., 199$) and n162
(Busque et al., 1996). In mïddle age females (17-50 yo), the incidence of skewed Xi in the PMN
fraction of PB was 16.7% in one study (Tonon et al., 199$) and 22% when total white blood
ceWneutrophul fractions were analyzed (Gale et al., 1997). Both are similar to the 16.4% Xi skewing
incidence reported by (Busque et al., 1996) for females aged 2$-32 yo. When eîderly females were
analyzed (75 yo and older), resuits have been relatively consistent, with the incidence of skewed Xi
ranging from 35-56% (Gale et al., 1997), (Tonon et al., 199$), (Christensen et al., 2000).
Remarkably, when centenarians were analyzed (Christensen et aI., 2000), 67% of samples
demonstrated a skewed Xi pattem.
That the incidence of skewed Xi reached 67% in centenarians (p<O,0l versus 73-93 yo), implies
that the AS trait gradually increases with advancing age. However, that the variation in XIRs in
sequential analyses, 24 months apart (fonon et al., 199$) or longer (Prchal et al., 1996), were not
significantly different, suggests that XIRs vary veiy slowly. In a further study, XJR analysis during
an 1 $-month period of three hematopoietic lineages (granulocytes, monocytes and T celis) derived
from healthy females of varying age groups (young, middle-aged and elderly) detected no
significant fluctuation of KIRs (van Dijk et al., 2002). These resuits argue against the hypothesis
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that AS reflects the stochastic contribution of a small number of emerging stem ceils from the
inactive IISC pool.
9.2 Clarifications in light of the AS phenomenon
In light of the AS trait, ambiguities raised in prior studies may be better clarified.
j) AS plausibly represents the major confounding variable for discrepancies in the incidence of
skewed Xi observed in the human female population (section 7.2), thus invoking age as an
important variable in skewed Xi studies.
ii) The large range in estimates of stem ceil precursor size (section 7.3.1) may be invariably
explained by the AS trait. In effect, estimate of primordial pool size should be mathematically
dependent on age: as the incidence of skewed Xi ïncreases with advancing age, size estimation of
the primordial pooi should decrease. As sucS, estimates shoiild be based on neonatal samples
(Tonon et al., 199$).
iii) $ince AS mimics clonai derivation of ceils, ambiguity in the stem ceil origin (undifferentiated
versus more differentiated) for various MPDs (section 6.4.2) may be best explained by the AS trait.
For instance, in absence of AS, a skewed Xi pattem may be limited to pathological lineage(s) only.
However, in the event of AS, a skewed Xi pattem may appear in additional lineages, thus implying
a more undifferentiated stem celi origin. Thus, age should be considered a confounding variable in
clonality studies.
iv) A smaller progenitor pool size ascribed to the hematopoietic department (HD) versus Nuls
(section 2.1) may 5e best explained by the AS trait Consequently, and confounding for age, the
precursor pool size for the HD may not differ signiflcantly from NHTs.
y) The low correlation of )URs observed between blood and NNTs (section $.2.3) may be
reasonably explained by AS trait. In the absence of AS, as in the case of young females, )URs
among various tissues should be similar. In the event of AS however, as in older females, XIR
correlation between blood and NIITs should 5e tower.
10 ETI0L0GY 0F SKEWED Xi IN C0RD BLOOD: primary skewing trait
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b speculate on the cause of skewed Xi paffems in cord blood samples, the following was
considered. Foremost, it is unlikely to reflect a secondary etiology of skewing since X-iinked
disease alleles are relatively rare. Moreover, it is unlikely to reflect AS since it is a late-onset trait.
Rather, that XIRs and Xi pattems are generally body-wide, a primary etiology of Xi pattern
derivation (XCE-like) was specuiated. Consequently, we hypothesîze that in neonates, )URs of
varïous tissues be well correlated, warranting tissue-correlation studies for confirmation.
11 PLAUSIBLE ETIOLOGIES 0F ACQUIRED SKEWING
Plausible etiologies of AS are discussed below, these include both stochastic (clonai derivation,
stem ceil depletion) and genetic (X-Iinked polymorphisms). AS is unl&ely to reflect selection
against X-linked disease alleles as these are relativeiy rare.
11.1 Stochastic event: clona! dominance secondary (o stem ceil deptetion
Various estimates on the number of HSC contributing to hematopoiesis have been made, the
majority suggesting that the hematopoietic department bas an enormous reserve potential, with FISC
depletion plausibly prevented by relatively few stem celis being used at anyone time, i.e., clonai
succession model (Kay H.E.M, 1965). That HSCs are generally quiescent supports this model. In
fact, in mice, approximately 5% of HSC are believed to confribute to the maintenance of
hematopoiesis at any one point in time, with 99% estimated to enter ceil cycle once every 57 days
(Cheshier et al., 1999). Aitematively, others theorize that the FISC pool may be smali but capable of
continuous seif-renewai. In effect, regulation ofthe stem ceil pool requfres further analysis and is of
major therapeutic importance if manipulation of FISCs is warranted.
Preliminary insight into FISC behavior was provided in female Safari cats undergoing bone marrow
transplantation with a iimited number of autologous marrow celis. As these cats were heterozygous
for the G6PD locus, Xi pattera analysis was possible. While untransplanted cats retained polyclonal
hematopoiesis, transplanted cats developed a skewed Xi pattem, demonstrating that small doses of
marrow celis can induce a skewed Xi pattera (Abkowitz et al., 1995) (Abkowitz et al., 199$).
Moreover, these studies were the basis for mathematical modeling showing that clonai dominance
can occur simply by chance when the number of hematopoietic stem ceils (FISC) is small
(Abkowitz et aI., 1996). Consequently, assuming IISC decisions are stochastic and implementing
predefined rates of FISC seif-renewal, differentiation and apoptosis, simulation studies predicted
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that small differences in FISC kinetics can generate the observed drifi in G6PD phenotype (Catlln et
al., 1997).
As a human correlate, stochastic depletion of FISC with advancing age and random differentiation
of the few residual HSC bas been a plausible mechanism of AS (Gale et ai., 1997). In support of
this view, by age 70, hematopoietic cellularity of the iliac crest in bone marrow is reduced to
approximately 30% relative to that of young aduits (Gilleece and Dexter, 1993). Similar fmdings
were recently obtained, but only in much older females ($0-90 years olU) (Ogawa et al., 2000). A
trend towards a decreased abso]ute number of hematopoietic progenitors andlor CD34+ stem celis
in PB and bone marrow of elderly people bas also been observed (Egusa et al., 199$), (Bagnara et
al., 2000), (Hfrota et al., 1988), (Nilsson-Ehle et al., 1995). However, the ability of elderiy mouse
marrow to support serial transplantation is the same as that of young mice (Harrison and Astie,
1982), and FISC from bone marrow of eiderly mice are five times more frequent than those from
young mice, albeit a reduced homing capacity (Morrison et al., 1996). furthermore, in human
recipients of allograft bone marrow transplantation, whom receive a relatively smail number of the
donor’s FISC, hematopoiesis is stable and polyclonal (Nash et al., 198$), (Turban et al., 1989),
(Saunders et ai., 1995), Çfonon et al., 199$), (Mathioudakis et al., 2000), suggesting that severe
FISC depletion, well above that which occurs in transplanted patients, is an unfounded cause of AS.
To uttimately mie out stem celi depletion as a putative cause of AS, the number of FISCs present in
skewed versus non-skewed females should be investigated. ilowever, since HSCs are infrequent
(<1 in 106 nucieated marrow cetis) and difficuit to isolate by physical or immunological methods
(Wang et al., 1997), analysis may prove difficult.
11.2 Stochastic event: clonai “pre-neoptasia” hematopoiesis
According to the multi-hit model of neoplasia, a number of random genetic hits are required for
neoplastic transformation. In theory, a limited number of genetic mutations (autosomai andlor X
linked) acquired by a FISC may provide the celi with a non-pathological but measurable growth
advantage, ailowing it to dominate over polyclonal hemopoiesis, thus resulting in a clonallskewed
Xi pattern. An argument in favor of this hypothesis is the increased incidence of hematological
malignancies with age, particulariy for diseases such as MDS and AML (Oscier, 1997), (Sandler,
1987). However, the rarity of hematologic malignancies, incidences of less than 0,01% for even the
most common, makes this explanation favorably unlikeiy. As indirect support, women with a
skewed Xi pattem have normai blood counts (Busque et al., 1996). Moreover, when a group of
women exhibiting AS were prospectively examined for several years, no evidence for increased
occurrence of hematoiogic malignancy was observed (Tonon et al., 199$). Although the frequency
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of clonai populations of lymphocytes in heahhy females increases with advancing age (Posnett et
aI., 1994), clonai populations of T and B lymphocytes did flot differ between elderiy skewed and
elderly non-skewed females (Annex 2, page xviii), ruling out lymphocyte clonaiity as a probable
cause of AS. Nonetheiess, to directly impiicate clonai hematopoiesis as a probable cause of AS, one
must identify genetic mutations/aberrations directly responsïble for pre-neoplastic growth.
11.3 Continuation of the PS trait
Although the AS trait is late-onset and that of P5 early-onset, thus implying distinct traits, that both
are potentially X-linked theoreticaily implies that they may be one and the same. Because PS
normally resuits in a maximal skewing of 20-30%, it is possible that AS represents a continuation
(or completion) of the PS trait. If frue, we postulate that direction of AS (in favor of Xp or Xm)
shouid occur in favor of the same parental X preferentially inactivated in the primary Xi trait.
Analysis of the direction of AS as a function of the primary X pattern should provide insight.
11.4 Genetic: X-tinked hemizygous cett setection
Since the hematopoietic system is mitotically active (producing 1011 celis on a daily basis), thus
particularly sensitive to genetic polymorphisms affecting ceil growth, we speculate that AS may
resuit from a relative growth competition between celis expressing genetic variants of an X-linked
gene.
12 X-LINIŒD KEMIZYGOUS CELL SELECTION ETIOLOGY 0F AS
12.1 AS in felines
Insight into the genetic basis of AS was provided by Xi analysis of aging female Safari cats - the fi
generation derived from crossing the domestic cat with the Geoffioy cat. Since the parental strains
have evolved independently for 12 million years, it is highly probable that the FI generation will be
heterozygous for several genetÏc loci. In particular, the female Safari cats were heterozygous for the
G6PD locus (with the G aliele derived from the Geoffroy cat and the d aliele from the domestic
cat), thus informative for Xi-based assays. In young cats (2-3 months), balanced hematopoiesis (i.e.,
random Xi) (equal number of ceils expressing the G and d allele) was observed. With advancing age
however, and in absence of any pathological consequence, there was an increasing percentage of
blood cefls expressing the G aiieie. By 4-6 years of age, 67% of cats exhibited skewed Xi ( 75%
expression of a parental-specific X chromosome), with the X derived from the Geoffroy cat
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preferentially active. A primaiy etioiogy of skewing was rejected as hematopoiesis was iriitially
polycionai Attemativeiy, a relative growth advantage conferred by an X-llnked ailele was
speculated (Abkowitz et al., 1998). These flndings argue against both the stem ccli depletion and
clonai “pre-neoplasia” etiologies of AS since skewed Xi would have occurred in favor of either
parental X chromosome when Fi felines were examined. An imprinted autosomal basis is atso
uniikely as an imprinted gene can be paircd with either parental X chromosome. An imprinted X
linked genetic basis however, could flot be ruled out as parental derivation of G6PD alleles (i.e., Xp
versus Xm) was not investigated.
12.1.1 Hematopoietic stem ccli ongm of AS
Since hematopoiesis can be partially defined as differentiation ofpluripotent stem celis into various
differentiated hematopoietic lineages (Tili and McCulioch, 1980), identiI’ing the hematopoietic
lineages impiicated in AS may provide insight into the ccli origin of AS.
The contribution of lymphocytes to the AS trait lias been contradictory. In our initial study (Busque
et al., 1996), as a majority offemales were extremely skewed (XIR1O:1), we spcculated that both
myeloid and Iymphoid lineages contributed to the AS trait, consistent with a FISC origin of AS.
However, when ccli lincages were analyzed independently, significantly more Xi skewing was
observed in granuiocytes (46%) versus T lymphocytes (19%) of elderly females (63-95 years),
suggesting AS differently affects the granulocyte and T lymphocyte lineage (p<O,Ol) (Champion et
al., 1997). Similar findings were reported by (Gale et al., 1997) wlio observed a skewed Xi
incidence of 56% in neutrophuls of elderly females (aged 75 years and otder) versus 40% in T
lymphocytes. When a more stringent criterion of skewed Xi was used (> 90% expression of one
allele), 33% of females exhibited a skewed Xi pallem in neutrophuls versus 9% in T lymphocytes.
lii a fiirther study, although the overail correlation of )URs between PMN and T ceils was
significant (r=0,66), correlation was sfronger in younger females (25-32) (r=0,77) versus older
females (>75 years) (r=0,57) (Tonon et ai., 199$). These fïndings suggest that relative to T
lymphocytes, granulocytesfPMN are more affected by AS. Lack of T ccli contribution may reflcct
Iongevity of lymphocytes (Gale et al., 1997). Altematively, it may reflect restriction of the AS
process to the granulocyte/myeloid lineage.
Preliminary insight into the plausible H$C origin of AS was derived by analysis of autologous BM
transplantation studies in female Safari cats (Abkowitz et al., 199$). When individual hematopoietic
lineages were analyzed, Xi skewing was detected in progenitor celis, RBC, and granulocytes. T
lymphocytes, demonstrated a lack of Xi skewing, postulated to reflect either Iongevity of T celis
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and/or restriction of the AS phenomenon to the myeloid lineage. For clarification, autologous
Q transplantations were performed. Among elderly cats establïshed as having AS, although samplesize was small (n=2), BM was harvested and reserved for autologous infusion. The cats
subsequently received myeloablative therapy and re-infused with the harvested BM. Upon Xi
analysis 3-20 months post-BMT, a skewed Xi pattern was detected in ail lineages analyzed:
progenitor ceils, granulocytes and T lymphocytes. The latter was consistent witb derivation from a
common precursor, an argument in favor of a FISC origin of AS. These resuits corroborate that T
celis are Iess likely to contribute to the AS trait due to their long circulatory-half lives. Anecdotal
evidence from a pilot study also demonstrated a FISC origin of skewing (Annex 3, page xxii).
12.2 X-linked genetic basis of the AS trait extended to humans
The findmg of an AS-like trait in felines bas been instrumental is assigning an X-linked genetic
basis to the AS trait in humans. Due to the resemblance of various Xi skewing features between
felines and humans (e.g., age-related penetrance ami exclusion of T lymphocytes), we speculate an
X-linked genetic basis to the AS trait in humans. We speculate that in female carrier’s of the X
Iinked AS allele (i.e., heterozygous for the AS gene), HSCs bearhig a strong AS allele (on the active
X) will out-compete FISCs bearing a weak AS allele (on the active X), manifesting as AS. In theory,
the X-linked gene can modify FISC kinetics such as replication, differentiation and/or apoptosis. A
model ofthe AS trait is presented in figure 5 (page 49). As observed, XTRs in neonates are initially
random (reflective of die primary Xi pattern). With advancing age however, FISC bearing the
stronger X-linked AS allele outgrow celis expressing the weaker allele, significantly dominating in
cell number by age 60 and older.
12.3 Twin studies support an X-Iinked genetic basis to AS in humans
12.3.1 Correlation ofXlRs in elderly MZ twin pairs
Since MZ twins are essentially genetically identical, a genetically influenced trait should be weII
correlated within the pair. As such, PB was collected from 71 MZ twin pairs aged 73 to 93 yo and
)URs determined. 35% of the subjects exhibited a skewed Xi pattem. Moreover, twiii pairs
demonstrated preferential inactivation of the same parental X chromosome (r0,57), evidence in
favor of an X-linked genetic component (Christensen et al., 2000). 1f stochastic or autosomal
etiologies were implicated, littie or no correlation in preferential inactivation of a particular parental
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Figure 5. X-iinked genetic hemizygous theory of AS. Diagrammatic representation of a typicai
bone marrow where hematopoiesis occurs. Biow-up of the circular object depicts HSC expressing
either the maternai or patemal X chromosome. YeIIow celis - Xp active, blue celis - Xm active. In
neonates, X inactivation is initiaiiy random. With advancing age however, dominance of one ceil
type occurs. By age 30 and 60 yo and older, FISCs expressing the “stronger” X-iinked AS aliele (Xp
in this example) significantly outnumber HSCs expressing the “weaker” AS aliele. For this
hypotheticai example, XIRs and Xi-skewing in favor ofthe patemal X were arbitrariiy assigned.
Neonates
0000
0000
0000
0000
0000
0000
0000
0000
XPa: 50%
Xma: 50 %
30 years old
0000
0000
0000
0000
0000
0000
0000
0000
Xpa: 621 %
Xma: 37.5 %
> 60 years old
0000
0000
0000
0000
0000
0000
:0Q0
0000
XPa: $7.5 %
Xma: 12.5 %
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X chromosome would have been observed. A limitation however, is that a proportion MZ twins
may share a common biood supply during intra-uterine growth, thus possibly inflating the
corretation coefficient.
12.3.2 Genetic contribution to the AS trait
Classical twin studies offer a dynamic model in which to quantify the contribution of genetic factors
to human trait variation. Correlation of phenotype is compared among MZ twins, whom are
essentially genetically identical, versus dizygous (DZ) twins whom on average share 50% of their
autosomal material and 75% of their X-linked genetic material. Environmental influences are not
considered since MZ and DZ twiu pairs hypotheticaliy share similar environments. Consequently, if
a trait is genetically influenced, correlation should be stronger among MZ versus DZ twin pairs. To
quantify the contribution of genetic factors in the etiology of AS, the )UR (measured as a function
of Xp inactivated relative to Xm) of 29 MZ and 1$ DZ twin pairs were studied (Viekers et al.,
2001). Mean ages of twins were 61 and 63 years, respectively. Among the MZ twin pairs, the
intraclass correlation of ailele ratios was 0,53 and 0,26 for granulocytes and T celis respectively.
Among the DZ twin pairs, the intraclass correlation of allele ratios was 0,19 and 0,36 for
granulocytes and T ceils respectively, deriving a lieritability score [h2 = 2(r - rDz)] of 0,6$ for
granulocytes and zero for T celis, supporting a modest genetic (X-Iinked) component to derivation
ofXIRs in granulocyte. However, resuits may be artifactual since a proportion ofMZ twins share a
common blood suppiy during intra-uterine growth, thus artifactually increasing correlation of )URs.
It is flot clear why T celi )UR correlation was stronger in DZ versus MZ twin pairs, but significant
variability in correlation coefficients due to smaller sample size is speculated. That genetic factor(s)
explain only 68% of the variance of )GRs in granuiocytes suggests additional factors may play a
role in derivation of blood )UR: clonai disorders, environmentai influences, stochastic events and
experimental error.
12.4 Intrinsic versus extrinsic factors in the etiology of AS
That environmental factors possibly influence XIRs lias been previously documented. In South
African females heterozygous for X-linked G6PD deficiency, found were random MRs in youths
(thus haif the ceils deficient for G6PD activity and the other haif full enzyme activity). Despite the
hematopathology associated with G6PD deficient ceils, they are relatively resistant to malaria
(probably owing to impaired entry and growth of the parasites during eiythropoiesis), therefore
selectively retained in circulation (Luzzatto et al., 1969). Afler puberty however, as females acquire
a stronger immune system, immune-related anti-malarial activity is upregulated, thus eliminating
malarial parasites from circulation. Consequently, in absence of the stimulus (malaria), celis
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expressing the G6PD (-) allele, whom are at a relative growth disadvantage versus G6PD (+) celis,
are effectively eliminated from circulation (Hitzeroth and Bender, 1981). The study suggests
women fully exploit polymorphie X-linked genes. for instance, in the presence of a particular
external influence(s), ceils bearing an X-linked allele whïch haphazardly provides it with a growth
disadvantage is counter-balanced by preferential destruction (by malarial parasites) of ceils bearing
the stronger allele. Altematively, in absence of the extrinsic factor, celi survival kinetics are based
solely on intrinsie factor(s): X-linked allele(s) which can provide the celi with a relative growth
advantage.
In a similar study, the G6PD phenotype was analyzed in a group of 77 Sardinian females
heterozygous for G6PD deficiency. It was found that the majority of females had an excess of
G6PD (+) celis in their blood (Rinaldi et al., 1976). High susceptibility of G6PD (-) RBCs to
hemolytic noxae was the most likeiy explanation. This was further supported by the presence of
mild noncompensated anemia in heterozygotes. However, as not ail females were skewed in favor
ofthe normal (+) allele, but rather some in favor ofthe deficient (-) alIele, it was speculated that in
some instances, the G6PD (-) allele may have a relative growth advantage. As mentioned above,
G6PD (-) ceils are retained/selected in young females with active malarial parasitemia. However,
other causative agents are possible.
Thus, the G6PD locus offers a dynamic model to illustrate the intricacies of the AS trait. It
introduces the mechanism by which both intrinsic and extrinsic factors influence preferential
dominance of X-Iinked alleles, thus implying a multifactorial trait where genetic, environment and
gene-environment interactions are plausible. Thus we predict that both intrinsic (X-linked
potymorphisms) and extrinsic factors may play a role in the etiology of AS. Possible
externallenvironmental factor(s) includes infectious diseases, the BM microenvironment, medicinal
products, allergens, pollutants, altitude, diet, and certain lifestyle factors (smoking habits,
psychological state, physical activity).
12.5 Molecular characteristics of the AS trait: Genetic modet
Assuming i) that AS occurs in females who are heterozygous for an AS gene, ii) that females
heterozygous for the AS gene are flot at a viable disadvantage and iii) that the AS gene is fully
penetrant, a two-al]ele model for the AS gene would predict a maximum incidence of skewed Xi of
50%. That 67% of centenarians demonstrated a skewed Xi pattern argues against such a model. This
implies 1) if limited to a single locus, there are more then two alleles; ii) genetic heterogeneity;
and/or iii) a polygenic trait (additive or multiplicative epistasis model).
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The X-linked genetic variation / polymorphism may consist of a single base-pair substitution or
may vary in length of a simple sequence repeat. It is however uniikely to be a gross genetic
alteration or a deleterlous X-linked mutation since these are I) relatively rare, ii) normaiiy manifest
as a clinical condition in female carriers and iii) lethai in males, inducing a high female-to-male
ratio distortion among offspring. The poiymorphism may reside within coding regions and/or
regulatory etements. The genetic variant may flot be limited to the DNA sequence as epigenetic
modffication(s) are also plausible.
Aside from clonai derivation, the AS trait does flot preclude the involvement of autosomal factors,
the limiting factor however, would have to be heterozygosity for an X-linked genetic polymorphism
as homozygosity would equally favor the parental X’s, resulting in a random Xi paftem. X-linked
genetic candidate elements include: a gene promoter region(s), transcription factor, enzyme, signal
transduction molecule, ceil surface receptor, celI membrane channe], and/or structural protein.
Linkage analysis of families segregating the trait is one method of identifying potential candidate
gene(s) (Naumova et al., 199$). However, a candidate gene approach is also feasib]e (Plenge et al.,
1997).
13 CLINICAL ASSOCIATIONS 0F SKEWED Xi
Although the vast majority of females with skewed Xi appear physiologically normal, various
pathophysiological associations have been cited. Whether the clinical association is a consequence
or a cause of skewing, or associated with a primaiy or secondary etiology of skewing is sometimes
discussed.
131 Skewing and expression of X-Iinked disease allele(s)
In the “unfortunate” event of a skewed Xi pattem in favor of the X bearing the mutant alleie
preferentially active, femafe carriers of recessive X-linked disease alleles can manifest X-Iinked
recessive traits (Tihy et al., 1994), (AraI et al., 1996), (Favier et al., 2000), (Orstavik et al., 1999),
(Azofeifa et al., 1995). As secondary skewing normally reflects negative selection of flic mutant
clone, these females are likely to reflect a primary etiology of Xi skewing, or selection against a
‘more’ detrimental X-linked disease allele (Migeon, 1993). Moreover, based on observation that
some obligate carriers of various X-Iinked hematologicai discase alleles exhibit late-onset disease
symptoms, a role for AS in decreasing expression is specuiated. This list includes X-linked
sideroblastic anemia (Cazzola et al., 2000), G6PD deflciency (Beutier et al., 1996), X-linked
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agammaglobulinemia (Aruffo et al., 1994), X-linked SCID ($mith and Notarangelo, 1997), and X
linked chronic granulomatous disease (Cazzola et al., 19$5), (Rosen-Wolff et al., 2001).
Surprïsingly, hematopoietic ceils with the X chromosome expressing the mutant allele were
preferentially selected over thefr wild type counter-part, suggesting j) that the AS gene is a stronger
determinant of Xi pattems over X-linked mutant alleles or ii) expression of the AS allele occurs in a
less differentiated FISC versus the an X-tinked mutant allele.
13.2 Skewing and RSA
Versus controls, a high frequency of skewed Xi was observed among females’ experiencing
recurrent spontaneous abortions (R$A). RSA lias been defined as 2-3 or more consecutive losses
under 20 weeks gestation, and estimated to affect 1-2% of couples wishing to bear chuidren
(Pegoraro et aI., 1997), (Sangha et al., 1999), (Lanasa et al., 1999). A plausible etiology is
transmission of a lethal X-Iinked allele inducing both skewed Xi in the female carrier (wild-type X
preferentially active) and the spontaneous abortion ofa male conceptus (Lanasa and Hogge, 2000).
13.3 Skewing and susceptibility to ovarian/breast cancer
(E Ktinefelter males (XXY genotype) comprise a unique set of individuals in which to analyze the role
of the extra X chromosome and its associated gene products in promoting or protecting disease
pathogenesis. M increased incidence of autoimmune diseases (rheumatoid arthritis and systemic
lupus erythematosus) and breast carcinoma were noted among Klinefelter subjects, suggestiiig that
a gene derived ftom the extra X chromosome (possibly escaping Xi) may increase dïsease
susceptibility (Bandmann et al., 1984). Moreover, versus controls, a higher incidence of skewed Xi
lias been observed in leukocytes of females experiencing invasive ovarian cancer and in ovarian
cancer patients carrying a germiine BRCAI mutation (Buller et al., 1999), however a cause and
effect relationship could not be determined. Moreover, because of the AS trait, lack of proper age
matched controls may have confounded resuks. Nonetheless, that BRCA1 associates with die
inactive X chromosome (Ganesan et al., 2002) supports a relationship between Xi and breast cancer
susceptibility. Moreover, ftequent loss of heterozygosity of the X chromosome in ovarian cancer
patients (Osborne and Leech, 1994) suggests that an unidentified tumor suppressor gene (TSG) may
reside on the X chromosome (Cheng et aI., 1996). The AR gene is a candidate locus since mutations
have been associated with male breast cancer (Lobaccaro et aL, 1993). Moreover, length of the
CAG polymorphism in exon I of the AR gene has been controversialty associated with female
breast cancer development. Although some studies associate aggressive fonns of breast cancer with
shorter CAG repeat lengths (Yu et aÏ., 2000), other studies, versus age-matched controls, found no
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association between CAG repeat length and early-onset breast cancer (Spurdie et al., 1999),
(Kristiansen et aI., 2002). However, among BRCAI mutation carriers, longer repeat Iengths were
associated with increased risk of developing early-age breast cancer (Rebbeck et al., 1999). In spite
of these conflicting resuits, the relationship between skewing (whether primary or secondary) and
ovarian/breast cancer susceptibility merits further investigation.
13.4 Skewing and predisposition to autoimmunity
Compared to males, females have enhanced immuno-reactivity, which although protects them from
many types of infections, has also been associated with increased susceptibility to autoimmune
disorders. For example, females demonstrate an increased prevalence of systemic lupus
erythematosus (SLE), multiple scierosis (MS), and rheumatoid arthritis (RA), suggesting disease
susceptibility alleles are sex-influenced, developmentally andlor hormonally regulated. Estrogens
for example, which possïbly elicit an immuno-stimulatory effect, have been associated with disease
exacerbation (Cooper et al., 199$). Mdrogens on the other hand, have been linked with a decrease
in autoimmune activity (Cutolo and Masi, 199$). Altematively, the XX genotype of females may
pose a disease risk factor. Since severa] genes escape Xi, dosage imba]ance for any one of these
genes may increase disease susceptibility. Similarly, a protective role for Y-linked genes in males,
SRY for example, is another possibility.
Moreover, an association between Xi pattems and autoimmunity was speculated. In one study, the
authors, in combination with their own data, conducted a survey of the literature and found that
female carriers of X-linked immunodeflciency diseases normally associated with random Xi, i.e.,
X-linked lymphoproliferative syndrome (XLP), X-linked Hyper-IgM (XLHM), and X-linked
granulomatous disease (XCGD), had clear features of autoimmunity versus immunodeficiency
diseases normally associated with skewed Xi patterns, i.e., agammaglobulinemia (XLA) and X
linked severe combined immunodeficiency (X-SCIE)). These results suggest that a skewed Xi
pattern protects females from an autoimmune-retated phenotype (Martin-Villa et al., 1999), possibly
owing to negative selection of the mutant allele. Altematively, theoretical data suggests that a
skewed Xi pattem may pose a risk factor for susceptibility to autoimmune disorders. As first
speculated by (Stewart, 199$), the Xi paffem of the thymus may constitute a risk factor for loss of T
cdl tolerance to seif-antigens. Theoretically, a skewed pattern of Xi in thymic tissue may lead to
inadequate elimination of potentially seif-reactive T celis. Consequently, in visceral tissues, antigen
expression from the X chromosome preferentially inactivated in the thymus (but preferentially
active in visceral tissue) may be recognized by T ceils as non-self possibly eliciting an autoimmune
response. Recently, the incidence of skewed Xi in leukocytes in a population of females with
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putative autoimmune disorders (MS, $LE, juvenile RA, and type I diabetes mellitus) was compared
with control females. A major role for skewed Xi in female predisposition to autoimmune disorders
however could not be supported nor disproved. One possibility may be lack of appropriate tissue
analysis, as thymus was unavailable (Chitnis et al., 2000). Nonetheless, the relationship between
skewing (whether primaiy or secondary) and autoimmune function merits further investigation.
13.5 Skewing and longevity
Since i) AS occurs in a vast majority of elderly females and ii) females live relatively longer than
males, an X-linked genetic basis to longevity was postulated (Christensen et al., 2000). AS
reflecting the selection ofX-linked ‘longevity alleIe(s)’ may be one possibility.
13.6 Iherapeutic applications
Since the AS gene plausibly modulates FISC kinetics (replication, differentiation, survival),
identification of the AS gene(s) may be of clinicaVtherapeutic relevance. For example, assuming
that the AS gene can be identified and manipulated, the following are theoretically possible: i)
stimulation of FISC to replicate, thus assisting horizontal DNA integration into normally quiescent
celis. ii) Stimulation of HSC to differentiate, thus inducing differentiation of hematopoietic
malignancies characterized by inhibition of differentiation. iii) Regulation of apoptosis, ideal for
inducing apoptosis in malignancies.
Consequently, identifying the AS gene may promote novel therapies in treating medical disorders
and provide a clearer understanding of the aging hematopoietic system.
14 HYPOTHESIS and GOALS
We hypothesize that Xi pattem analysis in humans is hampered by two unrelated events. One which
corresponds to the primary Xi trait, and the other to the AS trait. By proper tissue, age and clinical /
biological analyses, we speculate that both traits can be properly distinguished, quantitated and
etiologies determined.
Our goals therefore were to distinguish the two traits.
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1) Characterizafion ofthe two traits
(E • Detennine incidence of skewed Xi as a function of tissue type
• Analyze )URs as a function of age
• Analyze mtraindividual correlation ofXIRs between different tissues
• Analyze intraindividual correlation of XIRs among various hematopoietic lineages
2) Determine etiologies of skewed Xi patterns
• Determine heritability coefficient ofXIRs
• Analyze segregation ofthe skewed Xi trait
• Analyze familial aggregation of skewed Xi
• Determine role of environmental factors
3) Clinical relevance of Xi patterns
• Analyze association between XWs and family data
• Determine impact of AS on hematopoietic indexes
• Determine whether skewed Xi is associated with disease pathogenesis
(E 15 STRATEGIES, RATIONALE AND EXPERIMENTAL DESIGN
We speculate that prior attempts to map the XCE-Jike gene, although putatively mapped to two
regions of the X chromosome, one consistent with the )UC region (Naumova et al., 199$), was
primarily confounded by etiologic heterogeneity. for instance, since their sample population did flot
consist of neonates and choice of study tissue was lymphocytes, we speculate that their skewing
trait was confounded by both the P5 and AS traits. Moreover, since selection criterion was flot
based on ethnicity, thus increasing overali probability of genetic and environmental variability,
increased genetic variability is speculated. Thus, to circumvent these confounding variables,
prudent choices such as appropriate tissue controls, age and ethnicity were considered in our study
design.
Our approach therefore was to analyze skewed Xi in a population of females where i) the skewed Xi
trait would 5e relatively high. ii) Etiologic heterogeneity wou]d 5e relatively reduced. iii)
Appropriate tissue controls would be available. iv) Large family size would be available, permitting
trait segregation and potential genetic linkage analyses.
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15.1 Recruitment of elderly females
Since AS is a late-onset trait, analysis of elderly females was required. In addition, a family versus a
population-based approach was elected, thus permitting genetic linkage analysis in the event of
significant evidence of heritability.
15.2 Genefic analyses: sib-pair approach to dissect a complex genetic trait
Notwithstanding an X-linked genetic component of inheritance, on basis of variable expressivity,
impossibility of assigning Xi phenotype in males, age-dependant phenotype, tissue-specificity of
phenotype, plausible role of environmental factors and specuiation of genetic heterogeneity, a
complex genetic basis to skewed Xi was speculated. As specification of mode of inheritance ami
large multigeneration families are flot required, the most robust approach to dissect the genetics of a
complex trait would be by non-parametric sib-pair analysis. Parametricflarge pedigree analyses
would flot be ideal since it requires a specific genetic model and large muÏtigeneration families. In
addition, since the AS trait is late onset ( 60 yo), the likelihood of obtaining living parents is
markedly reduced, and chiidren moreover would not be informative for AS, thus limiting analyses
to a single generation.
15.3 Collection of familles
To reduce or eliminate ascertainment biases, families were ascertained without regard to trait status
and family history. However, relatively large families were selected as this would increase i) the
number of affectids for qualitative analyses ami ii) the number of informative meioses in which to
study genetic transmission of the skewïng trait. M arbifrarily assigned criterion for family sïze was
4 or more female siblings. Further, since AS is a late-onset trait, a criterion for study enrollment was
to have at least one female sibling 60 years of age or older. To be eligible for study enroliment,
subjects had to be relatively heaithy with no active cancer; and with the exception of self-reported
anemia, no active b]ood disorder. Upon recruitment of a subject, she was responsible for
recruitment ofher sisters.
15.3.1 Benefit of a relatively isolated population
Ideally, when conducting a genetic-epidemiologic and/or linkage study, minimal population
stratification, population admixture and environmental influences are warranted. As such, study of
an isolated population offers several key advantages [sec (Peltonen et al., 2000) for review] as
background noise is reduced thus increasing statistical power. for one, isolated populations are
5$
founded by a relatively small founder population, reducing overali genetic heterogeneity, thus
families in the sample should have a similar underlying genetic predisposition. By studying isolated
populations in which genetic variability is relatively reduced,, a complex paftern of inheritance can
be converted to one resembling a simple Mendelian trait (Jorde, 1995), thus improving the ability to
detect the effects of a particular gene. Due to linguistic and geographical considerations, french
Canadian families residing in the province of Québec, Canada, founded by a relatively smafl
population (estimated to range from 2500 to $500 individuats) between the years 1609 - 1759, has
been relatively isolated until the early I 900’s; thus providing a relatively homogeneous population
in which to study complex genetic traits. Noting that people in isolated populations typically share a
common environment and culture (diet, exercise, seasonal influences and exposure to infectious
diseases) reduced variability by non-genetic factors (phenocopies) to trait variance is speculated. In
addition, well maintained geneaiogical records, minimal ethnie outbreeding and relatively large
family sizes are ideal criteria for genetic-epidemiologic analyses. Due to the lifestyle during the
early I 900’s, e.g., Catholic upbringing thus the banning of contraception by the church, it was not
uncommon to find families with a large number ofchildren. In addition to being remotely available,
it was on basis of these criteria that familïes of French-Canadian origin were accrued for study
analysis.
15.4 Sample size Q. estimation): power studies
For complex diseases, power to detect linkage is dependant on the following factors: unit of
relationship, level of recombination between marker and trait, marker heterozygosity, mode of
inheritance, genetic heterogeneity and the relative risk (X value) (Risch, 1990). The X value, a
measure of familial aggregation possibly due to genetic effects, is generally obtained by comparing
the trait incidence in affected family members to that observed in the general population. For
common trait alleles, the preferred model to estimate X value is among sibs. However, since
ftequency of the skewing trait is both age and tissue dependent, thus prevalence of the trait in the
general population an inappropriate measure, a modification was made to calculation ofthe X value
as follows. The recurrence risk ratio (or Xr) of the skewed Xi phenotype was calculated by using a
bank of families (n9$) recruited on basis of other diseases, namely HLA typing and calcium stone
formation. Two-generation familles where at least one daughter and mother were both informative
for the HUMÀRA clonality assay (i.e., )UR available) were included in the analysis (n=53
families). )UR determination was performed on DNA extracted from PB. Briefly, one daugliter was
randomly selected from each family and dichotomized as skewed (case) or non-skewed (control).
The Xi pattern of the corresponding mother was then analyzed. 0f n 16 cases (skewed Xi pattem),
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62,5% (10/16) had mothers who atso demonstrated a skewed Xi pattera. On the other hand, of n37
controls (random Xi pattera); 37,8% (14/37) had a mother with a skewed Xi pattera, deriving a
value of 1,65. Although small, the value is above 1, supporting a familial / genetic component.
Since calculation of Â is influence by trait prevalence in the general population, a low value is flot
surprising for a common trait such as skewed Xi. Other diseases with a low Â value included
Alzheimer disease (Â 3,5). Nonetheless, assuming a trait ftequency of approximately 40% in a 60
yo population, and an average sib-ship size of 6, we estimate 2 affected sib pairs per family.
Following published tables, a Â of 1,6 requires 400 affected sib pairs to detect iinkage (bd score>
3,0) with 59% power. This translates to an accrual of approximately 1200 females (200 families).
15.5 Definition of the phenotype
An obstacle ftequently encountered in complex trait analyses is uncertainty of phenotype defmition.
For skewed Xi, most studies have traditionally quantitated significant departure from random Xi
(i.e., )UR 3:1) in P3. However, in light that both the P5 and AS traits influence Xi paffems in PB
(i.e., a combination of both the primary Xi pattera and AS trait), re-evaluation of methods to
quant itate the Xi pattern in P3 is warranted. Thus a mode I to quantify the AS trait in absence of the
primary Xi pattera (i.e., relative AS) was developed. Although there is as yet no “correct” model
from which to quantify relative AS, the utilization of T celis as a control tissue from which to
quantify AS has been previously examined (Vickers et al., 2001). However, since j) T cells clonally
expand in response to antigenic exposure, ii) clonai populations of T lymphocytes increase with
advancing age and iii) as there is no evidence which unequivocally precludes T ccli involvement in
the AS trait, it appears that T ceils are not an ideai control tissue from which to quantify AS.
Alternatively, to properly quantify relative AS, the primary )UR (derived from a NHT) should be
subtracted from the blood )UR, deriving a putative true AS value (relative AS).
Chapter II
MATERIALS AND METHODS
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2.1 Subjects
‘Healthy’ eiderly female subjects and ber ‘healthy’ female siblings were recruited through multiple
sources, including advertisements in senior cïtizen newsletters and through word of mouth. When
available, mothers (n=37) and ber female siblings were also recruited. Ail procedures were
undertaken with ethical approval from the Hopital Maisonneuve-Rosemont Etbics Committee (sec
Annex 5 for consent fonu) and with the subjects’ written informed consent. for confidentiaiity,
family pedigrees were diagrammed and each family and individual received an identifier code
number.
2.2 Medical Questionnaire
Each participant responded to a medical questionnafre (Annex 6) administered by trained hcaith
care professionals. Data was collected on age, smoking habits, family data, ami clinical data (self
reported medical conditions and medicinal use). Some of these variables were selected a priori and
others as a resuit of exploratoiy analyses. MI data was collected in two instaliments, by interview
on the day of biological sample collection and by phone interview approximately 6-12 months afier
sample collection. Information was collected about themselves, parents, siblings, and offspring. It is
not clear whether self-reported conditions were self-diagnosed or derived from a medical clinician.
2.2.1 Age
Age of participant was derived dfrectly by interview and verified by medical ID cards.
2.2.2 Smoking habits: environmental stimulus
The role of environmental factor(s) as a cause of Xi pattern skewing was investigated. Rationale for
selecting cigarette smoke as a possible stimulus is I) an affect on hematopoiesis bas been
documented, ii) smoking habits are quantifiable (discrete and continuous), and iii) cigarette smoke,
with many ofthe undesfrable effects attributed to nicotine, benzene and/or carbon monoxide, causes
hemato-toxicity (leading to an imba]ance in hematopoietic homeostasis), leukocytosis and altered
immunologicai function.
Discrete variables of smoking habits included current smoker and ex-smoker status. Current
smokers were defmed as those currently exposed to directlvoluntary cigarette consumption and ex
smokers as those who had ever regularly smoked cigarettes but have now quit. for the ex-smoker
variable, in our data sheets, a nuli-value was given if the subject was neyer a smoker, a zero value if
a current smoker, and a truc value (i.e., 1) if an ex-smoker. Current smoker was given a zero value
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figure 6. Distribution of family size, i.e, number of participant female siblings per family. N193
families, median sibling size offive, mean of 5,6.
Figure 7. Age distribution of female participants. Ages ranged from 38 to 96 years, with a mean of
63,3 years ± 10,0.
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Figure 8. Incidence of skewed X inactivation (DS score 0,25). The percentage of femaÏes skewed
for each ce!! type is indicated above the bar. for buccal cel!s, the incidence of skewing
speculatively corresponds to flic frequency of primary skewing (PS). The incidence of skewing in
blood hypothetically reflects the contribution from both the primary skewing and AS traits.
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Figure 9. Incidence of AS in hematopoietic lineages. A) Qualitative analyses (skewed in blood, flot
skewed in BC). B) Quantitative analyses (ASDS score 0,25).
a) Incidence of AS - qualitative analyses: ASQI
b) Incidence of AS - quantitative analyses: ASQT
40
35
Incidence of AS (BC not-skewed, blood skewed)
In
0
E
I
30
25
20
15
10
5
o
Granulocytes Monocytes T lymphocytes B lymphocytes
ccii type
Incidence of ASqt (ASds>O.25)
30 2TZ
;
____
Iil
H
Granulocytes Monocytes T lymphocytes B lymphocytes
hematopoietic lineage
4t
C
C
Fr
eq
ue
nc
y
Fr
eq
ue
nc
y
o
-
•1 3
-
ø j
C,, C
,,
4
,.
.
Fr
eq
ue
no
y
C,
)
Fr
eq
ue
nc
y
-
o z o D j
o C,,
3
•
0 o CD U)
z I
I
.
,11
C,
,1I
g
:
: p
3
1
CD r...
)
figure 11. Frequency distribution of ASDS scores (range: O to 0,75).
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Figure 12. Age-PAmat score scatter-plots. Resuits of LR method provided. a) BC, b) PMN, e)
monocytes, d) T celis, e) B celis.
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Figure 13. Age-DS score (skewing) scatter-plots. Resuits of GEE method provided. a) BC, b)
PMN, c) monocytes, d) T lymphocytes, e) B lymphocytes.
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figure 14. Age-ASpAm score scatter-plots. Resuits of LR method provided. a) PMN, b) monocytes,
e) T ceils, d) B celis.
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Figure 15. Age-ASD5 score (AS) scatter-ptots. Resuits ofGEE statistical method provided. a) PMN
b) monocytes c) T lymphocytes d) and B lymphocytes. Lower ASDS scores (stronger correlation) in
younger versus older females is consistent with AS representïng deviation from the primaly Xi
ratio.
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Figure 16. Primary XIR: intra-individual correlation of PAmat scores between BC and the varlous
hematopoietic lincages. Regression prediction une and 95% confidence intervals are shown. Sec
Table XII (page 105) for table format ofresuits.
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figure 17. B]ood skewing: intra-individual correlation of PAmat scores among hematopoietic
lineages. Regression prediction une and 95% confidence intervals are shown. See Table b) XII
(page 105) for table format of resuhs.
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Figure 18. AS: intra-individual correlation of scores among hematopoietic lineages.
Regression prediction une and 95% confidence intervals are shown. See Table XII e) (page 105) for
table format of resuits.
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Figure 19. Direction of AS relative to the primary )UR: suggestive evidence for distinct Xi skewing
traits. Method: The score was analyzed as a function ofthe primary )UR (BC PAmat score).
Scailer plots for each hematopoietic lineage are shown. The BC PAmat score ranged ftom O to 1, a
score of 1 defïning complete inactivation of the paternal X. In leukocytes, scores ranged
from —0,8 to 0,8, a score of +0,8 defining preferential inactivation of the patemal X. As shown, the
direction of AS in PMN and monocytes appears to occur random to the BC PAmat score,
suggesting the AS trait does flot reflect a continuation of the primary Xi trait. In T and B
lymphocytes however (particularly for T lymphocytes), direction of AS does not appear normatly
distributed. In fact, as seen in Table XIV (page 107), T celi AS relative to the BC XIR appears to
reflect selection ofcells bearing the alternate inactive X. Regression prediction unes are shown.
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Q Table VIII. Number of informative females (DNA amplified and heterozygous for the HUMARAclonality assay). For buccal ceils and granulocytes, ail DNA samples amplified, deriving a
heterozygosity rate of 90,8%.
Number ofsamples Number of informative samples (DNA
Cel] type ampllfied and heterozygous)
Buccal cells 1144 1039 (90,8%)
PMN (granulocytes) 1144 1039 (90,8%)
CDI4 (monocytes) 1144 1000 (87,4%)
CD3 (T lymphocytes) 1144 1026 (89,7%)
CD19 (B lymphocytes) 1144 1022 (89,3%)
Table IX. Incidence of skewing (D$ score 0,25) and AS (three methods given: estimated, ASQL,
ASQI). 0f the three methods used to measure the incidence of AS (see table below and text for
more details), the AS score may be a more accurate method as ii utilizes a more stringent criterion
of skewing.
Ceil type Skewed X Estimated incidence of ASQL QT
inactivation AS
-skewed m blood (ASs score
(DS score (incidence of blood -
. . . -not-skewed m BC 0 25)
> 0 25’ skewmg
- mcidence of
‘ BC skewing)
Buccal ceIl 12,4 % - - -
PMN 36,0 % 23,6 % 32,2 % 22,7 %
Monocyte 36,6 % 24,2 % 34,6 % 27,2 %
TcelIs 20,1% 7,7% 16,3% 11,4%
B cells 26,5 % 14,1 % 22,5 % 16,3 %
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Table X. Mean X inactivation ratios. a) Mean D$ scores and standard deviations. b) Mean ASDS
scores and standard deviations.
a) Mean DS scores
DS score Std. deviation
Cdl type n (mean) min max (+1-)
BC 1034 0,123 0,0000$6 0,5 0,094
PMN 1033 0,204 0,001001 0,5 0,129
Monocytes 995 0,207 0,000066 0,5 0,136
T lymphocytes 1016 0,153 0,000359 0,5 0,111
B lymphocytes 1012 0,174 0,001910 0,5 0,112
b) Mean ASDS scores
AS score
(mean) Std. deviation
Ccli type n min max (+1-)
PMN 874 0,159 0,000012 0,722287 0,125
Monocytes $40 0,173 0,000557 0,692075 0,133
T lymphocytes $5$ 0,127 0,000007 0,61$5$4 0,099
B lymphocytes 854 0,142 0,000146 0,692075 0,110
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Table XI. Skewing as a function of age. Resuits of LR, GEE and SOLAR statistical methods are
o provided (when available).
a) PAmat score
LR method GEE method SOLAR method
Cefl type p-value beta p-value beta p-value
BC 0,85 1 0,0001
PMN 0,556 0,0005
Monocytes 0,841 0,0002
T lymphocytes 0,171 - 0,0009
B lymphocytes 0,73$ - 0,0003
b) DS score (PS)
LR method GEE method SOLAR method
Ccli type p-value beta p-value beta p-value
DC 0,1752 - 0,0004 0,2069 - 0,0004 0,29
PMN <0,0001 0,001 $ 0,0004 0,0016 0,00009
Monocytes 0,0007 0,0015 0,0056 0,0013 0,005
T lymphocytes 0,1 224 0,0006 0,1341 0,0006 0,2$
B lymphocytes 0,0827 0,0007 0,3481 0,0004 0,23
c) score
LR method GEE method SOLAR method
Ccli type p-value beta p-value beta p-value
PMN 0,582 0,0004
Monocytes 0,782 0,0002
T lymphocytes 0,115 - 0,0009
B lymphocytes 0,596 - 0,0004
d) AS score (AS)
LR method GEE method SOLAR method
Ccli type p-value beta p-value beta p-value
PMN <0,000 1 0,0025 <0,0001 0,0024 9x10
Monocytes 0,0001 0,0019 0,0004 0,0019 0,0035
T lymphocytes 0,0095 0,0009 0,037$ 0,0009 0,13
B lymphocytes 0,0002 0,0015 0,0021 0,0013 0,14
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Table XII. Intra-individual correlation of X inactivation ratios, a-c.
a) Coi-relation between BC and blood ceils (PAmat score).
Coi-relation (PAmat) BC PMN Monocytes T cefis B cefis
BC
Pearson coi-relation 1,000 0,535 0,462 0,563 0,546
Sig. (2-tailed) <1017 <j-I7 <1017
N $96 $96 $63 $78 $76
b) Correlation among blood celis (PAmat score).
Correlation (PAmat) PMN Monocytes T cells B cdils
PMN
Pearson correlation 1,000 0,8$ 1 0,695 0,824
Sig. (2-tailed) <iOE <1OE17
N 896 863 $7$ 876
Monocytes
Pearson correlation 1,000 0,649 0,787
Sig. (2-tailed) <l0 <W’7
N 863 $51 849
Tcells
Pearson correlation 1,000 0,712
$1g. (2-taited) <iOE’
N $7$ $66
Bcells
Pearson correlation 1,000
Sig. (2-tailed)
N 876
c) Correlation among blood ceils (AS, score).
Correlation (PAmat) PMN Monocytes T ceNs B ceils
PMN
Pearson correlation 1,000 0,846 0,562 0,749
Sig. (2-tailed) <i0-’ <W’7 <W’7
N $87 860 $72 $71
Monocytes
Pearson correlation 1,000 0,550 0,728
Sig. (2-tailed) <10’ <iO’7
N 860 848 $47
Tcells
Pearson correlation 1,000 0,600
$1g. (2-tailed) <io-’7
N $72 $61
Bcells
Pearson coi-relation 1,000
Sig. (2-tailed)
N $71
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Table XIII. Evidence supporting a primaiy Xi skewing trait (PS). Methods: Females with a skewed
Xi pattern in BC were examined for Xi pattern analysis in hematopoietic tineages. We hypothesized
that in the event of a primaiy Xi skewing trait, BC skewing should be high]y concordant witli
leukocyte skewing (body-wide skewing). On the other hand, W Xi-skewing were tissue-specific, the
incidence of leukocyte skewing should be unrelated to BC skewing, thus expected to reflect the
incidence of skewing observed in our cohort population of females (column 3). As observed in
columu 4, concordance for a skewed Xi paffem between the two tissues vaned ftom 53,6 to 64,3%,
supporting both a body-wide and lineage-specific etioÏogy of skewed Xi paffems. Other etiologies
include the AS trait, clonai derivation of ceils, stochastic processes, methodologies used and/or
technical variability. Moreover, as direction of skewing (preferential inactivation of a parental
specific X chromosome) was highly concordant between the two tissues (94 to 98,6%, column 5)
suggesis a common mechanism in derivation of skewed Xi pafterns between the two tissues,
congruent with an X-linked etioiogy or derivation from a common stem ceil pool.
Celi type Expected incidence Expected incidence Observed incidence Concordance in
ofskewing in blood ofskewing in btood ofskewed Xi in direction of
if skewing were if skewing were blood when skewed skewing between
body-wide (%) tissue-specific (%) in BC (%) the two tissues
(%)
PMN 100 36,1 64,3 ($3/129) 94,0 (78/83)
Monocytes 100 37,3 53,6 (67/125) 94,0 (63/67)
T lymphocytes 100 20,2 47,2 (60/127) 98,3 (59/60)
B lymphocytes 100 26,8 56,7 (72/127) 98,6 (71/72)
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() Table XIV. Direction ofAS relative to the BC XII?. Method: The direction of AS relative to the BCPAmat score was anaiyzed for each hematopoietic lineage. Briefly, in informative subjects the BC
PAmat score was dichotomized as preferential inactivation of a paternal X (PAmat> 0,50) or
maternai X (PAmat < 0,50). Next, the PAmat score of b]ood as a function of BC PAmat was
analyzed. Direction of AS in blood was dichotomized as concordant with direction of skewmg in
BC or discordant with direction of skewing in BC. Resuits are provided in the table below. As
observed, direction of AS in both PMN and monocytes was random relative to the primary (BC) Xi
ratio, suggestive evidence that AS does flot represent completion of the primary Xi trait in BC
tissue. Ahernatively, in T and B lymphocytes, direction of AS was preferentially discordant with
direction of skewing in BC, i.e., skewing towards a rnndom Xi pattem was observed in B and
particuiarly T ceils.
Ceil type n Concordant in Discordant in Sigmficance
direction of skcwing direction of skewing (du-test)
PMN 906 451 455 0,$9
Monocytes 864 419 445 0,3$
T lymphocytes $79 365 514 <0,0001
B lymphocytes 877 404 473 0,02
oChapter IV
RESULTS (PART II)
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Since the AS and primary (body-wide) skewing traits were prevalent in a large proportion of our
French-Canadian female population (reviewed in Part I), a comprehensive investigation was
undertaken to identify clinical associations and etiologies. As explored in Section 13 of the
introduction, Xi skewing has been associated with several pathophysiological conditions
(expression of X-linked disease alleles, R$A, ovarian cancer, autoimmune disorders and plausibly
longevity). Other than the unfortunate preferential inactivation of the wild type X in female carriers
of X-linked mutant alleles as the cause of disease expression, whether Xi skewing is the cause or
consequence of phenotype expression and variability of the above mentioned medical conditions
and how it contributes to disease progression lias flot been clarified and well validated. Insight may
be provided by identifying the molecular elements implicated in the etiology of Xi skewing andlor
identifying the biomolecules I genes possibly altered as a consequence of Xi skewing. Altemative]y,
insight may also be gained through a prospective study where two groups of females: one
demonstrating skewed Xi patterns (cases) and the other random Xi patterns (controls), are examined
for clinical trait expression. We conjecture that if the clinical trait is a consequence of Xi skewing,
the case group should demonstrate a different incidence versus controls. Alternatively, to determine
whether skewing is the consequence of a medical condition a case-control prospective study where
females demonstrating early clinical disease symptoms and in the absence of a skewed Xi pattem
are recruited. Likewise, age-matched controls are aiso recruited. Analysis of Xi pattems as a
function of aging between the two groups would provide insight. Regardless, as no prospective
studies have been performed in this study, the maiority of analyses in this project have been 11m ited
to association studies.
Particular medical disordersfbiological variables selected for analysis include: blood counts, cancer
(ail-type), disorders with an autoimmune component, medicinal use and number and occurrence of
spontaneous abortions. An interesting facet to these disorders is whether 1) the finding can be
replicated in our populationlfamily based study and ii) whether the variable is associated with P5
andlor AS.
A first step to investigate the etiologies of Xi skewing (be they genetic, environmental andlor
stochastic) was to analyze familial resemblance of XlRs. This included both qualitative (familial
aggregation of skewing) and quantitative analyses (correlation of )URs within versus among
familles by ANOVA and maximum likelihood heritability estimates). The variance component
approacli of the SOLAR software allowed attribution of trait variance to both genetic and non
genetic factors. Non-genetic covariates taken into consideration were age and smoking habits.
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4.1 Characteristics of the sample population
L
Although demographic and skewing characteristics of our cohort population of females were
primarily described in Part 1, further characteristics are provided below; in particular,
hematopoietic, clinical, smoking and family/parity data.
4.1.1 Hematopoietic indices
Resuits of blood work and count differentials, as obtained for the majority of participants (97,5%),
are provided in Table XV (page 150). Whether these means are particular to French Canadian
females andlor to ail femaies of this age group was not thoroughly investigated. See (Tsang et al.,
199$) for review of hematopoietic indices as a function of age groups. The ftequency distributions
of blood counts are depicted in figure 20 and as shown, the majority of lineages demonstrated a
normal but slightly skewed distribution. The normal distribution of blood indices is likely due to
variabiiity liiduced by age, genetic and environmental influences. Whether the distribution departed
from Gaussian distribution (possibly tested by using the Shapïro-Wilk statistic and/or Kolmorogov
Smimov test for normal ity) was not investigated. The most extreme case was observed for
basophils. Artifactual basophil count by the celi-counter has been speculated as the primary
determinant.
Since outiiers can have a significant and drastic effect on statistical analyses, they were identified
and selectively removed for several of the statistical analyses. The criterion for removal was
arbifrarily based on extreme values. In some instances however, exclusion was also validated by
hematotogic standards. The criterion for exclusion were: counts 14,50 for WBC (n4), counts
11,00 for neutrophils (n4), counts 4,32 for lymphocytes (nl), counts 1,10 for monocytes
(n5), counts 0,60 for eosinophils (n$), a concentration 160 for hemoglobin (n =1), and counts
45 and 500 for platelets (n2). No significant outiiers were identified for MCV. Table XVI
(page 151) presents the number of cases removed ftom each particular hematopoietic lineage and
Figure 21 (page 14$-149) presents distribution of blood counts without extreme outliers, thus
depicting the distribution of a “healthier” population. As observed, distributions were less skewed.
Although femaies demonstrating extreme hematopoietic values are likely to represent chronic
andlor acute diseases, for instance increased leukocyte, WBC and eosinophil count has been
associated with increased mortality (de Labry et al., 1990) (Weiss et al., 1995) (Hospers et al.,
2000), on ethical grounds, no clinical follow-up was conducted.
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Possible factors contributing to variability of hematopoietic values includes inter-individual
variation (age, hormonal balance, genetic variation), intra-individual variation (diet, smoking habits,
medicinal use, altitude, exercise and clinical conditions) and possibly Iaboratory I technical error.
4.1.2 Clinical charactenstics
Ctinical data was self-reported as no clinical files were investigated for confirmation. Medical
conditions included asthma, RA, SLE, anemia and cancer history. Medicinal use included cancer
related therapy (radiotherapy and chemotherapy) and other medicinal types (n=9). A limitation to
the cancer analyses was the clustering of alt cancer types into one variable. Descriptive statistics for
clinical data is provided in Table XVII (page 152).
4.1.2.1 Prevalence ofclinicat traits versus reftrence populations:
Rheumatoid arthritis: Since i) RA has a population prevalence of 1% (occurs in ail ethnie
groups) (Lawrence et al., 1989), ii) is a common clinical problem in the elderly (although anyone
can get RA, the disease usually begins in middle adult years), and iii) demonstrates a high
female:male ratio distortion (approximateiy 3-to-l), the rate observed in this study (i.e., 6,1%) may
be an appropriate estimate. Moreover, a proportion of false-positives (55%) is speculated, lîkely to
reflect OA (Lynn et al., 1995).
Anemia: Although the diagnostic criterion for anemia in females is a hemoglobin concentration <
120 g/L (World Health Organization), anemia was self-reported in this study (plausibly determined
with the alU of a medical doctor). factors plausibly involved in the etiology of age-related anemia
are inflammation, chronic disease, blood Ioss and nutritional deficiencies (jwotein-energy
malnutrition: folie acid and vitamin B 12 deficiency — megaloblastic anemia). However, because of
increased iron stores with advancing age, iron-deficiency is an unlikely cause of anemia in the
elderly. Epidemiologic analyses have reported I) an annual incidence of 1-2% in the general
population, ii) a higher incidence in males versus females and iii) a significantly higher incidence in
older individuals: 4-6 fold higher in Caucasians >65 yo (Lipschitz, 1999). Thus, taking these factors
into consideration, the reported incidence in this study, i.e., 3,2%, is in agreement with
epidemiologic fmdings.
Asthma: In Canada, 10-15% of the population suffers from asthma, with the incidence on the rise
particularly in chiidren. The Iower incidence reported in our population therefore (7,8%), may
reflect selection of an elderly female study population whom may be Iess susceptible to asthma.
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The incidence of cancer (8,7%) and SLE (0,3%) was flot compared with reference populations.
4.1.3 Smoking characteristies
Discrete and quantitative variables of smoking habits are provided in Table XVIII (page 153).
Discrete variables included whether the subject was a non-smoker, current smoker or ex-smoker.
Quantitative measures of smoke included pack-years (pack/day x number of years smoked), years
smoke and years-stop smoking. Pack-years and years-smoke are the cumulative of both current and
ex-smokers. Whether smoking statistics for this population was consistent with reference
populations was flot investigated.
4.1.4 Family I parity data
Descriptive statistics for family I parity data are provided in Table XIX (page 154). Included were
variables such as number of participating families (n=193), number and sex of siblings, number of
participating mothers (n3 7), number and sex of offspring, sex ratio of offspring and the occurrence
/ number ofmiscarriages.
4.2 Confounding variables
Prior to analyzing the associations between skewing and the various biological variables (blood
counts, medical conditions, use of medicinal products, parity and smoking characteristics), it was
vital to identify potential confounding variables. The latter were investigated by several methods
that included linear or logistic regression analysis (LR) and multivariate linear regression
(Generalized Linear Model — GLM). Moreover, as the data was correlated, i.e., data was derived
from families, a more robust approach for regression analyses was to utilize the General Estimating
Equation (GEE method). A further approach, which also took familial correlation into
consideration, was the SOLAR statistical method, which tested various variables to determine
whether they accounted for a significant proportion of trait variance.
Once confounding variables were identifled, rather than selective]y removing these individuals from
statisticat analyses, the confounding variable(s) was (were) included as a covariate(s).
4.2.1 Age as a confoundmg variable
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Age-hematopoietic indices
As blood counts have been previously cited to vary with age (Keliy and Munan, 1977), (Jemigan et
al., 1980), (Zauber and Zauber, 1987), we elaborated whether blood counts varied signiflcantly in
our population of elderly females (mean age of 63.3). Hematopoietic outiiers as displayed in Table
XVI (page 151) were excluded from analyses and resu Its provided in Table XX (page 155). As
shown, age clearly predicted the blood counts of various hematopoietic lineages: monocytes,
eosinophils, hemoglobin concentration and MCV, as it was demonstrated by ail three statistical
methods. In particular, whule monocyte and eosinophil counts increased with age, hemoglobin and
MCV decreased. Whether the fluctuations are a normal consequence of the aging process or reflect
an underlying abnormality bas flot been determined. A possible association may also exist between
age and WBC, neutrophil and basophil count, as a significant p-value was demonstrated by the
SOLAR method and a statïstical trend by LR and GEE analyses. Lymphocyte and platelet count
demonstrated a statisticat trend by the LR and GEE methods but p-values were clearly insignificant
by the SOLAR method. The small influence of age on lymphocyte counts is consistent with
previous findings (Hait et al., 2000). Thus, since age predicted btood indices for various lineages, it
was included as a confounding variable in the blood-skewing analyses when appropriate.
Age-clinical data
Since medicinal use and the prevalence of various medical conditions are age-related, for instance
the prevalence of cancer increases significantly with each successive decade, the association
between age and clinical data was investigated. As shown in Table XXI (page 156), age predicted
(positive association) the occurrence of medical conditions such as aIl-type cancer (p=O,O37 LR)
and RA (p0,OO6 LR, pO,OO34 SOLAR), consistent with published data. Lack of an association
between age and anemia (p=O,1 5$) was consistent with published data: prevalence of anemia in
elderly females (>59 yo) was similar to that of women of childbearing age (Lipschïtz, 1999). Lack
of an association between age and asthma is consistent with a non-age-related form ofasthma.
Among medicinal use, age demonstrated an inverse relationship (-) with HRT (p<O,000I) but a
positive relationship (+) with use of med-heart (p<0,000Î), mcd anti-inflam (p<0,000I) and med
other (p<O,000I). Thus age was included as a confounding variable in the skewing-clinical data
analyses when appropriate.
Age-smoking habits
The relationship between age and smoking characteristics are provided in Table XXII (page 157).
for categoricat variables, while the number of current smokers significantly decreased with
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advancing age (p<O,000 1), the number of ex-smokers increased (p0,OO 1), suggesting that the
decrease of current smokers is due to the increased number of ex-smokers. Observation of an
inverse relationship (-) between age and the quantitative variables pack-years (p<O,0001 LR,
p=O,000I I SOLAR) and years-smoke (p=O,0003 LR) indicates that older females have been
exposed to less voluntary smoke (quantity and duration) versus younger females. Whether any
biases exist in the data, such as older females being less honest (or having a failed memory) on the
quantity and duration of cigarette smoking could flot be determined. A positive association (+)
between age and years-stop smoking (p<O,000 1, LR) is consistent with the increased number of ex
smokers with advancing age. Thus, age was mcluded as a confounding variable in the smoke
skewing analyses when appropriate.
Age-parity
The relationship between age and parity data (occurrence and number of miscarriages, offspring
sex-ratio and number of offspring) was investigated. As showu in Table XXIII a) (page 15$), age
signiflcantly (+) predicted two miscarriage variables: occurrence (p0,000l LR) and number of
miscarriages (p<0,0001 IR, p5x1OE7 SOLAR). However, adjusting for number of offspring
(muttivariate analyses — Table b) XXffl, page 158), significance was lost. This finding can be most
reasonably explained by the following: since eider females bore more children (p<O,000I) and
assuming that a greater number of pregnancies (offspring) translate into a greater number of
miscarriages, that older females had an increased prevalence of miscarriages was not surprising.
Offspring sex-ratio was atso significantly associated with age (pO,022), however, exciuding parity
data of mothers of subjects selected for study enroilment (n37), as they represent a selection bias
(i.e., familles with 4 or more female siblings were selected), the relationship was no longer
significant (p=O,l 97). Number of offspring significantly increased with advancing age (p<0,000 1),
as expected, reflective of the lifestyle of more elderly females. Thus, age was included as a
confounding variable in the skewing-parity analyses when appropnate.
4.2.2 Clinical data as a confounding variable
4.2.2J Clinical data-blood counts
In order to derive general andlor supportive information on clinical data, the association between
clinical data and blood counts was investigated (Table )OUV, page 159-160), thus providing insight
into the physiological basis of the clinical trait and possibly supportive evidence in favor of a
genuine medical trait. For instance, an association between asthma and eosmophilia is well
documented (Bousquet et al., 1990). However, since clinical data was self-reported, a proportion of
false positives may confound the findings. In addition, as each medicinal type (n=9) comprises a
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heterogeneous list of medications, associations cannot be directed to specific drugs. A similar
corollary can be made for medical conditions. That is, each medicinal condition is 1 ikely composed
of a heterogeneous group of diseases. For example, cancer is comprised of a heterogeneous group of
cancers, RA confounded by OA, and anemia possibly confounded by a non-specific fatigue
syndrome. Conditions that can mimic asthma include chronic obstructive pulmonary disease
(COPD), congestive heart failure, coronary obstruction due to various causes, vocal cord
dysfunction and esophageal spasrn. Nonetheless, controlling for age when necessary, various
associations were identified. Resuits provided in Table XXIV (page 159-160) are discussed be]ow.
Asthma / med-asthma: Since both asthma and med-asthma demonstrated a positive (+)
association with WBC, neutrophil and eosinophil count, evidence for a genuine asthma daim was
speculated. Flowever, upon multivariate analyses (controlling for asthma, med-asthma and age -
Table XXIV b) (page 159-160), WBC and neutrophil count were no longer associated with asthma
and med-asthma, suggesting a spurious fmding. The association between asthma and eosinophil
count however remained significant (p=O,023), in keeping with published data, consistent with a
genuine asthma daim. However, the association between med-asthma and eosinophil count was
lost, implying most of the variation was attributable to asthma.
C
Anemia: Although anemia was self-reported, that an inverse relatïonshïp (-) was observed between
anemia and both hemoglobin concentration (p=0,000l) and MCV (p=0,0O2), is consistent with a
hypochromic, microcytic form of anemia. Moreover, analysis of CBCs by the principal investigator
(L. Busque, MD, FRCPC, hematologist) validated an authentic form of anemia for the majority of
cases.
RA: Controlling for age, a positive association (+) was observed between RA and WBC (p0,O42)
and neutrophul count (p’0,O41). Whether this finding is consistent with the physiological basis of
RA, a resuit of the medicinal products used to treat RA or due to confounding variable(s) was flot
investigated.
Medicinal products: Several associations were observed between medicinal products and blood
counts. However, whether medicinal products had a direct effect on blood counts or was merely a
reflection of a clinical condition, which of itself influenced blood counts, could flot be determined.
Pharmacologie indications and/or prospective studies would be required. F indings are as follows: i)
an inverse relationship (-) was observed between chemotherapy intervention and lymphocyte count
(p0,046) and ii) between med-other and hemoglobin concentration (pO,O26). However, since the
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findings were limited to a single hematopoietic lineage and the p-values were barely significant, a
(E spurlous fmding is speeulated. A highly signiflcantlpositive (+) association was observed between
iii) med-anti-inllam use and eosinophil count (pO,OO4) and iv) med-anti-convulsants and MCV
(pO,OO6). flowever, whether these flndings are consistent with published data andlor due to
confounding variables was not investigated. y) The use of HRT, med-heart and med-hemato were
associated with the blood counts of several hematopoietic lineages, with highly sigiiiflcant p-values
in certain instances, thus suggestive of ai authentic fmding. Whether the finding is consistent with
published data and whether these medicinal products have a direct/primaiy effect on blood counts
(therefore blood count the responsive variable) was flot investigated. Nonetheless, medical
conditions and medicinal use were included as a confounding variable in the blood counts —
skewing analyses when appropriate.
4.2.2.2 Clinicat data —parity data analysis
The relationship between clinical and family data was investigated. A limitation to the analyses
however, as mean female age was 63,3, current medicinal use I medical condition may flot be
reflective of the clinical situation at the time of offspring deliverylmiscarriage. Nonetheless, it may
reveal consequences associated with family choices such as bearing a low versus high number of
children.
As shown in Table XXV (page 161), controlling for age, a positive relationship (+) was found
between use of med-heart and the number of offspring (p=O,004), the occurrence of a miscarriage
(pO,OlO) and a statistical trend with the number of miscarriages (p’’O,O55). Tiowever, when
controlling for number of chiidren, the association with miscarriage data was lost, implying only
increased parturition as a plausible cause of med-heart use.
Both asthma fa statistical frend with occurrence of a miscarriage (p”O,06O) and number of
miscarriages (p=O, 102)] and med-asthma (pO,O4$ with number of miscarriages), demonstrated a
positive (+) association with miscarriage data unconfounded by number of children, implying a
plausible association between miscarriage and asthma, possibly consistent with an
immunelautoimmune component common to both conditions.
RA was associated (+) with number of chiidren (pO,O42), number of miscarriages (pO,O3l) and a
statistical trend with occurrence of a miscarriage (pO,l 56). However, controlling for number of
chiidren, the association with miscarriage data was ]ost, implying that increased parturition may be
the only family variable associated with increased occurrence of RA. Assuming that med-anti
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inflam is used by females with RA, the latter fmding ïs compounded by a positive association
between med-anti-inflam and number ofchildren (p=O,017).
The relationship between use of HRT and offspring sex-ratio distortion (pO,043) is Iikely to be
spurious andlor biologically incomprehensible as females on HRT are typically menopausal,
therefore beyond the child-bearing age.
4.2.3 Smoke as a confounding variable
To determine whether cigarette smoke was a significant confounding variable, the relationship of
smoking habits with i) clinical data, ii) blood counts and iii) parity was investigated.
4.2.3.1 Smoke-cÏinical data
Since smokmg bas been î) associated with various medical conditions, for example, a potential risk
factor for RA (Flutchinson et al., 2001), MD$ (Bjork et al., 2000) and atherosclerosis (Blann et al.,
199$) and ii) demonstrates a suppressive effect on human immunity (Moszczynski et al., 2001), the
association between smoking habits and clinical data was investigated. Resuits are given in Table
XXVI (page 162). As discussed below, significance of the resu Its is dependent on several
assumptions and the medical condition in question. Age was included as a covariate when
necessary.
HRT: A significant inverse relationship (-) was observed between current smoker status and the use
of HRT (p=O,O34). ilowever, as the association was flot detected with other variables of smoke, a
spurious finding is speculated.
Med-asthma / asthma: Pack-years of cigarette smoke and years-smoked were both associated (+)
with use of med-asthma (p<O,000I and p=O,OO2 respectively). In addition, pack-years was also
associated (+) with asthma (p=O,0O2 GLM, p0,OO$7 SOLAR). In ail instances, the relationship
was positively correlated, consistent with published data citing exposure to cigarette smoke with
increased severity of symptoms (Landau, 2001). Moreover, assuming smoke is a risk-factor for
asthma, that ex-smoker and years-stop smoking were not associated with a decrease in med
asthmalasthma implies that onset of asthma is flot reversed by smoke-cessation. However, this
finding may be population-dependent and lirnited to our elderly population offemales. Furthermore,
that discrete variables of smoke (current and ex-smoker) were not associated with asthma suggests
that smoking in of itself may not be sufficient to induce asthma. That is, the quantity (intensity and
duration) ofsmoke may be a more important risk-factor. Altematively, discrete variables of smoke
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may be limited by smaller sample size (nl $9 for current smoker versus n=1 128 for pack-years),
thus statistically less powerful versus quantitative variables.
Med-other: Use of med-other was signiflcantly related (+) with pack-years (p=O,OO3) and number
ofyears-smoked (pO,OOO2). However, whether use of med-other is due to smoking or vice-versa is
not known.
Med-heart: Controlliiig for age, use of med-heart was associated (+) with pack-years (pO,Ol$) and
years-smoked (p’O,OO3), suggesting that large quantities of andlor many years of cigarette smoking
may result in heart complications necessitating medical attention. Smoking has been previously
associated with heart disease (Blann et al., 199$), consistent with a causal relationship. Curiously
however, discrete smoking variables, current smoker in particular, was not associated with use of
med-heart (p=O,$9l). This may be most reasonably explained by: i) smaller sample size (n1$9 for
current smokers versus n=1 12$ for pack-years), suggesting discrete variables of smoke are
statistically less powerful versus quantitative variables; ii) current smoking, for reasons that some
may be light smokers, is insufficient by itself to induce use of med-heart. Moreover, the resuits
suggest that once use of med-heart bas been initiated, the number of years-stop smoking is flot
statisticatty sufficient to reverse the use of med-heart (p=O,l 63).
Anemia: The flndings suggest that current smoking may be a risk-factor (+) for anemia (p0,065)
while quitting smoke (ex-smoker) a protective mechanism (-) (pO,O2O). That the findmgs are
complementary adds an element of authenticity to the fmding. That the association was flot
observed with the quantitative variables pack-years and years-smoke may most reasonably be
explained by confounding variables. That is, since these variables are the cumulative of both current
and ex-smokers, their individual effects may be plausibly neutrallzed. Therefore, reanalysis with the
variables pack-years and years-smoke but dichotomized into current and ex-smoker is warranted.
Altematively, the finding could be spurious or confounded by covariates. Paradoxically, smoking is
reported to increase hematocrit (Rampling, 1999) and hemoglobin concentration [(Kondo et al.,
1993) and present study included — see Table XXVII, page 163], thus plausibly confounding the
relationship between smoking and anemia.
RA: Results of the SOLAR statistical method, although those of the GLM were not significant,
suggest a significant relationship between RA and current-smoker status (pO,O34) and pack-years
of smoke (pO,O39). The former is consistent with data in the literature citing men who are current
smokers had an increased risk of developing seropositive RA (Uhhig et al., 1999) while the latter is
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consistent with the cumulative exposure of cigarette smoke as a risk-factor for RA (Hutchinson et
al., 2001).
4.2.3.2 Smoke-bÏood counts
Since cigarette smoke influences blood counts ((Corre et al., 1971), (Grimm, Jr. et al., 1985),
(Schwartz and Weiss, 1994), (Tsang et al., 199$)) and associated with B-cell lympliocytosis -
primarily in women (Delage et al., 2001), the relationship between smoking habits and
hematopoietic indices in our population of females was investigated. As presented in Table XXVII
(page 163) results of LR, GLM, GEE and most of the SOLAR statistical analyses clearly indicate
that current smoker status, pack-years and years-smoke predicted (+) the counts of WBC,
neutrophil, lymphocyte, monocyte, basophil, MCV and hemoglobin. Evidence of a relationship for
eosinophil count and platelet count with smoking habits was inconsistent, dependent on the
statistical method used and smoking variables anatyzed. Since platelet count was significantly
associated with quantitative variables of smoking habits (pack-years and years-smoked) however
implies an authentic finding. Although we failed to demonstrate a consistent association between
smoking habits and eosinophil counts, others have not (Mensinga et al., 1994), (Schwartz and
Weiss, 1994). Discrepancies may lie in sample size. That a negative association f-) was detected
between blood counts and ex-smoker status and years-stop smoking suggests that afier remova] of
the stimuli (i.e., smoke), hematopoietic indices return to original levels, suggesting that smoke is the
causal factor. These findings suggest that smoking habits should be included as a confounding
variable in the blood-skewing analyses.
4.2.3.3 $moke-parity
Although the association between smoking habits and parity data is flot clear, for instance i) are
current smoking habits reflective of past smoking habits when parturition occurred and ii) are
smoking habits the cause or consequence of parturition data. Analyses were nonetheless conducted
and parity data set as the dependent variable. As shown in Table XXVIII (page 164), other than a
negative association between number of children with pack-years and years-smoked, no other
significant associations were found, suggesting cigarette smoking is flot a significant predictor of
parity data or vice-versa.
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4.2.4 Parity data as a confounding variable(J Parity and bÏood
To determine whether parity data was predictive of blood counts, the association was investigated.
As presented in Table XXIX (page 165), other than some marginal associations, no strong or
consistent association was observed.
4.2.5 Covanates associated with blood counts: multivanate analyses
As several covariates were associated with hematopoietic indices, multivariate analyses were
conducted — resuits provided in Table XXX (page 166). For WBC, significant covariates were med
heart (p0,0 17), ex-smoker (pO,OO8) and pack-years of cigarette smoke (pO,OO4). Neutrophil
count was associated with asthma (p=O,OO9) and pack-years (pO,OO9). The oniy variable to
significantly influence lymphocyte count was ex-smoker (pO,OOl). Age was the only variable to
predict monocyte count (p<0,000 1). Eosinophil count was associated with HRT (pO,04 1), med
anti-inflam (p=O,Ol$) and asthma (p=O,O43). Age (p=0,024) and current smoker (p0,OOI)
predicted basophil count. Platelet count was associated with HRT (p0,035). Hemoglobin was
associated with med-asthma (p<O,000I), med-other (p=O,005), anemia (p<0,000I) and pack-years
(p=O,O43). MCV was predicted by age (p=O,025) and med-anti-conv (p=O,015). Thus for future(J statistical analyses pertaining to blood counts, the aforcmentioned variables shouid be considered.
4.2.6 Maximum likeihood heritability estimates of confounding variables
The phenotypic variance of confounding variables (blood counts, number of miscarriages, smoking
habits) attributable to genetic factors was investigated by maximum likelihood estimates (adjusted
for age, pack-years of cigarette smoke, current smoker and ever smoker). Although flot investigated
in this study, familial aggregation and heritability of RA (Deighton and Walker, 1991), asthma
(Palmer et al., 2000) and COPD (Khoury et al., 1985) has long been recognized. In fact, utilizing a
classic twin study design, 73% of the variation in susceptibility to asthma and 60% of the risk of
developing RA can be explained by genetic factors (Skadhauge et al., 1999) (MacGregor et al.,
2000).
Blood counts
As presented in Table XXXI (page 167), the variance of ail hematopoietic iineages demonstrated
significant heritability estimates (0,14 h 0,66; pO,O45), implying a genetic component to
derivation of blood counts. In particular, MCV demonstrated the strongest familial resemblance
(h20,66; p<lxlOE7), followed by platelet count (h2=0,54; p<1x107). Monocyte and lymphocyte
counts also demonstrated modest h2 values (0,44 and 0,43, respectivety, p<lxlOE7). Lack of strong
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heritability of basophil count may be attributed to a Iow mean count (0,033) and a high standard
deviation (± 0,055) — see Table XV (page 150).
Farity data
As shown in Table )OQU (page 167), a heritable / genetic component (h20,12; p=0,002) was
demonstrated for multiple miscarriage occurrence. Genetic components possibly include genetic
aberrations andfor miscarriage susceptibility allele(s).
Smoking habits
As shown in Table XXXI (page 167), phenotypic variance attributable to genetic effects for the
quantity of smoke inhaled (pack-years) was significant (h20, 1$; p’O,OOOO2), suggesting that
quantitative variables of smoking habits have a genetic component, consistent wïth a genetic
component to smoking addiction (Munafo et al., 2001).
4.3 familial aggregation of skewed Xi pafferus
To determine whether genetic and/or environmental factor(s) influence derivation of )URs, familial
aggregation of skewed Xi patterns was examined. As such, the recurrence risk (RR) and recurrence
risk ratio (RRR) were determined for each skewed Xi phenotype. Confidence intervals were flot
determined.
4.3.1 Pnmary skewing trait (DS score 0,25)
As shown in Table XXXII (page 168), familial aggregation of skewed Xi pattem in BC, PMN and
T lymphocytes was flot significant (RRR 1,01; 1,12 and 1,19; respectively), suggesting that
genetic andlor shared environmental factors do flot contribute to derivation of )URs for these tissues
/ lineages. These findings imply a stochastic and/or non-genetic mechanism(s) of skewed Xi pattern
derivation.
Nonetheless, and assumÏng a genetic component to skewed Xi patterns in BC, lack of familial
aggregation may be attributed to: i) Small sample size of cases (n20) versus controls (n=l7$), thus
necessitating a larger case sample size. ii) A too stringent criterion of skewing. For example, in
mice, as in the case of extreme heterozygotes (Xcea /Xcec heterozygotes), Xce X chromosome
skewing achieves a maximum skewing of 20-30%. A Iower degree is expected in weaker
heterozygotes (Xcea /xce’’ for exampie). Therefore, and assuming a shnilar mechanism of skewing
in humans, reanalysis of skewed Xi paffems BC but with a less stringent criterion, a DS score 0, 1$
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for example, is warranted. Pertaining to T lymphocytes, and assuming a genetic component to
skewed Xi patterns in T lymphocyte, iack of familial clustering may be explained by I) small
sample size of cases (n39) versus controls (n1 58), thus requiring a larger sample size. ii) As in
the case of BC skewing, a DS score 0,25 criterion may be too stringent, thus necessitating
reanalysis but with a less stringent criterion (e.g. DS score 0,18).
In monocytes and B lymphocytes on the other hand, evidence for signitïcanl familial clustering of
skewed Xi pattems was observed (RRR 1,2$; p<O,Ol and 1,62; p<O,OO1 respectively), evidence in
fayot of a genetic component and/or shared environmental influence(s). To decipher whether the
genetic component was plausibly X-linked, an estimate ofheritability and correlation in direction of
skewed Xi pattems (i.e., Xp versus Xm) among siblings vas analyzed (Chapter 4.5.2). The effect of
smoke as a possible environmental stimulus was also investigated (Chapter 4.5.1).
Surprisingly, as both monocytes and PMN are of myeloid origin, and strongly correlated for XIRs
(Figure 17, page 99), thus specutated to exhibit a similar Xi phenotype, lack of familial aggregation
for skewed Xi pattems in PMN is unclear. One possibility may be that analyses lacked sufficient
power, thus requiring a larger sample size. Alternatively, the finding may be genuine, implying a
strong stochastic etiology to derivation ofXlRs in PMN.
4.3.2 AS trait (ASDS score 0,25)
As presented in Table XXXII (page 16$), the AS trait (ASDS score 0,25) was significantly
aggregated within familles as demonstrated for ail four hematopoietic lineages (1.57RRR2,63;
p<O,Ol), suggesting that genetic andlor shared environmental factors play a role in derivation of the
AS trait. Among the various lineages, aggregation was strongest for T lymphocytes (RRR’2,63),
suggesting a strong heritable component. fleritability estimates may provide further insight for the
role of genetic factors in derivation of the AS trait (Chapter 4.5.2). To determine whether X-linked
genetic factor(s) are plausibly implicated in derivation ofthe AS trait, correlation in direction of AS
score) among siblings was also analyzed (Chapter 4.5.2.2). The role of cigarette smoke as
a possible environmental stimulus in derivation ofthe AS trait will be reviewed in Chapter 4.5.1.2.
4.4 Physiological relevance of skewed Xi patterns: association with
biological variables
The significance ofthe findings herein stated are dependent on several factors: i) statistical strength
(p-value), ii) whether the finding can be demonstrated in more than a single hematopoietic lineage,
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iii) the biological significance ofthe finding and iv) temporaÏity. Moreover, as multiple testing was
performed, thus increasing the probability of incurring a type I error, one can raise the argument
that resuits should be interpreted with caution. Therefore, a sfraight Bonferroni correction for
multiple testing should be included. Altematively a more stringent alpha level of 0,01 may be used.
Both DS and AS scores were utilized for the association studies. As introduced in Part 1, the BC
DS score putatively quantitates the primary XIR. further, in blood, the DS score putatively
quantitates the primary )UR confounded by the AS trait. Thus the AS5 was employed to quantitate
the AS trait more effectively. PAmat and scores on the other hand, as they provide a
measure of the direction of skewing (Xp versus Xm), were excluded from the analyses. That is, we
were interested in the relationship between ‘magnitude’ of Xi skewing and biological variables and
flot between ‘direction’ of Xi skewiiig and biological variables. The latter however may prove
fruitful for analyses wishing to investigate the relationship between parental source of Xi skewing
and biological end-points, potentiaïly identifying imprinted X-linked traits.
4.4.1 Hematopoietic indices and Xi skewing
To determine the physiological significance of AS, as modulation of H$C kinetics is speculated,
blond counts as a function of )URs was investigated. Association analyses included LR, GLM and
GEE statistical methods. Confounding variables are stated in parentheses of Table XXXIII (page
169-170).
4.4.1.1 D$ score
The relationship between DS score and blood counts are provided in Table XXXIII a) (page 169-
170).
BC DS score: As shown, other than a marginal association between the BC DS score and MCV
(p0,O49), the BC DS score did not predict hematopoietic counts for any of the remaining
hematopoietic lineages, suggesting that the primary Xi pattera is not associated with variations in
the hematopoietic department.
Blood DS score and eosinophil count: With or without adjusting for covariates, a negative
reiationship (-) was observed between DS scores of ail four hematopoietic lineages and eosinophil
count (resuits of LR, GLM and GEE aH significant). This result suggests that with increasing DS
scores, there are less eosinophils in PB. Lack of an association with the BC DS score limits th
e
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relationship to the hematopoietic department. An association with the AS trait is thus speculated
(see below).
Blood DS score and platelet count: Platelet count was negatively associated (-) with blood DS
scores, as observed with the DS scores of monocytes, B lymphocytes ami a statistical trend with T
lymphocytes. Lack of an association with PMN, a ccli type well correlated with the PAmat score of
monocytes, is presentiy unclear. Nonetheless, and although the mechanism is unknown, increasing
blood DS scores may be associated with vascular aiterations, such as reduced efficiency to control
bieeding and/or thrombocytopenia.
Blood D$ score and hemoglobin: With or without controliing for confounding variables,
hemoglobin concentration was significantly associated (+) with PMN and monocyte D$ scores (LR,
GLM ami GEE methods). As these ccli types demonstrated the highest incidence of AS, an
association with the AS trait was speculated. No relationship with ASDS scores was found [Table b)
)OOUII; page 169-170], limiting the association to DS values. Further, since hemoglobin
concentration is negatively related to anemia, we queried an association between XIRs and anemia.
As seen in Table XXXIV (page 171-172), although myeloid DS scores were not associated with
anemia, the AS05 scores of monocytes and B lymphocytes were. However, this association was lost
to confounding variables (smoke, ex-smoker and hemoglobin — GLM method). Thus increasing
hemoglobin concentration as a function of increasing DS scores appears unrelated to self-reported
anemia. Altematively, the positive association between DS scores and hemoglobin may be
associated with intravascular hemolysis. Analysis of DS scores as a function of RBC numbers
should derive further insight.
Blood D$ score and MCV: A marginal negative (-) association was observed between MCV and
T lymphocyte DS scores. However, a spurious finding ïs speculated as i) direction ofrelationship (-
) was not consistent with the finding in BC which was positive (+), ii) p-values were marginal
(p=0,049 for BC and p0,Ol2 for T ceils) and iii) DS scores for the other three hematopoietic
lineages were not significant.
4.4L2 A$Ds score
The relationship between AS and btood counts are provided in Table b) )QOUII (page 169-170).
ASE5 score and eosinophil count: Consistent with blood DS score results, eosinophil count was
negatively (-) associated with ASDS scores, as detected with various lineages (resuits of GEE
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method: pO,O35 with PMN; pzO,Ol3 with T lymphocytes, and pO,Oll with B lymphocytes).
Controlling for additional covariates slightly reduced the signifïcance of p-values (GEM method).
Monocyte ASD5 scores however, for reasons which are presently unclear, were flot associated with
eosinophil counts (p=O,357 GEE method). Nonethe]ess, that both DS and AS05 scores were
associated with decreasing eosinophil counts implies an authentic fmding. As such, an X-linked
genetic factor to eosinophil counts is speculated.
AS score and platelet count: A significantlpositive association (+) was observed between
platelet count and the ASDS score of PMN (p=O,043 GEE method), suggesting that AS may be
associated with mild thrombocytosis. However, since the finding was barely significant (pO,O43)
and was restricted to a single hematopoietic lineage (PMN), a spurious finding is speculated.
Moreover, this finding is in contrast to DS score results in which the relationship between DS
scores and platelet count was inversely related and was detected in more than a single hematopoietic
lineage.
4.4.2 CiinicaI data and Xi pattems
b determine whether varying Xi pattems were associated with clinical data, self-reported medical
C conditions and a partial list of medicinal use were anatyzed as a function ofDS and ASDS scores.
4.4.2.1 DS score
DS score and asthma: As shown in Table a) XXXIV (page 171-172), a positive relationship (+)
was observed between increasing DS scores and asthma. As the association was observed with BC
tissue (pO,O32; LR) and hematopoietic lineages: PMN (pO,O32; LR) and possibly monocytes
(p0,054; GEE), an association with the primaiy skewing trait is speculated. Lack of T and B ceil
contribution may be aftributed to the lower incidence of skewing for these lineages. Controlling for
confounding variables (GLM and GEE methods) did flot drastically alter p-values. A positive
association between med-asthma and the DS scores ofPMN (p=O,Ol3), monocytes (pO,O$l) and B
lymphocytes (p=O,04 I) further supports the relationship. Lack of a relationship between asthma I
med-asthma and ASDS scores [Table b) )OOUV (page 171-1 72)J delimits the association to the
primaiy skewing (DS score) trait. Since DS scores were not associated with med-allergy, grounds
for an association ofthe primaly Xi pattern with allergie diseases in general could flot be supported.
score and RA: With or without controHing for confounding variables, an inverse relationship
(-) was observed between myeloid DS scores and RA. As the observation was limited to the
hematopoietic department (PMN and monocytes), we conjecture an association with the AS trait. In
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fact, as seen in Table b) XXXIV (page 171-172), increasing ASDS scores for PJv1N and monocytes
( were associated with a decreased occurrence of RA (p0,045 for PMN, GLM method and a
statistical trend for monocytes ASDS scores for ail three statistical methods). Since med-anti-mflam
was flot associated with DS ami ASDS scores, a general association between DS scores and
inflammatory conditions could be concluded.
DS scores and I-TRI: A significant association (-) was observed between the fiSC 0f FIRT and the
DS score of PMN (LR resijit: p=O,O23). However, loss of significance upon multivariate analyses
and lack of association with monocytes suggests a spurious fmding.
No significant association was observed between skewing (D$ score) and cancer, cancer related
therapy (chemotherapy, radiotherapy), anemia, SLE, med-allergy, med-anti-inflam and med-heart.
4.4.2.2 score
ASDS score and anemia: As presented in Table b) XXXIV (page 171-172), although a negative
association (-) was detected between ASDS scores of PMN, B lymphocytes and T lymphocytes
(statistical trend) ami anemia as observed with the LR and GEE statistical methods, the association
(E was lost upon controlling for confounding variables (GLM method), thus attributmg trait variance
to the latter variables. Interestingly, this finding is consistent with a Jack of an association between
ASDS scores and hemoglobin concentration and MCV [Table b) XXXIII (page 169-170)].
score and RA: As presentcd in Table XXXIV b) (page 171-172), AS scores of PMN
(p=O,O45 for GLM and p=0,064 for GEE) and possibly monocytes (pO,O93 for GLM and p0,O57
for GEE), were associated with a decreased (-) reporting of RA. Similar fmdings with DS scores
suggest that increasing DS and ASDS scores in myeloid lineages plausibly affributable to the AS
trait, may be associated with protection from RA. Consistent with an ïntrinsïc X-linked growth
advantage model of AS, one possibility may be that genetic variants of the AS gene, in addition to
providing the celi with a relative growth advantage, confer reduced susceptibility to RA. Evidence
of an X-linked genetic component to RA (Jawaheer et aI., 2001) supports the latter.
No significant association was detected between ASDS scores and cancer, chemotherapy,
radiotherapy, asthma, SLE and use of [[RI, med-allergy, med anti-inflam and med-asthma.
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4.4.3 Parity data and Xi patterns
To determine whether the primary skewing trait (DS score) and/or the AS trait (ASDS score) were
associated with X-linked disease aflele(s), the association between parity data ami )URs was
investigated. Our rationale is that X-linked disease alJeIe(s) will induce both a skewed X
inactivation pattem in female carriers of the disease allele and the mîscarriage of a male conception
(as a female can transmit either of her X chromosomes, she is expected to transmit the mutant X
half the time. Moreover, as a male is hemizygous for the X, the disease alJele is likely to be ftuliy
penetrant, possibly inducing the spontaneous abortion of the developing fetus). 1f X-linked mutant
alleles are indeed common in the Québec female population, we speculate that skewed Xi pattems
are associated with increased miscarriages and an increased female:male offspring ratio. Resuits
provided in Table XXXV (page 173).
4.4.3.1 D$ score
No significant associations were identified between parity data and BC DS scores, implying that
primary skewed Xi paffems are unlikely due to the presence of X-linked mutant allele(s). Among
hematopoietic lineages, a negative association was observed between PMN DS score and
miscarriage occurrence (p0,04$) and number of offspring (p=O,047), implying that a skewed Xi
paffem in blood may be associated with reduced fertility. However, i) controlling for confounding
variables (GLM), the association with miscarriage occurrence was Iost (pO, 132), ii) Jack of an
association with monocytes, and iii) marginaHy significant p-values, ail impiy a spurious finding.
Moreover, Jack of an association with offspring sex-ratio (pO,$59) and number of mïscarriage
(pO,330) sfrongiy argue against a general role for X-linked mutant allele(s) in the etiology of
skewed Xi pattems. This fmding however is flot consistent with data in the literature citing a ‘high’
frequency of skewed X inactivation among femates experiencing RSA. Discrepancies are Iikely due
to i) clinical criterion, as we did flot collect information on the recurrence frequency of
miscarriages. Unlike previous studies that defined R$A as 2-to-3 (or more) consecutive Iosses under
20 weeks gestation, the criterion utilized in this study was unreiated to gestation period and
irrelevant to consequtiveness of the miscarriages. ii) Since D$ scores were obtained in an elderly
population of females (mean age 63,3) and flot derived strictJy ftom those whom have recently
undenvent parturition, temporal differences in DS scores are specuiated. iii) Statistical power may
be limited by smaller sample size of females experiencing a miscarriage (n=352) versus controls
(n792).
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4.4.3.2 ASDS score
Similar to the DS score resuits, a significant inverse relationship (-) was observed between
miscarriage occurrence and increasing ASDS scores, as observed for PMN, monocytes and B
lymphocytes, particularly when controlling for confounding variables (GLM). Since the current
ASDS score may flot be reflective of that when parturition occurred (as it occurs at a later age), the
finding implies that women who have experienced a miscarriage are less likely to develop AS.
Nonetheless, unlike DS score results, several features implicate an authentic finding: i) Like the DS
score analyses, PMN were significantly implicated. ii) PMN, monocytes and B lymphocytes (the
three hematopoietic tineages most implicated in AS) were consistent in direction of relationship,
i.e., inverse (-) relationship. iii) Like the DS score analyses, AS0 analyses also produced a negative
relationship. Nonetheless, these findings argue against X-linked mutant aileles as a general cause of
AS since X-linked disease alleles would have been associated with i) an ‘increased’ miscarriage
occurrence and ii) other variables of parity (offspring sex-ratio, number of miscarriages and number
of chiidren).
4.5 Etiotogies of skewed Xi patterns
As skewed Xi pattems for varlous hematopoietic lineages demonstrated significant familial
aggregation (Chapter 4.3), the role of environmental and genetic etiologies were investigated. The
role of age in trait evolution has been previously scrutinized (Part I ofResuits).
4.5.1 Environmental etiology: cigarette smoke
for reasons declared in Chapter 2.2.2, cigarette snioke was investigated as a possible environmental
stimulus in the etiology of skewed Xi patterns. Smoking characteristics of participant females are
provided in Table XVIII (page 153). )URs were set as the dependent variable and significant
predictors of XIRs were included as covariates.
4.5.1.1 138 score
As shown in Table a) XXXVI (page 174-175), the BC DS score was not associated with smoking
variables, an expected finding since the primary )UR is putatively acquired during embryogenesis
and relatively stable thereafter (Resuits, Part 1). Among hematopoietic lineages and controlling for
confounding variables, other then a marginal association between B ccli DS scores and current
smokcr (p=O,O4) and a statistical trend (pO,O7) with pack-years (SOLAR method), no other
significant associations were found, suggesting that cigarette smoke is not a significant factor in
derivation of blood DS scores. The association identified with B lymphocytes poses an interesting
dilemma since i) p-values derived with the other statistical methods (LR, GLM and GEE) were
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clearly insignificant and ii) since B lymphocyte DS scores did flot significantly increase with
advancing age, ït is flot clear how enviromuental factors are significantly implicated in derivation of
B ccli )GRs, thus implying a spurious finding.
4.5.L2 ASDS scores
As shown in Table b) XXXVI (page 174-175), controiling for confounding variables (GLM
method), current smoker status [statistical trend for both PMN (p=O,067) and monocytes (J)=O,O74)J
and pack-years of cigarette smoke (p=O,O 12 for PMN and pO,O69 for monocytes) predicted ASDS
scores, suggesting that cigarette smoke may be involved in the etiology of the AS trait. Lack of an
association with T and B lymphocytes may be attributed to the low incidence of AS for these
lineages. We hypothesize that a chemical particulate(s) of cigarette smoke, the smoking habit itseIf,
or a covariate associated with cigarette smoke be associated with derivation ofthe AS trait.
4.5.2 Familiailgenetic etiology: sibling correlation ofXIRs and hentability coefficients
To derive evidence of a plausible X-Iinked genetic component to derivation of XIRs, sibling
correlation of X[Rs (ANOVA) and maximum likelihood heritability estimates (adjusted for age,
pack-years of cigarette smoke, current smoker and ever-smoker) were analyzed. The latter derived
(f_
estimates of the genetic effect (h2). We speculate that if Xi patterns are influenced by a familial
“5 component, the magnitude of skewing (DS and ASDS scores) should be more similar within versus
among families. Moreover, if skewing is influenced by an X-Iinked genetic locus, direction of
skewing (that is preferential inactivation of a parental-specific X chromosome) should be more
similar within versus among families. The latter analysis was performed by evaluating PAmat and
ASPMmI scores.
4.5.2.] Xi Skewing trait: deviationfrom random Xi
Primary I BC XIR: As seen in Table a) XXXVII (page 176), although the magnitude of BC
skewing (DS score) was not significantly related among siblings (p=O,24 for ANOVA, h2=O,04),
thus consistent with the Jack of familial aggregation of skewed Xi pattems in BC (Table XXXII,
page 16$), PAmat scores were signilicantly related among siblings (p3.3x1W9 for ANOVA,
h2=0,30). The latter is consistent with an X-linked genetic component to derivation of BC PAmat
scores, plausibly consistent with an XCE-like etiology. Autosomal or stochastic etïologies are
improbable as they would favor a normal or random distribution ofPAmat scores among siblings.
0f special note, resuits pertainmg to DS and ASDS scores should be interpreted with caution as they
violate an assumption ofANOVA and SOLAR statisticai methods: these variables are flot normally
distributed as required (sec f igures 10, 11; pages 92, 93).
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() Blood XIR: Among the various hematopoietic imeages [Table a) XXXVII, page 176], both DS
scores (p2,9x104 for ANOVA, 0,1 1h20,24) and PAmat scores (p2,7x105 for ANOVA,
0,20h20,39) were signifïcantly related among siblings, evidence supporting a genetic, possibly X
linked, component to derivation of blood )URs. Similar to resuits in Table XXXII (j)age 168),
familial resemblance of DS scores was strongest for monocytes and B celis (h2=O,21 and h2=0,24,
respectively) and weakest for PMN (h2=0, 11). Interestingly, T ce!! PAmat scores demonstrated the
strongest familial resemblance (p=l ,6x I 02 for ANOVA, h2=0,39), implying a strong genetic (X
linked) component.
4.5.2.2 AS trait: Deviationfrom the BCXJR
Among the various hematopoietic lineages [Table b) )OCXWI, page 176], with the exception of the
PMN ASDS score, both the ASDS score (p5,2x10 for ANOVA, 0,1 7h20,30), and score
(p3,1x105 for ANOVA, 0,20h20,36), were signiflcantly related among siblings, compefling
evidence of a genetic basis, possibly X-linked, component to derivation of AS scores. Lack of
familial correlation for PMN ASDS scores utilizing the SOLAR statistical method is present!y
unclear as both ANOVA analyses (p=l,5x104) and familial aggregation resuits [RRR=1,71;
(j p<O,O05; Table XXXI! (page 16$)] demonstrated significant familial resemblance of PMN ASDs
scores. Similar to PAmat resuits, an extremely significant p-value was found for T lymphocyte
ASpAmat scores (p=3,lxlo” for ANOVA; h2=0,36), implying a strong X-linked genetic component
to T lymphocyte AS.
4.5.3 Segregation analysis of skewed Xi paffems (preliminary findmgs)
To derive further evidence for an X-Ïinked genetic component to derivation of skewed Xi patterns,
segregation analysis of skewed Xi pafterns within families was analyzed. We hypothesize that if the
trait is X-linked, the X of same parental origin (i.e., direction of skewed Xi) should be preferentially
inactivated among sib!ings more ofien then expected by chance alone.
4.5.3.1 Segregation anatysis ofskewedXipatterns (DS score 0,25)
BC tissue: Among families demonstrating a skewed Xi pattern in BC (DS score0,25) and
informative for parental derivation of X (i.e., Xp versus Xm) (n91 familles), n=27 carried at least
two sib!ings demonstrative of a skewed Xi pattern in BC, thus Informative for segregation analysis.
Results are presented in Table a) XXXVIII, (page 177-183). As found, when direction of skewed Xi
patteras (i.e., preferential inactivation of a parental-specific X; i.e., Xp versus Xm) was tabutated
among these familles, the X of same parental derivation (i.e., same) tended to be preferentially
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inactivated among siblings: 54 (same parental X) versus 8 (alternate parental Xs). These values
significantly differ from those expected if skewed Xi pattems were determined exclusively by a
stochastic process: 34 (same parental X) versus 2$ (alternate parental Xs). This fmding is consistent
with an X-linked genetic component (p<O,0001) to derivation of skewed Xi patterns in tIC tissue,
plausibly consistent with an XCE-like etiology. Lack of further concordance is congruent with a
genetically complex trait.
Interestingly, when parental derivatïon of the skewed (preferentially inactive) X chromosome was
tabulated among ail families carrying at Ieast one sibling with a skewed Xi pattem in BC, Xm was
found to be preferentiaiiy inactivated versus Xp (n=74 versus n52, pO,O5O). Various explanations
are provided in the discussion.
PMN: Among families demonstrating a skewed Xi paftern in PMN and informative for parental
derivation of X (Xp versus Xm) (n144 families), n=103 carried at least two siblings whom
demonstrated a skewed Xi paffem in PMN, thus informative for segregation analysis. As presented
in Table b), XXXVTII (page 177-183), when direction of Xi skewing (preferential inactivation of a
parental-specific X) was tabulated among these families, it appeared that the X of same parental
origin was preferentially selected among siblings: 235 (same parental X) versus 61 (alternate
parental Xs). These values were significantly higher than expected if skewed Xi pattems were
dictated solely by stochastic processes: 163 (same parental X) versus 133 (atternate parental Xs).
This finding is consistent with an X-linked genetic component (p<O,0001) to derivation of skewed
Xi patterns in PMN. Lack of further concordance in direction of skewed Xi patterns among siblings
is congruent with a genetically complex trait.
Similar to resuits observed in tIC tissue, when ail families containing at Ieast one sibling with a
skewed Xi pattem in PMN were tabulated, Xm (n=197) tended to be preferentially inactivated
versus Xp (n= 141) (pO,002), consistent with a parent-of-ongin effect for skewed Xi patterns in
PMN celis.
4.5.3.2 Segregation anaÏysis ofthe AS trait (ASDS score 0,25)
Among familles demonstrating an AS phenotype in PMN (ASDS score0,25) and informative for
parental derivation of X (Xp versus Xm) (n1 10 familles), n=5$ contained two or more siblings
demonstrating an AS phenotype in PMN, thus informative for segregation analysis. As presented in
Table e) XXXVIII (page 177-183), when direction ofthe AS trait (i.e., preferential inactivation ofa
parental-specific X) was tabulated among these families, it was found that a parental-specific X was
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preferentially inactivated among siblings demonstrating an AS phenotype in PMN: 119 (same
parental X) versus 29 (alternate parental Xs). This value was significantly different from those
expected if the AS trait was exclusively dictated by a stochastic process: $3 (same parental X)
versus 65 (alternate parental Xs). This finding is consistent with an X-linked genetic component
(p<O,000 1) to derivation of the AS trait in PMN. Lack of further concordance is congruent with a
genetically complex trait.
Unlike DS score resuits, when parental derivation of the preferentially inactivated X chromosome
was tabulated among ail families carrying at least one sibling with an AS phenotype hi PMN, Xm
and Xp were equally inactivated (99 versus 101, respectively), liiniting the parent-of-origrn effect to
DS score resuits.
DISCUSSION FOR PART II
Descriptive statistics and confounding variables
As presented in Tables (XV-XIX, pages 150-154) and Figures (20-21, pages 146-149), frequency
distributions, descriptive statistics and reference values for various biological variables were
determined for our elderly population of French-Canadian females. This included hematopoietic
indices, cimical characteristics, smoking habits and family/parity data. The distribution of blood
counts was analyzed and extreme outliers were identified and removed for some statistical analyses.
Prior to analyzïng the relationship between Xi pattems and these biological variables, the influence
of potential confounding variables was investigated. As found, age was a significant predictor of
particular blood counts (Table XX, page 155), medical conditions/medicinal use (Table XXI, page
156), smoking habits (Table )OUI, page 157) and parity data (Table XXIII, page 15$). [The
influence of age on )URs was previously analyzed - Part IJ. Various associations were identified
between ciinical data and hematopoietic indices (Table XXIV, page 159-160), thus providing i)
physiologica] background to the clinical trait and ii) data from which to support or refute a self
reported clinical condition (that is, to determine whether variations in blood counts were consistent
with published data of the medical trait). In addition, the relationship between medicinal use and
blood counts may be used as an indirect method to infer a medical condition. for example, the
association between use of med-asthma and blood counts was consistent with the association
between asthma and blood counts, thus use of med-asthma was an indirect method to infer a clinical
trait (i.e., asthma). However, in some instances, it was flot known whether medicinal use had a
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direct effect on blood counts, for example the effect of NRT on blood counts. Smoking habits were
(E linked to varlous clinical conditions (Table XXVI, page 162) (asthina, anemia, RA, use of med
heart and med-other) and associated with variance of blood counts (Table XXVII, page 163), a
finding consistent with published data, implying a causal role. Multivariate analyses of blood counts
identified covariates significantly associated with variance of blood counts (Table )OOÇ page 166).
familial resemblance (heritability estimates) identified a significant genetic component to blood
counts (O,14h20,66), number of miscarriages (h20 12) and smoking habits (h2=0,18), implying a
genetic contribution to trait variance (Table XXXI, page 167).
Genetic component to vanability of hematopoietic cd numbers
A heritable component to variance of blood counts is consistent with classical twin model
approaches, which aftributed 61 to 96% of variance in blood celi measures to genetic factors (Evans
et al., 1999). In a fiirther study comprised entirely of females, 50% of absolute T lymphocyte count
was attributable to geneticfheritable factors (Hall et al., 2000). Since the age of females participating
in the former study (12 yo) was younger versus our study (3$-96 yo) and the latter (1$-80 yo)
suggests that genetic effects, particularly so for T lymphocytes counts, decreases with advancmg
age. That lymphocyte count was predicted by current smoking habits and inversely related to ex
smoker status suggests that non-genetic factors (environment and possïbly clonai expansion) play
an increasing role in the decrease of lymphocyte levels with advancing age [(statistical trend —
Table XX, page 155) and as previously reported (Hall et al., 2000)]. Moreover, that the magnitude
of genetic effects may differ between the sexes (Evans et al., 1999), sex-limited attributes, such as
genetic linkage to the sex chromosomes, may be a further source of variation. Nonetheless, taldng
into consideration the various non-genetic factors as covariates, genetic linkage studies and/or
genetic association studies are merited to identify genetic determinants implicated in homeostatic
regulation of blood counts.
Pnmary Xi pattem: BC MR
Evidence ofan X-linkid genetic component: familial aggregation / correlation analyses
Although skewed Xi patterns in BC tissue were flot aggregated within families (RRR1,01),
(possibly owing to small sample size and/or DS score 0,25 too stringent of a criterion to defïne a
skewed Xi pattem), nor were BC DS scores significantly correlated among siblings (p=0,24;
h2=0,04) (possibly owing to analysis of a non-normally distributed trait), PAmat scores were
signiflcantly correlated among siblings (p=3,3x1 0) and demonstrated a modest heritability
coefficient (h2=0,30; p’1x1OE7). This finding implies preferential inactivation of a parental-specific
X chromosome among siblings, consistent with a genetic (possibly X-linked cis-acting) component
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to derivation of BC PAmat scores. Autosomal or stochastic processes are unlikely as they would not
foster familial correlation of PAmat scores. In addition, segregation analysis of skewed Xi pafferus
in BC tissue found significant concordance in preferential inactivation of a parent-specific X (Xp
versus Xm) among siblings, compelling evidence for an X-Iinked genetic component.
Candidate gene:
Because the )UC region plays an essentiat role in Xi, candidate genes likety reside within this
region. As discussed in the introduction (Section 7.3.2.1), several observations support an XCE-like
etiology in derivation of the primaiy XIR. As such we speculate that part of the variability of BC
PAmat scores reflect genetic variants of XCE-like alleles. Although the latter is consistent with a
monogenic trait (see below), severat fmdings in this project support a geneticaÎly comptex trait. X
linked mutant alleles have been excluded as a major cause of skewed Xi paftem in BC due to iack
of an association between BC DS scores and parity data.
Groundsfor a geneticaÏly complex trait
Assuming i) an X-linked genetic component in derivation of skewed Xi pafterns, ii) maternai or
paternal inheritance of the skewing gene, iii) genetic Iinkage of the skewing gene outside of the
(E PAR (thus no genetic recombïnation expected between the skewing gene and our
HUMARA marker on the paternal X) and iv) ah female siblings to share the same patemal X, we
expected to find some famïhies demonstrating a high incidence of skewed Xi pafterns among
siblings when the skewing gene was paternally derived (i.e., in 50% of families). However,
aithough some familles did demonstrate a high incidence of skewed Xi paffems in BC, in particular
famiiy 121 where 5 of $ siblings were skewed in favor of the same parental X (thus consistent with
an X-Iinked genetic etiology), the fmding was exceptional. These findings are consistent with a
genetically complex trait. Variability of BC )URs may plausibly be explained by variable
expressivity, incomplete penetrance, polygenic inheritance, genetic heterogeneity, environmentai
(in utero) influences and/or stochastic processes. In utero influences may include maternai factors
such as age, birth order and gestational diseases (e.g., gestational diabetes).
Number ofprogenitor celis present when Xi is initiated
In light of a genetically complex trait, it appears therefore that )URs are flot strictly reflective of a
random/stochastic process dependant on the number of stem celis present at the initiation of X
inactivation. Rather, a combination of both a stochastic process and X-hinked cis-acting controhliiig
element(s) plausibly play a rote in derivation of the primary Xi pattern. We speculate that this X
linked genetic element(s) gives the allusion that a smait number of progenitor celis are present when
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Xi is initiated. Therefore, we deduce that the number of progenitor present is actually higher than
previously suggested.
Liukage analysis of a geneticatly complex trait
Parametric analysis
One of several methods to map the putative XCE-Iike gene is by linkage analysis (LA). Genetic
Iinkage refers to the tendency of alleles from two bd on a chromosome to segregate together in a
family. The extent of Jinkage is a function ofthe distance between two loci, and can be measured by
the number of crossover events between the two bd among the observed meioses (i.e., the
recombination fraction). The bd are said to be linked if the recombination fraction between them is
less than 0,5. Calculation ofthe bd score estimates the recombination fraction and the significance
of the evidence for linkage. Lod score analysis requires specifying a genetic model, which includes
mode of inheritance, disease allele ftequency and penetrance. In addition, multigeneratïon families
may be required. The trait can be qualitative or quantitative. This model lias been successftut for
one-Iocus disease models and occasionally for genetically complex traits (early-onset breast cancer
for example (1-lali JM et al., 1990)).
For the primary Xi trait, several parameters of the genetic model cnn be derived. Inheritance eau be
set as X-linked. Setting the trait alleIe frequency is more difficuit as both stochastic (environment)
and genetic factors (Table XXXVII, page 176) likely participate in derivation of the primary Xi
paffem. Nonetheless, a heritabilily coefficient of 30% was observed for BC PAmat scores, thus 30%
of variability in BC XIRs atiributable to X-linked genetic effect(s). Assuming a fully penetrant trait,
disease allele frequency can be set to approximately 12,4% (i.e., frequency of skewed Xi pattern in
BC) x 30% 0,037. Alternatively, penetrance may be set Iower, thus trait allele frequency set
higher. Disease phenotype may be set as affected, unaffected or unknown (the latter is ideal when
penetrance is unknown as in complex genetic traits). An affecteds-only approach may also be used
for parametric LA of a genetically complex trait since assumptions concerning unaffected
individuals are eliminated. Lod scores are summed across families, and a score 3,0 is indicative of
linkage. A Iower score requires additional methodologies to narrow the region, this may include
multipoint bd score analysis, recruitment of additional families, saturation genotyping of the region
and/or analysis of key recombinants. Candidate genes may then be sequenced to identify trait
allele(s). As a first approach, saturation genotyping of the MC region could be performed since the
XCE-Iike element is speculated to reside here.
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Nonparamefric analysis
Although a parametric approach may be used to map complex genetic traits, it ïs susceptible to
producing misleading resuits since genetic parameters are flot fully known. Alternatively, since
nonparametric methodologies of LA do not require knowledge ofthe genetic model, they have been
advocated as the method of choice for mapping susceptibility genes in genetically complex traits.
Both qualitative and quantitative traits can be studied by this approach. for common trait alleles,
the most powerfifi affected relative pair sampling unit is affected sibs. For qualitative traits, affected
sib-pair Iinkage is measured by allele sharing (J or 2 alleles for an X-lïnked marker) between a
known marker and a trait. This is based on the assumption that affected sibs who share marker
alleles will be phenotypically similar for traits influenced by a nearby gene. For quantitative traits,
testing for linkage between a marker locus and a quantitative trait consists of regressing the squared
difference in trait values between two sibs on the number of shared marker alleles. further, three
types of sib-pairs may be analyzed: i) random sampling of sib-pairs, ii) sib-pairs that are both
concordant for trait value and iii) sib pairs who are discordant for trait values. The latter appears to
be the most powerful (Risch N. ami Zhang H, 1995). A more powerfut approach are multipoint
methods such as variance components approach, which uses sibship data rather than sib pairs
(Goidgar DE, 1990). Because the primary Xi trait demonstrates a complex genetic architecture: i.e.,
genetic and stochastic (environment) factors contribute to trait variance, penetrance unknown, and
the fact that most recruited families consist of sib-ships, the sib-pair allele sharing method and/or
variance components approach is advocated. Utilizing a panel of X-linked markers, both qualitative
and quantitative analyses of the Xi trait can be analyzed for LA as previously performed (Naumova
et al., 199$). As a first step, for qualitative analyses, families containing two or more affected sibs
may be selected for linkage analysis. This could inciude both concordant and discordant sib pairs.
For quantitative analyses, to obtain maximum information, analyses should utilize ail three types of
sib-pair modeis. Once a region of interest is found, and if the region is small enough (1-2 Mbp), one
option is to select candidate genes and sequence for functional polymorphisms. Aiternatively if this
is not possible, the goal is to narrow the regions as much as possible which may include saturation
genotyping ofthe region, recruitment ofadditional familles and reanalysis ofthe data by LA and/or
by alielic association studïes (such as TDT).
Altelic association
A further tool to identify susceptibility genes in genetically complex traits is through atielic
association. Ailelic association refers to significant deviation in occurrence ofa marker allele with a
trait versus a controi group. The association can be bioiogically true (the APOE-4 aliele in
Alzheimer disease for example) or due to tight iinkage (i.e., Iinkage disequilibrium) with a nearby
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susceptibility locus, the doser they are the stronger the disequilibrium. Linkage disequilibrium (LD)
mappmg is especially powerful in isolated populations since trait susceptibility haplotypes in such
populations are speculated to have arisen from a common ancestor. LD mapping utilizes ail
recombination events in that population, thus statistically more powerful versus family-based LA.
Allelic association studies can be family andlor population (case-control) based.
Population (case-control) studies compare allele frequency in a group of unrelated affecteds to a
matched control group. However spurious associations can arise due to population stratification.
Unlike population-based methods, family-based association studies use nuclear family data to
estimate control marker allele frequencies, thus avoids possible confounding factors introduced by
population sub-structure. The transmission disequilibrium test (TDT) tests for evidence of both
iinkage and LD when the two co-exist. The TDT is advocated for analysis of geneticatly complex
traits, particularly in relatively isolated populations and for detecting genes of minor or modest
effect size. Utilizing mother-father-affected child trios, the TDT evaluates whether the ftequency of
a particular disease-marker haplotype among affected chiidren deviates from those expected by
Hardy-Weinberg equilibrium. Utilizing genotypic data from affected and unaffected siblings the
sib-TDT is applicable for late onset disorders (Spielman RS and Ewens WJ, 1998) thus applicab]e
for analysis of the AS trait.
AS trait: hematopoietic XIRs
Evidence ofan X-lïnked genetic component: familial aggregation /correlation analyses
Among hematopoietic lineages, skewed Xi patterns (DS score 0,25) were significantly aggregated
within families for monocytes and $ lymphocytes. Lack of familial aggregation for PMN and T
lymphocytes may be due to small sample size as the criterion to define a skewed Xi pattern may
have been too stringent. This may be particularly true for T lymphocytes that demonstrated a low
incidence of skewed Xi (20,1%). Pertaining to the AS trait (ASDS score 0,25), although ail
hematopoietic lineages demonstrated significant familial aggregation, thus evidence in favor of a
heritable component to derivation of the AS trait, T lymphocytes demonstrated strongest evidence
of familial aggregation. Corroborating data was observed with quantitative analyses: DS, AS05,
PAmat and scores were significantiy correlated among siblings, compeiling evidence for a
genetic (X-linked) component to trait derivation. Strongest familial correlation was observed for B
lymphocytes for DS and AS0 scores and strongest for T lymphocytes when PAmat and AS
scores were considered. Surprisingly, although modest evidence for familial aggregation for skewed
Xi paffems (DS score 0,25, ASDS score 0,25) in PMN was observed, corroborated by modest
familial correlation of DS and ASDS score scores (h2 0,11), segregation analysis of the AS
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phenotype (Table XXXVIII, page 177-183) reveaied significant familial aggregation in direction of
skewing, compeiling evidence for a genetic / X-linked component.
Although deviation from both random Xi (DS score) and from the BC (primary) Xi pattem (i.e.,
AS score) was weaker in lymphocytes versus myeloid lineages (Figures 13 and 15, pages 95 and
97), thus weaker genetÏc effects speculated for lymphocytic lineages, familial correlation and
heritabiiity coefficients of XIRs were approximately simïtar for ail fout hematopoietic iineages
(Table XXXVII, page 176). This finding implies that utilizing qualitative methods of Xi trait
analyses, such as a DS score 0,25 to define skewed Xi pattems may undermine underlying genetic
components to trait variance, thus warranting quantitative trait analyses as the preferred method.
T lymphocyte XIRs: strong evidence ofafamiliat /X-tinked genetic component
A stronger heritability coefficient was observed for T lymphocyte PAmat and ASpA. scores versus
PMN, monocytes and B lymphocytes, implying a stronger genetic component to trait derivation,
suggesting strong selection ofX-linked allele(s) 15 occurring in T cells. Clonai expansion of T ceils
is unhikeiy as this would flot foster correlation of PAmat and ASus scores among siblings. Because
T ceil DS and ASDS scores were relatively stable with agmg suggests that X-]inked allele selection
occurred prïmarily prior to age range 3$-96, thus an etiology different from AS is speculated.
AS trait: groundsfor a geneticaÏly complex trait
The above fmdings provide unequivocai evidence and rationaie to map the genetic determinants of
the AS trait. Similar to skewed Xi pafterns in BC, the AS trait may be anaIyzed by parametric
methods. Inheritance can be set as X-linked; allele frequency can 5e calculated by factoring the
heritability coefficient (Table XXXVII, page 176) by trait frequency (ASDS score 0,25) (Figure 9,
page 91). However, because trait penetrance is unknown, env ironmental factor(s) (cigarette smoke)
possibly implicated, stochastic processes and genetic heterogeneity speculated, a multifactoriai
(complex) trait is specuiated. Consequently, a nonparametric method of linkage analysis is merited.
Candidate gene(s) for AS: modulation of HSC ldnetics
$ince we postulate modulation of HSC kinetics in derivation of the AS trait and that the X
chromosome is peppered with varions interieukin receptors, candidate loci include: IL-1R, IL-1-
RAPLI, IL-l-RAPL2, IL-2-Rg, IL-3-Ra, IL-9-R, and 1L-13-RA2. Other hematopoietic growth
factor receptors, signaling peptides or transcription factors include: CSF-2R BMX, PIG-A, GATA
J and DKC-1. The role of these genes may be tested by analyzing frequency distribution of
polymorphisms in these genes between affecteds and matched control groups. In the event of
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positive linkage, a TDT may be pursued. In addition, saturation genotyping may also provide
insight. X-linked disease alleles have been excluded as candidate genes since AS was flot associated
with increased miscarriage occurrence and offspring sex-ratio distortion. However, subtie mutations
/ poiymorphisms in these genes cannot be excluded.
Role of environmental factor(s) in variance of the AS trait: cigarette smoke
Analysis of smoking habits as a potential environmental stimulus in the etiology of AS found
current smoker and pack-years of cigarette smoke to be positively associated with the ASDS score of
both PMN and monocytes, suggesting cigarette smoke is a potentïal environmental stimulus in the
etiology of AS. That removal of the stimulus (ex-smoker) was negatively associated (statistical
trend) with monocyte ASDS scores is a complementary fmding, implying a causal role. Slightly
smaller p-values with discrete smoking variables may be explained by smalier sample size (thus Iess
power) versus quantitative variables. Absence of an association with T and B lymphocytes may be
exp]ained by a lower contribution ofthese celi types in the AS trait. An undetermined component(s)
of cigarette smoke, a biological metabolite activated in response to smoking, and/or a covariate
associated with cigarette smoking (diet for example) may be implicated. In light of this finding, the
increase of ASDS scores with aging (Part I) may be explained in part by the cumulative exposure of
cigarette smoke with advancing age, thus meriting reanalysis of age-XIR analyses controlling for
confounding variables.
Since the AS trait is conjectured to reflect modulation of H$C kinetics and that cigarette smoke
elicits the production of pro-inflammatory mediators (TNF-Œ, IL-i, -6, -s) and hematopoietic
growth factors (GM-CSF and G-CSF) (reviewed in (Van Eeden and Hogg, 2000)), evidence for a
plausible interaction between cigarette smoke and HSC modulation, resulting in AS, is supported.
Hypothetically, the X chromosome may carry receptors for any of these mediator(s), and in the
heterozygous state, HSCs bearing the ‘stronger’ receptor will demonstrate a graduai growth
advantage, resuiting in AS. further investigation is thus warranted.
The drawback of having environmental factors (cigarette smoke) contributing to trait variance is a
reduction in power to detect linkage (Risch NJ and Zhang H, 1996).
Hematologic associations I consequence of AS
Although a relative growth advantage conferred by an X-linked allele(s) in FISCs bas been
postulated as a mechanism of AS, that the AS trait was flot associated with a general increase or
decrease of blood counts implies that hematopoiesis is stili under the control of ‘normal’
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hematopoiesis. Rather, the data is consistent witli a territorial / ‘Darwinian’ competition between
the two X-linked alleles, with HSCs expressing the stronger aliele outcompeting HSC expressing
the weaker allele. Nonetheless, blood )URs were associated with variations in particular lineages,
thus possibly associated witli lineage-specific hemato-pathologies.
BloodXi-skewing (DS score) and hemogtobin concentration
Increasing DS scores of PMN and monocytes were associated with an increase of hemoglobin
concentration unrelated to anemia. An association with hemolysis (perhaps insufficient to cause
clinicai hemolysis) is thus speculated. Indeed, evidence for an X-iinked genetic component(s) to
variability in hemoglobin has been previously demonstrated (Dover et ai., 1992), (Huebner et al.,
1986). 0f interest, mutations in the X-Ïinked FiG-A gene [associated with the clinical condition
paroxysmal noctumai hemoglobinuria (PNN)] have been associated with intravascular hemolysis.
And although PIG-A mutations are found in normal individuals, albeit a low frequency (0,002%),
(Araten et aI., 1999), an aplastic BM environment lias been speculated as the causative factor for
clonai expansion of PIG-A mutant FISCs. The latter is consistent with extrinsic factor(s) in the
etiology of clonai expansion (Araten et al., 2002). Moreover, that cytopenias associated with PNN
respond to immunosuppresion, thus implying an association with immuno-modulation (possibly
autoimmunity favoring selection of the PIG-A mutant clone - i.e., selection against FISCs
expressing the wild-type PIG-A gene product), is consistent with the association of the AS trait with
autoimmune diseases. We hypotliesize that a subtie mutation(s) I polymorphism(s) in the FIG-A
gene be a candidate iocus for skewed Xi pattems in hematopoietic Jineages. Supporting evidence
stems from the following: like PNH, the AS Irait has i) a HSC origin, ii) a putative immuno
modulating role, iii) associated with hemolysis and iv) a rote for extrinsic factors (cigarette smoke
in the case of AS) in trait evolution.
AS trait (DS andASDs scores) and eosinophil counts
Increasing DS and AS scores of hematopoietic lineages were associated with a decrease in
eosinophul counts, suggesting an X-linked genetic basis to eosinophul counts. Physiologically, since
eosinophils are implicated in varlous biological fiinctions, the relation with clinical data merits
discussion. Although vanous allergic diseases are associated with eosinophulia, ASDS scores were
flot associated with allergic conditions such as asthma and use of med-aftergy [Table b) XXXIV
(page 171-172)], thus arguing against such a relationship. Altemativeiy, since the naturai role of
eosinophils is to defend against parasites, we conjecture that AS (DS and ASDS scores) be
associated with an increased occurrence of parasitic infections. However, sïnce parasitÏc infections
are not common in Québec, this type of data was flot availabie ftom our female participants, thus
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meriting investigation in a more relevant population. Nonetheless, employing the extrinsic model of
(E AS, the finding suggests that in Iack of particular environmental factors (parasites),
genetic determinant(s) which offer resistance to parasitic infections (i.e., X-linked allelïc variants
coding for high eosinophui numbers versus low number allele) have a relative growth disadvantage,
selectively eliminated with advancing age. An other hypothesis may be that females preferentially
expressing X-linked genetic factors coding for high eosinophul numbers demonstrate a survival
disadvantage, selectively eliminated with advancing age. In fact, since eosinophilia is associated
with increased ail-cause mortality (Hospers et al., 2000), we speculate that increasing blood
DS/AS scores, thus decreased eosinophil count, be associated with increased longevity. The latter
may be a significant factor as to why women live longer then men. Although a role for skewed Xi
pattems in the Iongevity differences between males and females lias been previously addressed
(Christensen et aI., 2000), this is the first piece ofevideace linldng )URs and eosinophul counts with
Iongevity. A prospective study examining the relationship between XIRs, eosinophul count and
Iongevity is thus merited.
BloodXi-skewing (DS score) andpÏatelet count
A possible association may exist between Increasing blood DS scores and a decrease in platelet
count, suggesting skewed Xi pafterns in blood may be associated with increased bleeding, mild
thrombocytopenia andlor reduced thrombotic complications (thrombosis and hemorrhage). Lack of
an association with the AS trait limits the relationship to DS scores ofhematopoietic lïneages.
Whether ail three hematoiogic fïndings are reiated to a single X-linked gene is presently unclear. If
liinited to a single gene, it is likely to have pleiotropic activity. Alternatively, if multiple genes are
implicated, one specific for each liematopoietic lineage, the etiology of skewed Xi pattems is likely
to be family-speciflc. The latter poses a limitation to genetic linkage studies as multiple loci may be
identified. To circumvent this problem, Xi traits may be sub-phenotyped by additional clinical /
biological features such as hemoglobin concentration, eosinophil and platelet counts for example.
As such, genetic linkage studies can be performed on subtypes of skewed Xi traits, thus increasing
the power of linkage analysis by plausibly decreasing genetic heterogeneity.
Clinical cousequence ofthe pnmary Xi paffem
Primwy Xi pattern and asthma
Increasing D$ scores were associated with an increased reporting of asthma and use of med-asthma.
And since the primary XIR is relatively stable with advancing age (as presented in Part I), we
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speculate that a skewed Xi pattem in TIC tissue poses a risk-factor (rather then a consequence) of
asthma susceptibility.: increasing D$ scores equates with increased asthma susceptibility.
Moreover, since asthma is associated with eosinophilia (De Monchy et al., 1985), we anticipated a
positive relationship between BC DS score and eosinophil count. However, as seen in Table a)
)OOUII (page 169-170), TIC DS scores were flot associated with eosinophil counts, arguing against
such a relationship. One possibility may be that the clinical condition ‘asthma’, as it was self
reported, may in fact be a related phenotype (chronic obstructive pulmonary disease (COPD) for
example), thus possïbly unrelated to eosinophul counts. Interestingly, the negative relationship
between eosinophul counts and AS (DS and AS scores) is speculatively unrelated to the relationship
between skewing (DS scores) and asthma since the former is linked to the AS trait while the latter
to the primary Xi trait.
A plausible association between asthma and skewed Xi pattems is consistent with published data
where an X-linked genetic component to asthma susceptibility was reported (Lynch et al., 1999). In
this seminal paper, the researchers mapped the gene for the human cysteiriyl leukotriene receptor- 1
(CysLT1) — an important mediator of human bronchai asthma, to the long arm of the X
chromosome (Xq I 3-Xq2 1). In addition to the Cy5LT1 receptor, a second is CysLI2, both of which
are activated by cysteinyl leukotrienes (LIC4 LTD4. LIE4) — important mediators of bronchial
asthma (Lewis et al., 1990). Biochemical analyses found that activation of the CysLT1 receptor by
leukotriene D4 (LTD4) resulted in hallmark features of asthma: constriction and proliferation of
smooth muscle tissue, eosinophil migration, edema, and damage to the mucosal lining of the lung.
Consequently, treatment of asthma has included pharmacologic development of CysLT1 — selective
antagonists. Another important X-linked mediator of asthma is interleukin- 13.
XCE-Ïike locus may influence expression ofX-tinkedgenes
Atthough the mechanism by which a primary skewed Xi pattem increases the susceptibility to
asthmalCOPD is presently unclear, one can theorize that upregulation of the X-linked CysLT1
receptor gene may pose a risk-factor for asthma susceptibitfty. Since the molecular consequences of
a primaiy skewed Xi pattem are unknown, one can theorize that the Xce iocus, in addition to
influencing overali probabitity of undergoing Xi, increases expression of particular (or
chromosome-wide) gene expression. Supporting evïdence was drawn from twin studies which
demonstrated stronger correlation of X-linked gene expression in MZ versus DZ twins (Brewer
et al., 1967), thus consistent with a role of genetic factors influencing quantitative X-linked gene
expression. Consequentiy, mcreased expression of CysLT1 for exampie, wilI translate into an
increased susceptibility to asthmalCOPD. Quantitative expression analysis of the CysLT1 receptor
in skewed versus non-skewed females is thus merited. That the CysLIj receptor is expressed in
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both PB leukocytes and smooth muscle tissue is consistent with our resuits, namely an association
C of asthma with increasing DS scores in both hematopoietic lineages and a NHT (i.e., BC).
Altematively, since T lymphocyte release of IL-14 and IL-4 can also up-regulate CysLT1 receptor
expression, a fiirther possibility may be that the PS trait affects T lymphocyte immune function.
In spite of a positive association between increasing BC DS scores and asthma susceptibility,
eosïnophil count was flot associated with BC DS scores. Interestingly however, eosinophil count
was ‘inversely’ related to increasing DS and ASDS scores in hematopoietic lineages. One reason
may be the use of anti-allergie therapies such as corticosteroids, anti-leukotrienes and anti
interleukin-5 among asthmatic patients, resulting in downregulation of eosinophul survivallcounts
((Wallen et al., 1991), (Gauvreau et aL, 2000)). However, controlling for med-asthma (Table
)OOUII, page 169-170) did flot alter the relationship between eosinophil count and D$ / ASDS
scores, evidence against the latter. As such, the relationship between the primary Xi pattern and
asthma susceptibility is likely unrelated to decreasing eosinophil counts as a function of increasing
blood DS / ASDs scores.
Preferentiat inactivation ofXm versus Xp
When parental derivation of the skewed (preferentiafly inactive) X chromosome was tabulated
among ail families carrying at least one sibling with a skewed Xi pattem in BC, Xm was found to
be preferentially inactivated versus Xp (n=74 versus n52, p0,O5O). Several explanations are
possible. 1) Females with the patemal X prefercntially inactivated in BC tissue have a survival
disadvantage, and are relatively elïminated with advancing age. Parental derivation ofthe skewed X
in young females versus older females may provide insight. 2) Altematively, the finding may
suggest a parent-of-origin effect. As such, perhaps the matemally derived X, relative to the patemal
one, is more susceptible to the inactivation signal during embryogenesis. If consistent with an XCE
like etiology of skewed Xi pattem, a possible mechanism may be that the action ofXCE-like alleles
are deperident on parental derivation. That is, consistent with the model in mice where Xce ailele
strength ïs correlated with methytation status, it is possible that XCE-like alteles are preferentially
methyiated (thus relatively stronger) when patemally versus matemally derived, resuhing if
preferential inactivation of the maternaI X. This hypothesis is consistent with stronger social
(verbal) skills in Tumer syndrome females whom have acquired Xp relative to Xm, consistent with
the notion that some X-Iinked genes are preferentially expressed when paternally versus maternally
derived. 3) A final possibility may be that the findings are artifactual, possibly reflecting a bias in
PCR amplification ofthe inactive Xrn versus the inactive Xp. That is, perhaps Xp is relatively more
heterochromatic versus Xm, therefore less accessible to PCR amplification. However, that the DNA
144
is denatured to 94°C prior to amplification (thus relaxing secondary DNA structures) argues against
C the latter.
Clinical associations of the AS trait
AS cwd susceptibility to RA
Both increasing DS and ASDS scores of hematopoietic lineages were associated with a significant
decrease in self-reported RA. Since RA has an autoimmune component, the fmding supports
published data Jinking skewed Xi pattems with protection from autoimmune-related phenotypes
(Martin-Villa et a1, 1999). This fmding implies that a RA-related gene(s) resides on the X
chromosome, in keeping with published data (Jawaheer et aI., 2001). A candidate gene in vicinity to
marker DXS6897 bas been postulated. Three models have been invoked to elucidate the findings. i)
Extrinsic factor(s) influencing selection of X-linked alleles. Hypothetically, similar to negative
selection of autoreactive T lymphocytes in the thymus or negative selection of HSC bearing wild
type PIG-A expression (versus FIG-A mutations) in an aplastic BM environment, perhaps the BM
environment (stromal layer, macrophages, fibroblasts and/or endothelium), for whatever reason,
may be dictating negative selection ofHSC bearing X-linked RA susceptibility aÎlete(s). ii) Intrinsic
factor(s) (X-linked genetic variants) goveming HSC growth kinetics. Assuming that a relative
growth advantage is gained by HSC expressing an X-linked RA protective allele versus a RA
susceptibility allele, the AS trait may reflect the growth competition conferred by HSCs expressing
RA protective allele(s). Nonetheless, in light that RA demonstrates a femate preponderance possibly
exacerbated by sex hormones, if our hypothesis holds true, we speculate that with advancing age,
since the frequency of the AS trait increases with aging, female preponderance of RA should
decrease. Epidemiologic analysis of RA as a function of advancing age is warranted for
confirmation. iii) Another possibility may be that females bearing X-Iinked RA susceptibility
allele(s) (versus RA protective allele) on the preferentially active X are selectively eliminated with
advancing age. Thus AS should reflect survival offemales bearing RA-protective allele(s).
AS and immune-modulation
Interestingly, increasing ASDS scores were associated with a ‘decreased’ occurrence of miscarriages.
Because multiple miscarriage occurrences have been associated with autoinunune disorders
(Shelton et al., 1994), we hypothesize that the AS trait may be associated with immune-modulation,
specilically with a ‘Iess’ autoreactive immune system. Supportive findings are reduced eosinophil
counts, and reduced reporting of RA with increasing DS and ASDS scores. A candidate gene may
reside in the region of Xq2$ as a small deletion mapped to this region has been associated with a
high rate of SA (Pegoraro et al., 1997). However, that about 70% of human conceptions are lost
145
before implantation, thus flot expected to be reported as miscarriage, may open the possibility that
(E perhaps miscarriage occurrence ïs equal between skewed and non-skewed females but occurring
much earlier in skewed versus non-skewed females. Although this argues against AS playing a role
in ‘decreased’ autoreactivity (as it supports ‘increased’ autoreactivity to allo-antigens), it
nonetheless stili supports a role of AS in immune-modulation.
Unlike previous studies citing an association between skewed Xi pattems and invasïve ovarian
cancer (Buller et al., 1999), we found no significant association between )URs and ail-type cancer.
However, reanalysis of )URs as a function of individual cancer subtype (breast, ovarianlutems,
skin, lymphatic, digestive) requires further elucidatïon.
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Table XV. Descriptive statistics for hematologic indices. Ail informative females (97,5%) were
included. Mean values, range, mean proportion and standard deviations were reported.
parameter n Mean Count Range Mean
proportion
White blood ccli 1115 6,387 ± 1,75$ (10g I L) 2,500 - 22,100
Neutrophil 1115 3,$99 ± 1,441 (10g IL) 0,576 - 18,697 0,602 ± 0,082
Lymphocyte 1115 1,$4$±0,561 (109/L) 0,504-4,715 0,296±0,075
Monocyte 1115 0,457 ± 0,162 (10/ L) 0,121 - 1,760 0,073 ± 0,022
Eosinophil 1115 0,147 ± 0,10$ (10g / L) 0- 0,859 0,023 ± 0,017
Basophil 1 115 0,033 ± 0,055 (1O / L) O - 1,550 0,005 ± 0,010
Platelet 1115 236,4±56,$(1091L) 9-539
Hemoglobin 1115 132,33±9,33g/l 93-169
MCV 1114 91,04±4,l5fL 70,3- 103,6
Abbreviations: MCV, mean corpuscular volume
o
o
o
15
1
T
ab
le
X
V
I.
O
ut
iie
rs
re
m
o
v
ed
fro
m
he
rn
at
op
oi
et
ic
v
ar
ia
bl
es
fo
r
as
so
ci
at
io
n
an
al
ys
es
.
Th
e
cr
ite
rio
n
fo
r
re
m
o
v
al
fro
m
st
ud
y
w
as
ba
se
d
o
n
ex
tr
er
ne
v
al
ue
s
as
de
pi
ct
ed
in
Fi
gu
re
20
(pa
ge
14
6-
14
7).
Se
ve
ra
l
o
ft
he
se
o
u
tli
er
s
w
er
e
co
n
fir
m
ed
by
he
m
at
ol
og
ic
al
st
an
da
rd
s.
In
di
vi
du
al
s
o
u
tti
ne
d
in
ye
llo
w
sig
ni
fy
m
o
re
th
an
a
sin
gl
e
ce
Il
ty
pe
w
ith
an
ex
tr
em
e
v
al
ue
.N
o
o
u
tii
er
s
w
er
e
fo
un
d
fo
rM
CV
.
ID
fa
m
le
tte
r
W
B
C
n
e
u
tr
op
hî
l
ly
m
ph
oc
yt
e
m
o
n
o
cy
te
eo
si
no
ph
il
ba
so
ph
il
pl
at
el
et
he
m
og
lo
bi
n
52
7
10
g
22
,1
18
,70
9
31
2
19
e
0,
85
46
1
19
f
17
,9
15
,86
32
9
24
C
4,
72
1,
16
36
7
31
x
a
1,1
1
66
5
37
d
0,
65
3
41
c
15
,5
11
,93
14
46
U
1,3
6
91
62
b
0,
86
33
0?
63
g
14
,6
53
74
a
1,
76
41
7
80
e
0,
20
65
4
95
f
0,
63
19
8
11
3
x
c
0,6
1
42
$
11
6
c
11
,0
2
47
4
12
0
a
0,
70
99
6
12
7
e
1,1
1
99
7
14
2
h
0,
15
69
7
14
2
b
53
9
88
1
15
8
b
1,5
5
43
5
16
1
b
0,
64
74
7
16
8
x
a
0,
90
61
4
17
2
b
16
9
54
2
17
6
a
0,
67
To
ta
l
ex
clu
de
d
4
4
1
5
8
4
2
(M
152
Tabie XVH. Descriptive statistïcs of clinical data. Medical conditions and medicinal use were self
reported.
Clinical characteristics I medicinal tise n mean range
Mean date ofbirth 1144 1936,4 1908 - 1961
Mean age 1144 63,3 ± 10,0 3$-96
Ever had cancer 99 8,7%
- chemotherapy 13 1,1%
- radiotherapy 3$ 3,3 %
Asthma $9 7,8%
Anemia 36 3,2%
$LE 3 0,3%
Rheumatoid artbritis 70 6,1%
Hormone replacement therapy (HRT) 539 47,1%
Med-allergy 9 0,8 %
Med-anti-conv 20 1,7 %
Med-anti-inflam 192 16,8 %
Med-asthma 3$ 3,3 %
Med-other 438 38,3 %
Med-hcart 441 38,5 %
Mcd-hemato 44 3,8 %
Med-vit-other 749 65,5 %
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(J Table XVIII. Descriptive statistics of smoking habits. Discrete variables included current smoker
and ex-smoker. The continuous variables years-smoke and pack-years (pack/day x years-smoked)
are the cumulative of both current and ex-smoker. If the subjcct was a non-smoker, a false value of
O was assigned for ycars-smoke and pack-years. Non-smokers were given a nuli value for years
stop smoking.
Smoking characteristic n mean range
Discrete variables:
Current smoker I $9 16,5 %
Ex-smoker 37$ 33,0%
Continuous variables:
Pack-years (current and cx) I 12$ 7,4 ± 13,7 0-99,2
Years-smoke (current and ex) 1139 10,2 ± 14,5 0-60
Years-stop smoking 546 13,5 ± 13,2 0-65
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Table XIX. Descriptive statisties offamily / parity data.
n mean range
No. of participation familles 193 - -
No. offemale siblings I family - 7,1 ± 2,1 4-14
No. ofparticipatiug female sibllngs I family - 5,6 ± 1,6 3-12
Number of male siblings 905 4,7 ± 2,2 0-11
Participatmg mothers 37 19,2 % -
Living children 2,9 ± 2,0 0-18
Daughters 1816 1,6 ± 1,$ 0-11
Sons 1762 1,5± 1,6 0-12
Offspring sex-ratio 932 0,49 ± 0,32 -
Ever had spontaneous abortioWmiscarriage 352 308 % -
Number of miscarriages 0,49 ± 0,95 0-9
0 794
I 21$
2 90
3 26
4 $
5 3
6 0
7 3
s I
9 1
‘j
Note: two females (id 439, 571) had missing values for number ofmiscarriages.
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Table XX. Association between age and hematopoietic indices. Blond outiiers were removed from
analyses. The relationship was analyzed by linear regression (LR), Generalized Estimating
Equation (GEE) and the SOLAR methods. When significant and known (pO,05), the direction of
relationship (+ or
-) is given in parentheses. Values in gray hidicate a statistical trend but p-values
are insignificant.
o
Age
Cd type u LR GEE SOLAR
.
p-value p-value p-value(dependant variable)
WBC count 1 111 0,090 (+) 0,075 0,0 17
Neutrophil count 1110 0,052 (-1-) 0,07 1 0,046
Lymphocyte count 1114 0,076 f-) 0,092 0,82
Monocyte count 1110 <0,0001 (+) <0,0002 (+) 2,$x107
Fosinophil count 1 107 0,0002 (+) 0,0026 (±) 0,00 15
Basophilcount 1111 0,059 (+) 0,113 0,016
Plateletcount 1113 0,074 (-) 0,126 0,2$
ilemoglobin conc. 1114 <0,0001 (-) <0,000 1 (-) 0,0043
MCV (fL) 1114 0,0005 (-) 0,0033 (-) 0,03$
Abbreviations: conc, concentration; MCV, mean corpuscular volume
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Table XXL Association between age and clinical data: medical conditions and medicinal use. The
relationship was analyzed by LR, GEE and SOLAR methods. Clinical data was collected on 1144
females. When signilicant (pO,O5) and known, the direction ofrelationship is given in parentheses.
Medical condition / Age
medicinal use LR GEE SOLAR
p-value p-value p-value
Cancer 0,03 7 (±) n.d. n.d.
- chemotherapy 0,30$ n.d. n.d.
- radiotherapy 0,157 n.d. n.d.
asthma 0,55$ n.d. 0,8
anemia 0,15$ n.d. n.d.
SLE 0,947 n.d. n.d.
RA 0,006 (±) n.d. 0,0034
HRT <0,0001 (-) n.d n.d.
Med-allergy 0,$01 n.d. n.d.
Med-anti-conv 0,887 n.d. n.d.
Med-anti-inflam <0,000 1 (±) n.d. n.d.
Med-asthma 0,193 n.d n.d.
Med-other <0,0001 (+) n.d. n.d.
Med-heart <0,0001 (+) n.d. n.d.
Med-hemato 0,696 n.d. n.d.
Med-vit-other 0,07$ nd. n.d.
Abbreviations: n.d., flot determined
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() Table XXII. Association between age and smoking characteristics. The relationship was analyzed
by LR, GEE and the SOLAR method. When significant (pO,O5), the direction of relationship is
given in parentheses. Years-smoke and pack-years of smoke are the cumulative of current ami ex
smoker. Smoking habit is the dependent variable.
Age
LR GEE SOLAR
Smoking habit p-value p-value p-valus
Current smoker <0,000 1 (-) n.d. n.d.
Ex-smoker 0,001 (+) n.d. n.d.
Years-smoke (current and ex) 0,0003 (-) n.d. n.&
Pack-years smoke (current and ex) <0,0001 (-) n.i 0,00011
Years-stop smoking <0,000 1 (+) nd. n.d.
Abbreviations: n.d., not determined
o
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s Table XXIII. Association between age and parity data. The relationship was analyzed by LR, GEE
and the SOLAR statistical methods. When significant (pOO,05), the direction of relationship is
given in parentheses. a) bi-variate analyses, b) multi-variate analyses
a) bi-variate analyses
Age
Parity data LR GIE SOLAR
(dependant variable) p-value p-value p-value
Had a miscarriage 0,0001(+) n.d. n.d.
Number ofmiscarriages <0,0001(+) n.d. 5x107
Offspring sex-ratio (including mothers) 0,022 (+) n.d. n.d.
Offspnng sex-ratio (exciuding mothers) 0,197 n.d. n.d.
Number ofchildren <0,000I(+) n.d. n.d.
G
b) Muhi-variate analysis (GLM)
Age
Parity data Dependant variable
p-value
Had a miscarriage 0,871
Number ofmiscarriages 0,144
Offspring sex-ratio (exciuding mothers) 0,416
Nuniber ofchildren <0,0001 (+)
Abbreviation: n.d., flot determined
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(D Table XXV. Association between clinical data and parity. Age was included as a confoundingvariable when significant (sec Tables )OU and )OUH, pages 156, 15$). When significant (pO,O5),
the direction of relationship is given in parentheses. Parïty data was the dependent variable.
Medical condition or Parity data
medicinal therapy had a number of offspring number of
(dependant variable) miscarriage miscarriages sex-ratio children
Chemotherapy
-GLM (age) 0,622 0,965 0,59$ 0,831
Radiotherapy
-GLM (age) 0,503 0,841 0,35 8 0,577
URT
-GLM (age) 0,733 0,846 0,043 (+) 0,300
Med-al]ergy
-GLM (age) 0,355 0,189 0,276 0,623
Med-anti-conv
-GLM (age) 0,927 0,980 0,3 77 0,202
Med-anti-inflam
-GEM (age) 0,111 0,15$ 0,844 0,017 (+)
Med-asthma
-GLM (age) 0,297 0,04$ (+) 0,892 0,223
Med-other
-GLM (age) 0,98$ 0,200 0,284 0,400
Med-heart
-GLM (age) 0,0 10 (+) 0,055 (+) 0,5 16 0,004 (+)
-GLM (age, num ofchildren) 0,057 0,200 - -
Med-hemato
-GLM (age) 0,576 0,4 19 0,749 0,188
Med-vil-others
-GLM (age) 0,103 0,934 0,643 0,190
Cancer
-GLM (age) 0,150 0,141 0,49$ 0,084
Asthma
-GLM (age) 0,060 (+) 0,102 (+) 0,211 0,473
Anemia
-GLM (age) 0,851 0,60$ 0,744 0,272
SLE
-GLM (age) 0,929 0,764 0,747 0,222
RA
-GLM (age) 0,156 (+) 0,03 1 (+) 0,887 0,042 (+)
-GEM (age, num ofchildren) 0,346 0,083
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Table XXVI. Association between smoking habits and clinica] data. The relationship was analyzed
Q by LR, GLM and SOLAR method in some instances. Age was included as a covariate whennecessary. When significant (pO,O5), the direction ofrelationship is given in parentheses. Direction
of association is not given for the SOLAR method.
Smoking habit
Medical condition or Current- Ex- Pack-years Years-smoke Years-stop
medicinal therapy smoker smoker smoke
(dependant variable)
Chemotherapy
-LR 0,389 0,802 0,246 0,196 0,61$
Radiotherapy
-LR 0,920 0,682 0,187 0,054 0,063
HRT
-GLM (age) 0,034(-) 0,124 0,525 0,849 0,119
Mcd-allergy
-LR 0,181 0,181 0,541 0,87$ 0,75$
Anti-convulsants
-LR 0,673 0,371 0,246 0,517 0,380
Anti-inflammatory
-GLM (age) 0,763 0,780 0,160 0,105 0,275
Med-asthma
-LR 0,902 0,620 <0,000 1 (+) 0,002 (+) 0,40$
Med-other
-GLM (age) 0,162 0,507 0,003 (+) 0,0002 (+) 0,442
Med-heart
-GLM (age) 0,891 0,949 0,0 18 (+) 0,003 (+) 0,163
Med-hematopoietic
-LR 0,34$ 0,512 0,139 0,287 0,351
BRT
-GLM (age) 0,055 0,112 0,521 0,847 0,078
Med-vit-others
-LR 0,195 0,315 0,740 0,705 0,504
Cancer
-GLM 0,532 0,308 0,975 0,246 0,084
Asthma
-LR 0,930 0,69$ 0,002 (+) 0,175 0,466
-SOLAR 0,16 nd 0,0087 nd nd
Anemia
-LR 0,065 (+) 0,020 (-) 0,592 0,393 0,152
SLE
-LR 0,44 1 0,346 0,528 0,798 0,38$
RA
-GLM (age) 0,184 0,086 0,577 0,700 0,682
-SOLAR 0,034 nU 0,039 nU nd
163
(D Table XXVII. Association between smoking habits and blood counts (without outliers). Statistical
methods included: LR, GLM, GEE and $OLAR. When signilicant (pO,05), the direction of
relationship (± or
-) is given in parentheses. Hematopoietic indices were the dependent variable.
Smoking habit
Blood count Current- Ex-smoker Pack- Years- Years-stop
(Dependent variable) smoker years smoke smoke
WBC
-GLM (age) <0,000 1 ± <0,000 1 - <0,0001 + <0,0001 + 0,002 -
-GEE (age) <0,0001 + 0,819 <0,0001 + nU nd
-SOLAR 0,007 nU 0,0003 nU nd
Neutrophil
-GLM (age) <0,0001 ± <0,0001 <0,0001 + <0,0001 + 0,017 -
-GEE (age) <0,0001 + 0,894 <0,000 1 + nd nU
-SOLAR 0,08$ nd 0,0009 nd nd
Lymphocyte
-LR <0,0001 + <0,0001 - <0,0001 + <0,0001 ÷ 0,001 -
-GEE (age) 0,0007 + 0,500 <0,0001 + nd nU
-SOLAR 0,002 nd 0,031 nd nU
Monocytes
G
-GLM (age) 0,002 + 0,020 - <0,0004 + <0,0001 + 0,072
-GEE (age) 0,0042 + 0,716 0,0043 + nd nU
-SOLAR 0,12 nU 0,10 nU nd
Eosinophil
-GLM (age) 0,67 1 0,566 0,137 0,046 + 0,707
-GEE (age) 0,646 0,08$ 0,246 nd nd
-SOLAR 0,96 nd 0,39 nU nU
Basophil
-GLM (age) 0,022 + 0,410 <0,0001 + <0,0001 + 0,659
-GEE (age) 0,036 + 0,171 0,0012 + nd nd
-SOLAR 0,0002 nd 0,40 nU nd
Platelet
-LR 0,04$ + 0,2 12 0,02$ + 0,001 + 0,392
-GEE (age) 0,213 0,957 0,109 nd nd
-SOLAR 0,47 nd 0,12 nd nd
Hemoglobin
-GLM (age) <0,0001 + <0,0001 - <0,0001 + <0,0001 + 0,0001
-GEE (age) <0,0001 + 0,939 <0,000 1 + nU nd
-SOLAR 0,0038 nd 0,0014 nd nd
MCV
-GLM (age) <0,0001 + <0,0001 - 0,001 + <0,0001 + 0,002 -
-GEE (age) <0,0001 + 0,0 122 - 0,0002 + nU nU
-SOLAR 0,00003 nU 0,084 nd nU
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() Table XXVIII. Association between smoking habits and parity. When age was a sigrnficant
confounding variable (sec Tables XXII and XXIII, pages 157, 15$), it was included as a
confoundiiig variable. When significant (p0,05), the direction of relationship (+ or -) is given in
parentheses. Parity data was the dependent variable.
___
___
___
___
___
___
___
__
___
___
__
___
___
__
Smoldn habit
___
___
___
__
o
Parity data Current- Ex- Pack- Years- Years-stop
(Dependent variable) smoker smoker years smoke smoke
Rad a miscarnage
-GLM (age) 0,555 0,511 0,328 0,562 0,261
Number of miscarriagcs
-GLM (age) 0,535 0,444 0,544 0,466 0,746
-SOLAR 0,40 - 0,40 - -
Offspring sex-ratio
-GLM (age) 0,916 0,722 0,809 0,796 0,710
Number ofchildren
-GLM (age) 0,419 0,111 0,064 (-) 0,020 (-) 0,155
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G Table XXIX. Association betwecn parity and blood counts (without outiiers). When significant (sec
Table XX, page 155), age was included as a confounding variable, stated in parentheses next to
variable name. When significant (pO,O5), the direction of relationship (+ or -) is given in
parentheses. Blood count was the dependent variable.
Parity data
Blood count Had a Number of Offspnng Number of
(dependant variable) miscamage miscamages sex-ratio chiidren
WBC
- GLM (age) 0,470 0,23 5 0,507 0,976
Neutrophïl
- GLM (age) 0,9 19 0,445 0,486 0,641
Lymphocyte
- LR 0,373 0,563 0,442 0,$44
Monocytes
- GLM (age) 0,711 0,990 0.156 0,183
Eosinophil
- GLM (age) 0,165 0,377 0,126 0,03$ (+)
Q Basophil- GLM (age) 0,281 0,192 0,048 (+) 0,075
Platelet
- LR 0,527 0,859 0,257 0,533
Hemog Iobïn
- GLM (age) 0,706 0,082 0,411 0,363
MCV
- GLM (age) 0,202 0,5 19 0,911 0,080
Tabfr XXX. Covariates associated with hematopoietic indices: mukivariate analyses (GLM).
covanates WBC count covanates Basophil count
Age 0,3 77 Age 0,024 (+)
Med-asthma 0,380 Smoker 0,001 (+)
Med-heart 0,017 (+) Pack-years 0,918
Asthma 0,069
RA 0,928
Smoker 0,296
Ex-smoker 0,008 (-)
Pack-years 0,004_(+)
Neatrophil count Platetets count
Age 0,098 URT 0,03 5 (+)
Med-asthma 0,807 Smoker 0,263
Asthma 0,009 (+) Pack-years 0,104
RA 0,980
Smoker 0,61$
Ex-smoker 0,056
Pack-years 0,009_(+)
Lymphocyte count ifemogtobin conc
Chemotherapy 0,333 Age 0,063
Med-heart 0,16$ Mcd-asthma <0,0001 (+)
Med-hematopoietic 0,833 Med-other 0,005 (-)
$moker 0,052 Med-heart 0,180
Ex-smoker 0,00 1 (-) Med-hemato 0,896
Pack-years 0,05$ Memia <0,0001 (-)
Smoker 0,751
Ex-smoker 0,1 16
Pack-years 0,043 (+)
Monocyte count MCV
Age <0,000 1 (+) Age 0,025 (-)
Med-heart 0,145 HRT 0,073
Smoker 0,663 Med-anti-conv 0,015 (+)
Ex-smoker 0,560 Anemia 0,084
Pack-years 0,177 Smoker 0,776
Ex-smoker 0,055
Pack-years 0,609
Eosinophil_count
Age 0,179
HRT 0,04 1 (-)
Med-anti-inflam 0,01$ (+)
Med-asthma 0,634
Med-heart 0,062
Asthma 0,043 (+)
Number_ofchildren 0,337
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Table XXXI. Heritability estimates of confoundmg variables. Included m the analyses were blood
counts, number of mïscarriages and pack-ycars of smoke. Provided are heritabllity coefficients (h2),
standard error (SE) and corresponding p-values.
fleritabiity coefficient
Variable h2 +1- SE p-value
Biood counts
White blood ccli 0,27 +1- 0,056 lxlOE7
Neutrophil 0,22 ±1- 0,05 lxlOE7
Lymphocyte 0,43 +1- 0,06 1x107
Monocyte 0,40 +1- 0,06 lxlOE7
Eosinophil 0,25 +1- 0,056 lxi OE7
Basophil 0,14 +1- 0,08 0,045
Platelet 0,54 +1- 0,067 1x107
llemogtobin 0,38 +1- 0,061 txlOE7
MCV 0,66 +1- 0,067 lxlW7
Parfty data
Number ofmiscarriages 0,12 +1- 0,05 0,002
Smoking characteristics
Pack-years of smoke 0,1$ +1- 0,05 0,00002
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() Table XXXII. familial aggregation of the skewing (DS score 0,25) and AS (AS05 score 0,25)
traits. Metbods: A proband was randomly selected from each family and categorïzed as case
(skewed) or control (random X inactivation). The relative risk (RR) of skewing in remaining
siblings was then determined for cases (RR) and controls (RRtr). The relative risk ratio
(RRR), derived by the following ratio: RR, / provides an indication as to whether the
trait is aggregated within families. A RRR-score >1,00 is normally indicative of familial
aggregatïon of the trait. Enviromnental versus genetic influences however, are not discemible.
RRR-scores highlighted in bolU are significant (p-values given).
Cdl type and RR RRtmi RRR p-value
skewing trait (chi2-value)
BC skewing 11/81 = 0,1358 96/716 = 0,1341 1,01 p>0,95 (0,002)
PMN skewing 118/302 0,3907 179/510 = 0,3510 1,12 p>0,10 (1,66)
Monocyte skewing 115/265 = 0,4340 171/505 = 0,3386 1,2$ p<O,Ol (6,76)
T ccli skewing 37/154 = 0,2403 129/638 = 0,2022 1,19 p>0,25 (1,0$)
B ccli skewing 75/191 = 0,3927 144/595 = 0,2420 1,62 p<O,OOl (16,32)
PMN AS 39/1 17 = 0,3333 113/580=0,1948 1,71 p<O,0O5 (10,59)
Monocyte AS 66/191 =0,3455 104/472=0,2203 1,57 p<O,001 (11,19)
Tcell AS 15/58 = 0,2586 61/621 = 0,0982 2,63 p<O,00I (17,74)
B ccli AS 23/100 = 0,2300 $3/584 = 0,1421 1,62 p<O,Ol (5,03)
169
() Table XXXIII. Association between skewing and blood counts (wïthout outliers). Analyses
included LR, GLM and GEE. Confounding variables for GLM and GEE are stated in parciitheses.
P-values and the type ofrelationship (+ or
-) for DS score (a) and ASDS score (b) are provided.
A) DS score
ci
_
_
_
_
Blood Count BC PMN Mono T ceils B ceils
(dependent variable) p-value p-value p-value p-value p-value
WBC
-LR 0,242 0,46$ 0,675 0,584 0,326
-GLM (age, m-ast, m-hrt, ast, RA. smlç pk-)T, x-smk) 0,62$ 0,745 0,45$ 0,757 0,355
-GEE (age, sink, pk-yr, x-smk) 0,194 0,$02 0,387 0,68$ 0,161
Neutrophil
-LR 0,352 0,352 0,953 0,722 0,399
-GLM (age, m-ast, ast, RA, smk, pk-yr, x-smk) 0,943 0,965 0,764 0,829 0,227
-GEE (age, smk, pk-yr, x-smk) 0,272 0,911 0,475 0,243 0,1 $0
Lymphocyte
-LR 0,409 0,593 0,710 0,096 0,751
-GLM (chemotherapy, m-hi-t, m-hem, sink, pk-yr, x-smk) 0,230 0,451 0,634 0,332 0,902
-GEE (age, smk, pk-yr, x-smk) 0,407 0,507 0,984 0,107 0,857
Monocyte
-LR 0,572 0,074 0,473 0,765 0,472
-GLM (age, m-hi-t, smk, pk-yr, x-smk) 0,300 0,820 0,60$ 0,853 0,997
-GEE (age, smk, pk-yr, x-smk) 0,270 0,433 0,299 0,792 0,404
Eosinophi!
-LR 0,24$ 0,024 (-) 0,014 (-) 0,019 (-) 0,0019 (-)
-GLM (age, HRT, m-anti-in flam, m-ast, m-hi-t, ast, 0,466 0,004 (-) 0,004 (-) 0,010 (-) 0,0008 (-)
num ofoflpr)
-GEE (age, smk, pk-yr, x-smk) 0,091 0,007 (-) 0,004 (-) 0,041 (-) 0,0002 (-)
Basophil
-LR 0,504 0,135 0,851 0,265 0,983
-GLM (age, smk, pk-yrs) 0,653 0,327 0,596 0,241 0,989
-GEE (age, smk, pk-yr, x-srnk) 0,587 0,396 0,446 0,271 0,69$
Platdet
-LR 0,260 0,492 0,006 (-) 0,060 (-) 0,054 (-)
-GLM (HRT, pk-yr) 0,37$ 0,650 0,0 10 (-) 0,073 (-) 0,0$4 (-)
-GEE (age, smk, pk-yr, x-smk) 0,155 0,902 0,049 (-) 0,170 0,02$ (-)
Hemolobin
-LR 0,6 14 0,04$ (+) 0,022 (-f) 0,785 0,3 12
-GLM (age, m-ast, m-oUi, m-hi-t, m-hem, an, smk, 0,21$ 0,015 (+) 0,003 (+) 0,859 0,326
pk-yr, x-smk)
-GEE (age, smk, pk-yr, x-smk) 0,666 0,025 (+) 0,048 (-f) 0,833 0,427
MCV
-LR 0,330 0,11$ 0,533 0,091 0,400
-GLM (age, HRT, m-anti-conv, an, smlç pk-yr, x-smk) 0,049 (+) 0,689 0,974 0,268 0,479
-GEE (age, smk, pk-yr, x-smk) 0,663 0,116 0,920 0,012 (-) 0,209
B) AS score
G
170
Blood count Mono T cefls B celis
(dependent variable) p-value p-value p-value p-value
WBC
-LR 0,637 0,722 0,103 0,495
-GLM (age, m-ast, m-hit, ast, RA, smk, pk-yr, x-smk) 0,327 0,649 0,123 0,47$
-GEE (age, smk, pk-yr, x-smk) 0,142 0,463 0,053 0,246
Neutrophil
-LR 0,66$ 0,705 0,190 0,627
-GLM (age, m-ast, ast, RA, smk, pk-yr, x-smk) 0,1 5$ 0,476 0,073 0,277
-GEE (age, smk, pk-yr, x-smk) 0,107 0,207 0,073 0,234
Lymphocyte
-LR 0,927 0,306 0,7$0 0,883
-GLM (chemotherapy, m-hit, m-hem, smlç pk-yr, x-smk) 0,841 0,400 0,852 0,850
-GIE (age, smk, pk-yr, x-smk) 0,85$ 0,10$ 0,941 0,818
Monocyte
-LR 0,75$ 0,491 0,919 0,590
-GLM (age, m-hit, smk, pk-yr, x-smk) 0,406 0,657 0,772 0,899
-GEE (age, smk, pk-yr, x-smk) 0,234 0,11 1 0,764 0,212
Eusinophil
-LR 0,112 0,384 0,027 (-) 0,064 f-)
-GLM (age, HRT, m-anti-inflam, m-ast, m-hrt, ast, num of offspr) 0,141 0,482 0,065 (-) 0,050 (-)
-GEE (age, smk, pk-yr, x-smk) 0,035 (-) 0,357 0,013 (-) 0,01 1 (-)
Basophil
-LR 0,15$ 0,283 0,461 0,324
-GLM (age, smk, pk-yrs) 0,394 0,457 0,450 0,434
-GEE (age, smk, pk-yr, x-smk) 0,315 0,542 0,475 0,59
Platelet
-LR 0,066 (+) 0,716 0,132 0,615
-GLM (HRT, pk-yr) 0,065 (+) 0,730 0,118 0,61$
-GEE (age, smk, pk-yr, x-smk) 0,043 (+) 0,78$ 0,061 0,7 14
Hemoglobin
-LR 0,800 0,935 0,457 0,921
-GLM (age, m-ast, m-oth, m-hrl, m-hem, an, smlç pk-yr, x-smk) 0,418 0,463 0,3 79 0,974
-GEE (age, snrk, pk-yr, x-smk) 0,665 0,984 0,203 0,962
MCV
-LR 0,667 0,486 0,06$ 0,225
-GLM (age, HRT, m-anti-conv, an, smk, pk-yr, x-smk) 0,873 0,136 0,840 0,534
-GEE (age, smk, pk-yr, x-smk) 0,510 0,20$ 0,190 0,05 9
Abbreviations: m-ast, med-asthma; m-hit, med-heart; ast, asthma; smk, cuffent smoker; pk-yr,
pack-years of cigarette smoke; x-smlç ex-smoker; m-hem, med-hemato; m-oth, med-other; an,
anemia; m-anti-conv, med-anti-conv; num of offspr, number of oflpring
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Table XXXIV. Association between skewing and clinïcal data. Analyses included LR, GLM and
GEE. Confounding variables are prmted in parentheses. P-values and direction of relationship (+ or
-) are given when known for DS score (a) and ASDS score (b).
A) DS score
Clinical data BC PMN Mono T celis B cefls
(dependant variable) p-value p-value p-value p-value 7-value
Cancer
-LR 0,594 0,650 0,43$ 0,156 0,611
-GLM (age) 0,546 0,8 14 0,567 0,180 0,671
-GEE (age) 0,479 0,703 0,440 0,133 0,680
Chemotherapy
-LR 0,876 0,131 0,524 0,6$3 0,685
-GLM (lymphocyte) 0,$98 0,131 0,523 0,601 0,714
Radiotherapy
-LR 0,889 0,537 0,323 0,145 0,743
-GLM (years-smoke, years stop-smoke) 0,080 0,700 0,544 0,960 0,816
Asthma
-LR 0,032 (+) 0,032 (+) 0,123 0,143 0,160
-GLM (WBC, neut, eos, pk-yr) 0,05 1 (+) 0,02$ (+) 0,113 0,129 0,104
-GEE (age, ces, pk-yr, pk-yr sec) 0,063 0,016 (+) 0,054 (+) 0,101 0,105
Anemia
-ER 0,69 1 0,902 0,291 0,634 0,742
-GLM (hemo, MCV, smk, x-smk) 0,409 0,26$ 0,913 0,773 0,545
-GEE (age, MCV) 0,605 0,940 0,242 0,887 0,605
SLE
-LR 0,647 0,57$ 0,176 0,522 0,237
RA
-LR 0,546 0,048 (-) 0,040 (-) 0,3 17 0,829
-GLM (age, WBC, neut, smk, x-smk) 0,534 0,062 (-) 0,059 (-) 0,784 0,399
-GEE (age) 0,604 0,007 (-) 0,0 10 (-) 0,326 0,708
HRT
-LR 0,634 0,023 (-) 0,48$ 0,745 0,214
-GLM (age, eos, plat, MCV, smk) 0,365 0,226 0,980 0,08 1 0,40$
Med-alkrlijr
-LR 0,721 0,397 0,261 0,314 0,531
Med-anti-inflam
-LR 0,21$ 0,610 0,627 0,909 0,269
-GLM (age, ces) 0,205 0,74$ 0,297 0,805 0,121
Med-asthma
-LR 0,331 0,028(+) 0,111 0,771 0,112
-GLM (WBC, neut, ces, hemo, pk-yr) 0,304 0,0 13 (+) 0,081 (+) 0,453 0,041 (+)
Med-hcart
-LR 0,765 0,084 0,135 0,885 0,749
-GLM (age, WBC, Iymp, mono, ces, hemo, pk-yr) 0,679 0,996 0,783 0,96$ 0,543
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B) AS score
Abbreviations: eos, eosinophil count; pk-yr, pack-years of cigarette smoke; pack-yrs cig sec, pack
years of cigarette smoke second-hand smoke exposure; RA, rheumatoid arthritis, SUE, systemic
Clinical condition PMN Mono T cefls B ceils
(dependant variable) p-value p-value p-value p-value
Cancer
-LR 0,797 0,489 0,147 0,632
-GLM (age) 0,525 0,697 0,200 0,813
-GEE (age) 0,559 0,654 0,245 0,8 10
Chemotherapy
-LR 0,053 0,513 0,884 0,506
-GLM (lymphocyte) 0,056 0,567 0,900 0,498
Radiothcrapy
-LR 0,854 0,863 0,46$ 0,967
-GLM (years smoke, years stop smoke) 0,91 1 0,685 0,287 0,895
Asthma
-LR 0,196 0,487 0,692 0,756
-GLM (WBC, neut, eos, pk-yr) 0,182 0,3 96 0,8 13 0,707
-GEE (age, cos, pk-yr, pk-yr sec) 0,130 0,37$ 0,978 0,514
Anemia
-LR 0,277 0,026 (-) 0,066 (-) 0,033 (-)
-GLM (hemo, MCV, smk, x-smk) 0,775 0,31$ 0,143 0,701
-GEE (age, MCV) 0,292 0,002 (-) 0,219 0,050 (-)
SUE
-LR 0,103 0,590 0,138 0,266
RA
-LR 0,095 0,083 0,782 0,540
-GEM (age, WBC, neut, smk, x-smk) 0,045 (-) 0,093 -) 0,587 0,632
-GEE (age) 0,064 (-) 0,057 (-) 0,81$ 0,471
HRT
-LR 0,711 0,365 0,341 0,556
-GLM (age, ces, plat, MCV, smk) 0,88 8 0,211 0,303 0,761
Med-allergy
-LR 0,740 0,176 0,987 0,424
Med-anti-inftam
-LR 0,697 0,111 0,279 0,276
-GLM (age, ces) 0,336 0,055 0,147 0,209
Med-asthma
-LR 0,808 0,643 0,070 0,505
-GLM (WBC, ncut, ces, hemo, pk-yr) 0,666 0,58$ 0,139 0,572
Med-heart
-LR 0,893 0,709 0,16$ 0,771
-GLM (age, WBC, Iymp, mono, ces, hemo, pk-yr) 0,051 0,291 0,041 (-) 0,533
lupus erythematosus; HRT, hormone replacement therapy
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Table XXXV. Parity data and skewing (search for X-]inked disease alleles). Analyses included LR,
GLM and GEE. Confounding variables are given in parentheses. P-values and direction of
relationship (+ or
-) are provided for DS scores (a) and ASDS scores (b).
A) DS score
B) AS5 score
Parity data PMN Mono T cdils B ceils
(dependant variable) p-value p-value p-value p-value
Offspring sex-ratio
-LR 0,957 0,656 0,571 0,882
-GLM (FRT) 0,97$ 0,696 0,522 0,8 19
-GEE (age) 0,841 0,701 0,359 0,972
Miscarriage occurrence
-LR 0,046 (-) 0,1 1$ 0,247 0,141
-GLM (age, med-hrt, num ofchild) 0,030 (-) 0,036 (-) 0,260 0,041 (-)
-GEE (age) 0,019 (-) 0,057 f-) 0,235 0,0%
Numbcr of misca triages
-LR 0,290 0,443 0,422 0,474
-GLM (age, med-asthma, RA, nuin of child) 0,197 0,253 0,355 0,2 12
-GEE (age) 0,167 0,28$ 0,356 0,419
Number of offspring
-LR 0,592 0,123 0,865 0,070
-GLM (age, med-anti-inflam, med-hrt, RA) 0,259 0,57$ 0,620 0,437
o
Panty data BC PMJ1 Mono T ceils B ceils
(dependant variable) p-value p-value p-value p-value p-value
Offspring sex-ratio
-LR 0,610 0,948 0,305 0,316 0,979
-GLM (HRT) 0,599 0,859 0,289 0,311 0,964
-GEE (age) 0,590 0,9 13 0,379 0,355 0,934
Miscarriage occurrence
-LR 0,50$ 0,140 0,454 0,793 0,444
-GLM (age, med-hrt, num ofchild) 0,692 0,132 0,336 0,731 0,455
-GEE (age) 0,393 0,04$ (-) 0,267 0,687 0,302
Numbcr of miscarriages
-LR 0,907 0,429 0,984 0,383 0,4 19
-GEM (age, med-asthma, RA, num of child) 0,857 0,384 0,876 0,49$ 0,479
-GEE (age) 0,687 0,330 0,73$ 0,480 0,540
Number of offspring
-ER 0,349 0,954 0,544 0,722 0,941
-GLM (age, med-anti-inflam, med-hrt, RA) 0,1 19 0,047 (-) 0,456 0,727 0,553
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() Table XXXVI. Association between smoking habits and skewing: role of smoke as a plausible
environmental stimulus. Analyses incltided LR, GLM and GEE. Confounding variables are
provided in parentheses. P-values and direction of relationship (+ or -) are provided for DS scores
(a) and ASDS scores (b).
A) DS score
o
Ccli type — skewing Current Ix-smoker Pack-yrs
(dependant variable) smoker p-value p-value
p-value
BC
-LR 0,277 0,740 0,903
-GLM (asthma) 0,284 0,730 0,91$
-GEE (age) 0,375 0,27$ 0,920
-SOLAR 0,07 - 0,19
PMN
-LR 0,384 0,55 1 0,97$
-GLM (age, eos, hemo, asthma, RA, HRT, m-ast, SA) 0,167 0,600 0,941
-GEE (age) 0,077 0,972 0,581
-SOLAR 0,11 - 0,71
Monocytes
-LR 0,840 0,620 0,497
-GLM (age, eos, plat, hemo, RA) 0,534 0,702 0,7 14
-GEE (age) 0,569 0,92 1 0,949
-SOLAR 0,60 - 0,70
Tcefls
-LR 0,353 0,251 0,082
-GLM (eos) 0,346 0,233 0,15 1
-GEE (age) 0,297 0,022 (-) 0,089
-SOLAR 0,20 - 0,09
Bcells
-LR 0,314 0,082 0,264
-GLM (eos) 0,230 0,579 0,57 1
-GEE (age) 0,2 14 0,089 0,385
-SOLAR 0,04 - 0,07
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B) ASDS SCOre
Celi type — skewing Current smoker fx-smolœr Pack-yrs
(dependant variable) p-value p-value p-value
PMN
-LR 0,3 75 0,457 0,079 (+)
-GLM (age, SA) 0,067 (+) 0,204 0,012 (+)
-GEE (age) 0,061 0,7$7 0,009 (+)
-SOLAR 0,7$ - 0,59
Monocytes
-LR 0,325 0,202 0,168
-GLM (age, anemia) 0,074 (+) 0,0$ 1 (-) 0,069 (+)
-GEE (age) 0,083 0,569 0,032 (+)
-SOLAR 0,74 - 0,61
Tcefts
-LR 0,664 0,470 0,65$
-GLM (age, eosinophil) 0,26$ 0,342 0,999
-GEE (age) 0,59 1 0,581 0,720
-SOLAR 0,81 - 0,72
Bcells
-LR 0,553 0,565 0,766
-GLM (age, anemia) 0,1 $9 0,31 $ 0,491
-GEE (age) 0,319 0,343 0,3 $6
-SOLAR 0,52 - 0,72
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Table XXXVIL familial resemblance of XIRs; familial correlation and heritability estimates by
ANOVA and SOLAR statistical methods trait analysis included I) DS and ASDS scores (magnitude
of Xi skewing) and ii) PAmat and ASpA,, scores (magnitude aiid direction of skewing). a)
Deviation from random Xi (DS and PAmat scores). for the primary I BC )UR, although the
magnitude of skewing (DS score) was flot significant]y related among siblings, direction of skewmg
(PAmat score) was, implying an X-lmked genetic component. A significant h2 coefficient supports
the latter. Among hematopoietic lineages, both DS and PAmat scores were significantly related
within families (ANOVA resuits) and demonstrated significant heritability coefficients (SOLAR
resuits), consistent with an X-linked genetic component to derivation of blood )URs. T ceils
interestingly, demonstrated the strongest familial resemblance for PAmat scores, implying a strong
X-linked genetic component. b) AS Irait (ASDS and scores). With the exception of the PMN
ASDS score, ail hematopoietic lineages demonstrated significant resemblance of AS0 and ASpft
scores witbin families. This was compiemented by modest heritability coefficients, consistent with
an X-Jinked genetic component in derivation of AS scores. An extremely significant p-value for T
ceil scores and a strong heritabillty coefficient imply a strong X-linked genetic component
to derivation of T ceil AS.
n) Xi skewing trait: deviation from random Xi
BC PMN Monocytes T ceils B ceNs
p-value p-value p-value p-value p-value
DS
ANOVA: p-value 0,242 2,9x104 2,$x104 5,2x1OE5 1,3x1 W7
SOLAR: p-value (h2) 0,1$ (0,035) 0,005 (0,11) 4x104 (0,21) 4x104 (0,20) 3x1OE7 (0,24)
PAmat
ANOVA 3,3x1OE9 1,lxlW5 2,7x1OE5 1,6xlOE’2 7,3x104
SOLAR; p-value (h2) I x1OE (0,30) 1,1x105 (0,22) 5x1 W5 (0,20) lxi W7 (0,3 $5) 9,2x107 (0,20)
b) AS trait: deviation from the primary Xi pattern
PMN Monocytes T ceNs B cetls
p-value p-value p-value p-value
AS9
ANOVA: p-value 1,5x104 5,2x103 2,1x104 1,5x1OE5
SOLAR p-value (h2) 0,05$ (0,069) 1,2x1 W5(0,20) 5,6x1 W5 (0,17) lxi0 (0,30)
ASpA11t
ANOVA: p-value 8,2x104 7,8x104 3,lxlW” 3,lxlW5
SOLAR p-value (h2) 6,3x1 (0,23) 6x1 W5 (0,23) 1x1 W 0,36) 7x105 (0,20)
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Table XXXVIII. Segregation analysis of skewed Xi pattems. a) skewed Xi paftern in BC tissue
(DS score 0,25), b) skewed Xi pattern in PMN (DS score 0,25), e) AS trait in PMN (ASDS score
0,25). families where at least one sibling demonstrating a skewed Xi pattem (X preferenhially
inactivated) and where parental derivation (Xp versus Xm) was known were included in the tables
below. ‘Family TD’ refers to family number; ‘Number skewed’ refers to the number of Xi skewed
sïblings per family, ‘X skewed (observed)’ refers to the number of siblings demonstrating a skewed
Xi pattera for a parental specific X (Xp versus Xm); ‘Direction of skewing (observed)’ refers to the
same values as in column ‘X skewed (observed)’, however only when n2 siblings demonstrated a
skewed Xi pattera were included. further, preferential inactivation of a parental-specific X was
redressed as ‘same’ (i.e., versus the index case, the number of siblings Xi skewed in favor of the
same parental X) and ‘different’ (i.e., versus the index case, the number of siblings Xi skewed in
favor of the altemate parental X); ‘Direction of skewing (expected)’ refers b the expected number
of sibllngs demonstrating a skewed Xi pattem in favor of the same parental X (same) versus
number of individuals expected to inactivate the altemate parental X (different) if skewed Xi
patterns were determined exclusively by stochastic processes.
a) slœwed Xi pattern in BC tissue (DS score 0,25)
family ID Number X skewed (observed) Direction ofskewing Direction ofskewing
skewed (observed) (expected)
Xm Xp Saine Different Same Different
2 ¼ 1 0
4 1/6 1 0
9 ¼ 1 0
10 1/7 0 1
14 2/5 1 1 1 1 1 1
15 21$ 2 0 2 0 1
17 1/6 1 0
26 1/10 1 0
27 1/5 0 1
29 ¼ 1 0
33 2/7 2 0 2 0 1 1
41 1/5 0
44 1/6 0
47 1/6 1 0
50 1/3 1 0
53 2/4 2 2 2 0 1 1
59 1/8 1 0
64 ¼ 0 1
6$ 2/9 2 0 2 0 1 1
71 2/9 1 1 1 1 1 1
73 ¼ 1 0
78 2/6 0 2 2 0 1 t
79 2/5 2 0 2 0 1 1
$0 115 1 0
$2 1/5 1 0
83 1/5 0 1
87 ¼ 1 0
91 ¼ 1 0
94 1/3 0 1
96 2/5 1 1 1 1 1 1
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98 1/3 1 1
O 99 215 2 0 2 0100 2/3 0 2 2 0102 ¼ 1 0
103 2/5 2 0 1 1
104 3/5 3 0 3 0 2
107 1/8 1 0
10$ ¼ 1 0
113 1/6 1 0
114 ¼ 1 0
115 1/1 1 0
120 2/4 2 0 2 0
121 5/8 5 0 5 0 3 2
122 1/6 0 1
123 3/6 0 3 3 0 2
124 ¼ 1 0
125 1/6 0 1
128 ¼ 1 0
131 ¼ 0 1
134 2/4 0 2 2 0
136 1/6 1 0
137 ¼ 0 1
141 1/5 0 1
142 ¼ 1 0
143 1/5 1 0
144 1/5 1 0
145 3/6 1 2 2 1 2
147 ¼ 0 1
14$ ¼ 0 1
149 1/7 1 0
152 2/5 1 1 1 1
153 2/6 2 0 2 0
154 ¼ 0 1
155 2/5 2 0 2 0
160 1/5 0 1
162 ¼ 0 1
16$ 2/3 0 2 2 0
169 1/5 0 1
170 1/6 0 1
172 217 0 2 2 0
174 1/8 0 1
175 1/5 1 0
176 1/7 0 1
17$ 1/6 1 0
185 ¼ 1 0
187 1/6 0 1
1$$ 1/5 1 0
1$9 1/5 1 0
191 3/7 0 3 3 0 2
194 1/7 0 1
201 1/ 0 J
204 1/11 1 0
205 1/6 1 0
207 2/6 1 1 1
213 11$ 1 0
215 1/6 1 0
216 ¼ 0 1
217 2/6 0 2
____
2 0
o
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21$ 115 1 0
220 1/9 1 0
222 3/9 2 1 2 1 2 1
91 126/492 74 52 54 $ 34 2$
b) Skewed Xi pattern in PMN (DS score 0,25)
Family ID Number X skewed (observed) Direction of skewing Direction ofskewing
skewed (observed) (expeded)
Xm Xp Same Different Saine Different
2
3
4
5
6
7
9
10
12
14
15
16
17
20
21
24
25
26
27
29
31
33
35
36
38
41
42
43
44
46
50
53
54
56
57
5$
59
61
62
63
M
65
66
67
68
69
70
2/4
4/6
2/4
2/4
2/3
¼
2/7
¼
4/5
3/8
1/3
1/6
¼
¼
¾
1/3
6/10
2/5
2/4
1/6
1/7
2/5
¾
I/I
2/5
3/5
3/6
5/6
1/5
2/3
¾
1/3
2/6
¼
4/5
4/8
11$
1/5
4/7
4/4
1/3
1/6
215
3/9
1/6
4/6
2
2
4
I
o
I
O
4
2
o
I
O
1
o
I
2
2
I
I
2
I
I
o
o
2
4
I
I
2
I
2
o
2
3
O
3
2
O
o
I
2
o
3
o
I
o
I
1
2
o
I
I
O
I
I
O
I
o
3
o
4
I
o
o
o
o
2
o
2
3
1
I
o
1
I
O
o
I
2
I
I
o
I
2
1
I
I
I
1
2
2
4
I
I
2
I
4
2
3
4
I
2
2
2
2
3
2
4
I
2
2
2
3
3
2
I
2
3
o
I
o
I
I
O
I
O
I
O
2
I
o
o
I
o
o
I
I
I
I
o
2
I
1
2
I
J
I
2
2
I
1
2
2
2
3
J
I
2
1
2
2
3
2
I
2
2
2
2
2
2
I
I
2
1
I
I
1
2
I
I
3
I
I
I
I
I
I
I
2
I
I
1
2
2
2
2
I
I
2
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71 419 4 1 4 - 0 2 2
Q 72 1/5 1 073 ¼ 1 074 ‘/ 0 1
76 2/4 2 0 2 0 1 1
77 ¼ 0 1
7$ 216 0 2 2 0 1 1
79 3/5 2 1 2 1 2 1
$0 215 2 0 2 0 1 1
$1 3/4 2 1 2 1 2 1
$2 4/5 3 1 3 1 2 2
$3 4/5 1 3 3 1 2 2
91 4/4 4 0 4 0 2 2
92 2/5 0 2 2 0 1 1
93 4/6 3 1 3 1 2 2
94 2/3 1 1 1 1 1 1
95 1/6 0 1
96 3/5 1 2 2 1 2 1
97 ¼ 1 0
98 213 1 1 1 1 1 1
99 1/5 1 0
100 2/3 0 2 2 0 1 1
101 2/4 1 1 1 1 1 1
102 ¼ 1 0
103 2/5 2 0 2 0 1 1
104 5/5 5 0 5 0 3 2
105 3/7 0 3 3 0 2 1
107 2/8 2 0 2 0 1 1
10$ 1/4 1 0
111 4/4 2 2 2 2 2 2
113 2/6 0 2 2 0 1 1
114 2/4 2 0 2 0 1 1
115 1/1 1 0
116 2/$ I I J I J
117 2/5 2 0 2 0 1 1
118 1/6 0 1
120 2/4 2 0 2 0 1 1
121 3/8 3 0 3 0 2 1
122 2/6 0 2 2 0 1 1
123 3/6 0 3 3 0 2 J
124 4/4 3 1 3 1 2 2
125 2/6 1 1 1 1 1 1
127 4/6 3 1 3 1 2 2
12$ 1/5 1 0
129 2/$ J I 1 1 1 1
131 2/4 1 0 2 0 1 1
133 2/4 1 1 1 1 1 1
136 116 1 0
137 2/4 2 1 1 1 1 1
13$ 2/6 0 2 2 0 1 1
140 2/5 2 0 2 0 1 J
141 1/5 1 0
142 2/2 2 0 2 0 1 1
143 2/5 2 0 2 0 1 1
144 1/5 1 0
145 5/6 1 4 4 J 3 2
147 2/4 1 1 1 1 1 1
14$ 2/4 1 1 1 1 1
______
1
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c) AS trait in PMN (A çscoreO,25)
Family ID Number X skewed (observed) Direction ofskewiig Direction ofskewing
skewed (observed) (expected)
Xm Xp Saine Different Saine Diffetent
2 1/1 0 1
3 ¾ 2 1 2 1 2 1
4 1/6 1 0
5 ¼ 0 1
6 2/4 1 1 1 1 1 1
10 1/7 0 1
12 ¼ 0 1
14 4/5 4 0 4 0 2 2
15 3/$ 0 3 3 0 2 1
16 1/3 0 1
17 1/6 1 0
182
21 1/4 1 0
Q 25 1/3 0 126 4/10 1 3 3 1 2 229 1/4 1 0
31 2/6 1 1 1 1 1 1
35 2/5 2 0 2 0 1 1
42 2/5 0 2 2 0 1 1
43 1/6 1 0
44 2/6 2 0 2 0 1 1
46 ‘/ O I
47 1/6 1 0
50 1/3 0 1
53 1/ 0 1
5$ 4/5 2 2 2 2 2 2
59 31$ 2 1 2 1 2 1
63 2/7 1 1 1 1 1 1
M 2/4 1 1 1 1 1 1
66 1/6 0 1
67 2/5 1 1 1 1 1 1
68 2/9 1 1 1 1 1 1
71 2/9 2 0 2 0 1 1
72 2/5 2 0 2 0 1 1
74 Y4 0 1
75 1/5 0 1
76 1/4 1 0
80 1/3 1 0
81 2 1 2 1 2 1
$2 1/5 0 1
$3 3/5 1 2 2 1 2 1
91 ‘/4 1 0
93 2/6 1 1 1 1 1 1
94 1/3 0 1
95 1/6 0 1
96 1/5 0 1
97 ‘/4 1 0
9$ 213 1 1 1 1 1 1
101 ¼ 0 1
104 1/5 1 0
105 3/7 0 3 3 0 2 1
107 1/8 1 0
113 2/6 0 2 2 0 1 1
114 ¼ 1 0
115 3/3 0 3 3 0 2 1
116 2/8 0 2 2 0 1 1
117 2/5 2 0 2 0 1 1
118 1/6 0 1
120 y O i
121 2/8 0 2 2 0 1 1
123 2/6 2 0 2 0 1 1
124 2/4 1 1 1 1 1 1
127 2/6 1 1 1 1 1 1
129 2/$ 1 1 1 1 1 1
131 2/4 2 0 2 0 1 1
133 2/4 1 1 1 1 1 1
137 ¼ 1 0
138 1/6 0 1
140 2/5 2 0 2 0 1 1
141 1/5 0 1
_________ _________ _________
—
142
143
144
145
147
149
150
152
155
15$
160
162
163
166
168
169
173
174
175
176
17$
1$’
185
186
187
lxx
195
200
201
202
204
205
207
209
213
214
215
216
217
220
222
2/4
2/5
1/5
3/6
¼
1/7
¾
2/5
1/5
1/3
3/5
1/4
1/5
3/5
2/3
4/5
4/9
5/8
3/5
4/7
3/6
2/7
¼
2/9
3/6
3/5
1/1
2/8
1/2
1/5
2/11
1/6
1/6
1/1
2/2
1/6
3/6
¼
2/6
1/9
3/9
1
2
1
O
1
o
o
1
o
I
2
I
3
2
o
3
5
o
2
3
o
o
I
I
O
o
o
I
O
2
o
1
I
2
o
I
o
2
I
1
I
O
o
3
o
I
3
I
O
o
o
o
O
4
I
O
3
2
o
2
2
3
2
o
I
o
1
o
o
o
1
2
I
O
o
2
2
3
3
1
2
3
2
4
3
5
3
2
3
2
I
2
3
2
2
2
2
2
2
O
O
o
1
o
o
o
I
O
o
2
o
o
I
O
o
O
o
I
o
I
2
2
2
2
2
2
3
2
2
2
I
2
2
1
2
2
I
I
1
I
I
I
I
2
2
2
I
2
1
I
I
I
1
I
I
I
I
I
110 200/571 99 101 119 29 $3 65
o
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Chapter V
CONCLUSION, PERSPECTIVES AND FUTURE DIRECTIONS
J $5
5.7 Conclusion
b further elucidate the etiologies and characterization of Xi phenotypes in human females, a cohort
population of French Canadian females were recruited for study analysis. This was a monumental
work necessitating recruitment of 193 families (1144 females) from various regions of the province
of Québec Canada, the Iargest study of its kind. Because analysis of Xi phenotypes in human
females is confounded by two unrelated phenotypes: the primary Xi trait versus the secondary (or
acquired) Xi pattern of blood ceils. methodologies to effectively distinguisli and quantitate the two
were developed. Careful analysis of the literature suggested that Xi patteras of NHTs were
generally body-wide and relatively resistant to secondary factors of skewing (X-linked disease
alleles). Consequently, the Xi pattern of a NHT (i.e., BC tissue) was used to further characterize the
primary Xi trait and used as a control tissue te quantitate AS. Because a higher incidence of
skewing occurs in P3 versus NHTs, we speculated that the acquired from of skewing (i.e., AS)
represents deviation from the primary Xi trait. Thus methodologies were derived to further
characterize and quantitate the AS trait. In fact it was quantitated by measuring deviation from the
primary (BC) XIR. This is the first study to our knowledge utilizing such a measure ofthe AS trait.
Pnmary Xi trait
12,4% of females demonstrated a skewed Xi pattera in BC tissue, a low incidence of skewing
similar to that found in cord blood of neonates. Age- DS score analysis of BC tissue suggested that
the incidence of skewing was retatively stable between the ages 3 8-96 yo, implying a stable Xi trait.
Convincing support for a primary (body-wide) Xi pattera was derived by significant intraindividual
correlation of PAmat scores between BC tissue and hematopoietic lineages. Lack of complete
correlation however may be explained by the AS trait occurring in hematopoietic.
Genetic (X-linked) component to variability ofBC XIRs
Because the X-linked Xce locus in mice plays a role in derivation of the primary Xi paftern, we
speculated a similar mechanism may be occurring in humans. That PAmat scores of BC tissue was
signïficantly similar between siblings (h2=O.30) and that the X of same parental derivation (i.e., Xp
versus Xm) was preferentially inactivated among siblings is consistent with an X-linked genetic
component (possibly XCE-Iike) influencing the primary Xi pattern. If so we speculate genetic
linkage of skewed Xi patteras in 3C tissue to the XIC region. These findings provide clear and
rational support to map the trait(s) influencing variability of the primary Xi pattera. plausibly
identifying the long sought XCE locus and/or factors implicated in the choice step of Xi.
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Clinicalfindings associated with the BC XII?
The primaiy Xi pattern (BC DS score) was associated with an increased reporting of asthma I
COPD, suggesting a primary skewed Xi pattem may pose a risk factor for asthma / COPD
susceptibility. A possible mechanism may be upregulation ofX-linked asthma /COPD susceptibility
aileles as a consequence ofa prhiiary skewed pattem.
AS trait
Great undertakings were initiated to characterize the AS trait as a function of independent
hematopoietic lineages, the first such extensive study of its kind. Two sets of variables were used to
quantitate the AS trait of hematopoietic lineages: i) deviation from random Xi (DS and PAmat
scores) and ii) deviation from the primaly Xi pattem (ASDS and AS scores). Versus BC tissue, a
higher incidence of skewing was observed in hematopoietic lineages. And because DS score-age
analyses found the incidence of skewing of hematopoietic lineages to increase with age, the higher
incidence of skewing was attributed to the AS trait. Utilizing both sets of variables to measure AS, a
hig-ier incidence of skewing was observed in PMN, monocytes and B celis versus T lymphocytes.
The higher incidence of skewing in PMN versus T ceils vas previously reported and may reflect
longevity differences between short-iived myeloid versus long-iiveU T ceils andlor other etiologies.
Hematopoietic stem ceil origin ofAS
Supporting evidence for a HSC origin of AS was derived by strong intraindividual correlation of
PAmat and scores among PMN, monocytes and B celis.
Genetic (X-linked) component to variability ofAS values
Significant correlation ofPAmat and ASpAmat scores among siblings and significant concordance in
direction of AS (i.e., preferential inactivation of a parental-specific X) among siblings, with h2
coefficients ranging from 0,39 h2 0,20 is consistent with both genetic (plausibly X-linked) and
stochastic (possibiy environmental factors such as cigarette smoke) influencing the AS trait,
consistent with a multifactoriai trait. Evidence of a genetic factor provides clear and rationai support
to map the AS gene(s). X-linked candidate genes possibly include any gene that can influence fISC
kinetics: growth factors, transcription factors, intracellular transduction molecules, chemokines and
related receptors. Aitematively, the entire X chromosome may be scanned for genetic linkage.
Hematologic associations ofthe AS trait
Although AS vas flot associated with variability of total WBC count, AS was associated with
variability of particular lineages. i) Increasing DS scores in hematopoietic lineages were associated
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with increasing hemoglobin concentration, suggesting AS may reflect selection ofX-linked allele(s)
coding for iow hemogiobin expression, a candidate gene could be FIG-A. ii) increasing DS and
ASDS scores were associated with decreasing eosinophul counts, suggesting a gene coding for
variability in eosinophii numbers is X-f inked and that the AS trait may reflect seiection ofX-Iinked
alleles coding for iow eosinophif numbers. Since eosinophils are implicated in ail-cause mortality,
the finding suggests AS may be associated with increased Iongevity.
Clinical associations ofAS
AS (DS and AS5 scores) was associated with a decreased reporting of RA, suggesting that the X
chromosome may code for a RA susceptibi]ity allele (consistent with publisbed data). The fmding
may suggest that the AS trait reflects selection ofX-linked RA protective alleIe(s).
Because the AS trait was associated with a decreased reporting of miscarriage occurrence, in
addition to decreased eosinophil count and decreased reporting of RA, a role for AS in decreased
autoimmune activity (or reduced disease susceptibility) is insinuated. Genetic identification of the
btood skewingfAS gene(s) may provide elucidation of genetic determinant(s) for these disorders,
possibly identifying immune-modulating gene(s). Whether a single gene of pleiotropic activity
andlor whether genetic heterogeneity is responsible for the various clinical features of AS merits
investigation. If severai genes are implicated, sub-phenotypes of skewed Xi patterns based on
clinical features vill assist in the genetic linkage studies, since individuals with a more common
phenotype are more likely to share a common genetic predisposition. 1f limited to a single gene
however, the finding is consistent with one of immune-modulation, thus affecting several
hematopoietic and immunological functions. An X-linked transcription factor controiling the
expression of various immunelhematopoietic related genes (which need flot be X-linked) is
plausible. The mechanism however by which this X-linked aileie(s) is favored as a function of
aging remains elusive. Consistent with the X-linked aliele competitive growth model of AS, one
possibility may be that the X-Jinked protective disease allele(s) confers an intrinsic growth
advantage to FISC. Altemativety, extrinsic factors such as cigarette smoke andlor the BM
microenvironment may dictate survival kineties of HSCs expressing particular X-Jinked ailele(s).
Other extrinsic factors which may be considered for further investigation include: bioactive
compounds (hormones, growth factors and cytokines), infectious agents, vaccines, diet, medicinal
products, pollutants and lifestyle factors (stress, psychological temperament and physical activity).
A final possibility may be that, in part, AS reflects survival of females bearing X-linked disease
protective allele(s).
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5.2 Perspectives and Future Directions
Aside from the various ‘additional works merited I warranted’ mentioned in the Resuits section,
additionai analyses sbould include the followinu.
Since the DS score of BCs sllghtly decreased with advancing age, analysis of younger females may
provide ftirther insi%ht as to whether a sinnificant decrease occurs with advancinOE ane. For a more
powerful analysis, XIR-age analysis may be anatyzed as a cross-sectional study of various age
groups.
Because cigarette smoke may be an environmental factor in the etiology of AS, in vitro studies to
identifv the bioIoicatly active constituent(s) and/or the hioloicat metabotite(s) altered in response
to cigarette smoke is warranted. However, as cigarette smoke contains over 3800 chemicals, many
bioIoicatty active (Vineis and Caporaso. 1995). identifvin% the active compound(s) appears
overwhe1minlv tedious.
Segregation analysis of the HUMARA Iocus among familles where the mother demonstrated a
skewed Xi paftern (DS score 0.25) in the PMN fraction (n=1 6) found that the preferetitiallv
inactive X was preferentially transmitted to daughters more often than expected by chance. That is,
ofthe 94 female offsprin ofthese mothers. 59 received the HUMARA allele ofthe preferentiallv
inactive X versus 35 the preferentially active X (59 of 94 meioses, pO,O13). This finding implies a
transmission-ratio distortion (TRD) ofthe maternai Xs. A similar findin was observed amonn male
offspring of skewed mothers (Naumova et aI., 1995). Possible mechanisms include meiotic drive
(biased se%renation duriwz rneiosis), ametic selection (differential success of 2amates achievin
fertilization) and postzygotic survïval selection based on particular genotypes, with the latter
seeminlv plavinu an important role (Zollner S et aL 2004). Reardiess of the rnechanism. our
finding suggests that the two maternai Xs in oocytes of skewed mothers are flot equal. One X (the
one that is preferentiallv inactive in maternai tissue) dernonstrates better survival kinetics when
paired with the paternally derived X versus the X that is preferentiafly active in maternai tissues.
This fïndinu insinuates that a ene(s) retated to fertilitv tesides on the X chromosome, consistent
with pubiished data (Lanasa and Hogge, 2000), (Di Pasquale E et al., 2004). Paradoxically, it
appears that while the X-[inked fertilily allele provides a relative survival advantage to develooing
embryos, it provides a relative growth disadvantage to adult HSCs. Nonetheless, it implicates the
AS ene in both embrvo survival kinetics and HSC rowth kinetics.
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Since blood skewing I AS may be associated with altered expression of immune related gene(s)
(E (cytokines, growth factors, associated receptors and transcription factors), expression analysis of
these factors in skewed versus non-skewed, by enzyme-linked immunoabsorbant assay, may
provide pivotai evidence.
In die event that power to detect linkage is insufficient, and providing additional familles are
available, an efficient mthod to recruit additional families is to analyze a single sibhing per family.
1f skewed (XIR score 0,25), the rest of the family could be recruited. On die other hand, if a
random XIR is found, die family could be dropped ftom enroilment. This is based on our findings
that familial aggregation is consistent with a genetic contribution. Although a biased approach, it is
efficient for genetic Iinkage analyses.
To hetp determine whether RA is a cause, a consequence or mutually exclusive with the AS trait, a
prospective study is merited. Ideally, a case (skewed) — control (non-skewed) group of females
(matched for age) without RA could be monitored for disease onset as a function of aging.
However, that die prevalence of both traits increase concurrently with advancing age, analysis may
prove inconctusive.
Because the FIIJMARA locus is reportedly associated with vanous diseases / conditions, and that
allele sizes have been determined for 90,8% of our study participants, the relationship between
allele size and self-reported diseases could be investigated. Moreover, and assuming i) that the
HIJMARA locus is a candidate gene for die skewinglAS trait and ii) that different alleles of the
CAGE polymorphism in exon I represent a gradient of alleles - each conferring a relative but
different growth advantage to HSC (akin to the relation between HUMARA allele length and
androgen receptor actwity in prostate cancer) - we hypothesize that the magnitude of skewing (DS
and ASDS scores) may be associated with HUMARA allele Iengths. For example, XIRs could be
analyzed as a function ofthe difference (allele I — allele 2) in HUMARA allele sizes.
That the incidence of the AS trait reported in our Québec population was similar to that observed in
European populations (35-56%) (Gale et al., 1997), (Tonon et al., 199$), (Christensen et al., 2000)
suggests a commonly found trait, ruling ont founder effects to explain die high ftequency of skewed
Xi pallems. Mternatively, die wide geographic range of AS argues in favor of a heterozygote
advantage. Nonetheless, as vanous regions of die province of Québec demonstrate characteristics of
a founder population, particularly the region of Saguenay, Lac-St-Jean, the incidence of skewed Xi
could be analyzed as a function of region, allowing potential detection ofa founder effoet.
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The heterozygote advantage mode! may be invoked to account for the high frequency of skewed Xi
(E by several models. i) Assumirig a genetic basis to variability of the AS trait, one method is to
analyze reproductive fitness measures among carriers of the trait allele versus non-carriers. In fact,
for the pnmary Xi pattem, no increased reproductive fitness was associated with the BC Xi paffem,
thus no link can be made with the primary Xi trait. Altematively, increasing ASDS scores were
associated with reduced reporting of miscarriage occurrence. However, since the AS trait is late
onset, thus unlikely to re&ct the Xi pafferu at time of parturition, and assuming that time of
miscarriage occurrence is the same between females with a low versus a high ASDS score, the
finding implies that women whom have iucurred a miscarriage are less Iikely to undergo AS. Since
the AS trait may reduce female susceptibility to RA and is associated with reduced eosinophil
count, invokes a link between AS and reduced autoimmune complications. As such, although
elderly females tbemselves may flot be reproductively active, that they are relatively heaithier may
imply beffer caring of thefr chiidren / grandchildren. Consequently, and speculatively, befter
conditions promotmg active reproductive choices for their chiidren. Consequently, AS susceptibility
alIele(s) are selectively passed on to future generations. further data corroborating this model can
be invoked by analyzing other measures of improved reproductive fitness and measures of
improved health in females demonstrating the AS trait versus non-AS females. ii) A further method
to support the heterozygote advantage mode! is to identi1y factors associated with the AS
susceptibility alIele(s) which increases the carrier’s probability of attaining age of reproductive
capability. Consistent with a role of the immune system, such factors could include increased
resistance to childhood diseases. iii) Genetic data to corroborate the heterozygote advantage mode!
includes 1) estimation of allele age, 2) number of trait-associated alleles and 3) inferred geographic
origin ofalleles (Risch N et al., 2003).
Because an association between )URs and diseases with a putative X-linked genetic component was
observed (i.e., RA, astiuna, miscarriages), investigation of other disease/syndromes with an X
linked genetic component is warranted. further, assuming diseases demonstrating a female
preponderance have an X-Iinked genetic component, the investigation of female preponderant
diseases (osteoporosis and Alzheimer’s disease (Gao et al., 199$) for example) as a function of
skewing is justifled. These studies may provide further elucidation in the role of skewed Xi in
femate health.
M a genetic (X-linked) component to variance of )URs was presented, segregation analysis may be
used to evaluate whether a major gene contributes to variability ofthe phenotype.
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Abstract
Nom-andom X-mactivation occurs m a significant proportion of normal females. This phenomenon is
thought to be caused by the small number of celis present at time of X-inactivation, most of which
stochastically inactivate the same X-chromosome. However, it is also possible that nonrandom X
inactivation is genetically determined as in the mouse Xce model. In this model, alleles of different
strengths have an influence, in cis, on which X chromosome is to be inactivated. To test for heritability of
nonrandom X-inactivation in humans, we examined X-inactivation ratios at the human androgen receptor
(HUMARA) Iocus in 142 heterozygous female neonate-mother pairs for concordance of nonrandom X
inactivation. Neonates were categonzed into two groups: those exhibiting random X-inactivation (1.0
ratio < 3.0) or those with nonrandom X-inactivation (ratio? 3.0). The incidence ofskewing in the mothers
ofnon-skewed neonates was 20.8% (26/125), while the incidence was 58.8% (10/17) in mothers ofskewed
neonates (p = 00018). Cornordance for nonrandom X-iiiactivation between neonates and their respective
mothers indicates that primary nonrandom X-inactivation is a heritabte trait in hemans, possibly determined
genetically. This implies that the estimation of the primordial hematopoietic stem oeil pool size cannot be
made accurately ifbased exclusively on the stochastic mode] ofnonrandom X-inactivation. No evidence for a
rare XIST mutation predisposing tu skewing was detected Further studies are required to determine whether
genetic ffictors are implicated in pnmary nonrandom X-inachvation.
(J Key words: X chromosome ïnactïvation, nonrandom X inactivation, HUMARA, Xce, XIST PGK
Introduction
X-chromosome inactivation allows gene dosage compensation between XX females and XY males.’
Malysis of X chromosome deletions and X-autosome transiocations have suggested X-inactivation to be
dependent oit a cis residing segment, termed the X-iiiactivation center (Xic),2’3 regionalized to Xq I 3•4
Brown et al identified a gene, localized to the same interval as Xic, that was expressed exclusively from the
inactive X (Xi).4’5 The gene was termed XJ$T for X-inactivation specific transcript. The human XIST gene
dors flot appear to encode a protein, but may fimction as a structural RNA.6 Penny et al have recently
provided clear evidence for the involvement ofXist in X-inactivation: X chromosomes bearing a knockout
Xist gene ml to undergo cis inactivation while the norma] X chromosome would undergo X-inactivation.7
In the developing normal embryo, both X-chromosomes of the new]y fertilized egg are in the active state.8
The flrst occurrence ofXIST expression was found at the 4-ceit stage and is limited to the trophoectoderm of
the developing blastocyst and is imprinted with exclusive expression of the unmethylated patemal allele9’1°
This is followed by preferential paternal X-inactivation in extraembryonic tissues. A genome wide
demethylation mechanism thought to occur between the $ oeil and the blastocyst stage is believed
responsibte for erasure of the parental imprints,10” I resultiiig in random XIST expression of the inner oeil
Vmass, hence random X-inactivation as seen at the gastrula stage. Once X-inactivation lias occurred, it is
stably inherited through successive ceil divisions.12 Random X-mactivation resuits in females being
mosaics for X-iinked aileles, with a baianced expression between maternai (Xm) and patemal (Xp)
afleles.’3 Any significant deviation from the theoreticai 1:1 ratio between the Xp/Xm is termed nonrandom
X-inactivation (synonymous for excessive Lyonization or skewing).
Clonai disorders such as leukemias (reviewed in 14), carrier states for a deleterious mutation on the X
chromosome such as in the Wiskott-Aldrich syndrome (reviewed in 15) and possiNy stem ceÎÎ depletion,1 6
1g cause skewed pafterns of X-inactivation. Furthermore, close to 25% of normal females exhibit
nonrandom X-inactivation paftems in blood-derived cefls.’921 These females are presuined to be
excessively Lyonized and exhibit no evidence for one of the causes of skewing above stated. The exact
etiology of primary nonrandom X-inactivation in normal females is flot kno. The most accepted
hypothesis is based on a pure stochastic model of X-inactivation, where inactivation occurs when the
primordial ccii pool is composed of as few as I O-20 celis.1 9,22 Accordingly, the variance ofthe distribution
of X-inactivation pallems in females wiil follow a binomial distribution with a significant proportion
carrying unbalanced X-chromosome inactivation pattems. In contrast to the situation in humans, a genetic
model for nonrandom X-inactivation lias been well documented in mice.23 The X chromosome controiiing
element (Xce) can bias the choice ofwhich X is to be inactivated during embryogenesis, thereby interfering
with the randomness of X-inactivation. Xce lias three weIi characterized alleles classified in a gradient of
strength: XceC > XceÏE > Xce”,24 whereby heterozygotes manifest nonrandom X-inactivation. Xce maps to
or within the vicinity of the Xic region,25 and lias been showr both biochemically24 and cytological]y26 to
cause primary nonrandom X-inactivation rather than secondary seiection of celis. furthermore, the effects
ofdifferent Xce alleles can modi1j the imprinted preferential inactivation ofXp in extraembryonic tissues.27
Recently, Xce and Xist were found to be separable genetic ioci.28
As in the mense model, demonstration of hentability of nonrandom X-inactivation in humans may provide
evidence for a genetic basis of skewing. Mthough the fàmilial ctustering of skewed X inactivation has been
previously reported (Orstavik, Pegoraro, P]enge, Naumova), thus imp)ying a genetic (X-]inked) genetic basis
to skewing, selection against X-linked mutant alleles is stiil a plausible mechanism, thus warranting ffirther
investigation. Nonctheless, the lack of highly informative X-inacflvation assays lias preciuded such
investigations in the past. The identification of a highly polymorphic CAG short tandem repeat in the first
exon ofthe X-linked human androgen receptor gene (FIUMARA) coupled with differential methylaflon sites
allowing the distinction between the active (Xa) and inactive X (Xi) chromosome has provided a powerfiul
means of analyzing X-inactivation patterns in more thaii 90% of females.29 The HUMARA assay bas been
validated in numerous studies,30’3’ ,32 and lias aliowed us to search for evidence of heritability of primary
nonrandom X-inactivation by analyzing the relationship between the degree ofnonrandom X-inactivation in
mother-daughter (neonate) pairs. Neonate-mother pairs were chosen because we have recently documented
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that the incidence ofnomandom X-inactivation increases with age in blood celis of normal females.33 The
incidence in female neonates was 8.6%, increasing to 16.4% in females close to 30 years old, and to 37.9%
in females aged 60 years and over. As neonates have flot been submitted to environmental exposure to the
same extent as older females, they represent a group where a genetic influence on primaiy nonrandom X
inactivation might be casier to detect.
Matenals and Methods
Normalfemale population.
Peripheral blood from 177 female neonate-mother pairs (total of 354 female individuals) was screened for
heterozygosity at the HUMARA locus under the auspices of institutional approval for analysis of anonymous
discarded blood samples. Only samples where both the mother and daughter were heterozygous for the
NUMARA Iocus were included in this study. The mother group was compnsed ofhealthy females comiiig
to the obstetric department for delivery. The neonatal group was comprised of at term heatthy singleton
babies. for this group, cord blood was selected instead of peripheral blood. Each of these lèmales were
hematologically healthy, had a normal CBC and WBC differential, including normal red cdl indices.
DNA extraction.
Peripheral blood was processed for DNA extraction as follows: 3-5 ml of peripheral blood was lysed with
Triton X-100 (Sigma, St.-Louis) lysis solution (0.32 M Sucrose; lOmM Tris pH 7.5; 5 mM MgCl; 1%
Triton X-100), digested with proteinase K in SDS buffer (Proteinase K 2 mglml, 5% SDS) at 37°C for 24
hours. Then DNA was extracted with phenol, phenol/chloroform and chloroform, precipitated with 2
volumes ofabsolute ethanol and 1/10 volume of 3 M sodium acetate, and resuspended in Tris-EDTA (TE)
buffer.
HUM4RA ctonality assay.
The HUMARA assay was carried out as previously described29 with minor modifications. Briefly, genomic
DNA was pre-cut by mixing sample DNA (IOOng-1 ig in 2 j.tl) with Hpa 11 (1 t1, high concentration, 40
U/t1), Rsa 1(0.5 pI, high concentration, 40 U/pl), L buffer (2 pI, Boehringer Mannheim) and H20 (14.5 pI).
M auto-control was prepared in the same way except that Hpa II was omifted from the mix. PCR
amp1cation ofthe HUM4RA locus: 2p1 of digested DNA were added to 23 jtI of a PCR mix containing
buflèr, dNTPs (200 tiM each); 12.5 pmol each primer: HUMARA 1 (5’-
GCTGTGAAGGTTGCTGTTCCTCAT-3’), and HUMARA II: (5’-TCCAGAATCTGTTCCAGAGCGTGC-
3’) ; DMSO (1.0 tl, Sigma); D-32P end Iabeled HUMARJ1. J primer (1.25 pmol), Taq polymerase (0.5 units,
Perkin Elmer-Cetus); H20 to final volume of 23 p1. Samples were amplified on a programmable thermal
cycler (MJ Research, hic.); initial DNA denaturation at 94°C for 3 min., then 2$ cycles starting with 94°C
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for 45 sec, 60°C for 30 sec and 72°C for 30 sec. Amplified PCR products (8-10 t1) were electrophoresed on
a 4% acrylamide-urea-formamide denaturing gel at 60 watts for approximately 3 hours.
Quantitation ofatteles.
The allele ratio was defined as the ratio between the two X-linked alleles in a given sample. The corrected
ratio (CR) was defined as the allele ratio of the pre-cut sample divided by the ailele ratio of the non-precut
sample ofthe same specimen. The CR compensates for potentiaÎ preferential amplification ofone ofthe two
alleles. Gels were exposed to high performance autoradiography film overnight at -80°C. Developed film
was scanned on a LKB Bromma Ultroscan XL laser densitometer (Pharmacia AB, Bromma, Sweden) and
the ratios between the two X-linked alleles were measured using Gel Scan XL software (Pharmacia LKB
Biotechnology AB, Bromma, Sweden).
Phosphoglycerate kinase (PGK)-PCR clonality assay (PPCA)
This technique was performed as described previously.34
Hha I restriction digest.
The restriction assay was carried out as previously described (Plenge) with minor modifications. Briefly, PB
DNA (30 ng) were added to 23 rI ofa PCR mix containing buffer; dNTPs (200 jiM each); 12.5 pmol ofeach
C primer: G7R (5’-GAAGTTGTGACTCCTGGTCT-3’) and GIOR (5’-GAGAGATCTTCAGTCAGGAAG-3’);
DMSO (4%), Taq DNA polymerase (0.5 units, BM); H20 to final volume of 23 rl. Samples were amplified
on a programmable thermal cycler (MJ Research, hic.); initial DNA denaturation at 94°C for 3 min., then
35 cycles starting with 94°C for 45 sec, 55°C for 30 sec and 72°C for 30 sec. Amplified PCR products (10
111) were electrophoresed on a 3% etidium bromide-stained agarose gel.
Criteriafor nonrandom X-inactivation
Criteria for nonrandom X-inactivation is arbitrary. However, to allow comparison with previous literature
we chose CR 3:1 which corresponds to greater than 75% expression ofone allele. This ratio was widely
accepted in the literature.’9’20’33’35’36
Statisticat anatysis.
Overali comparison ofthe two neonate categories (CR <3.0, CR 3.0), with respect to allele ratios in the
mother population, was performed via chi-square analysis or fisher exact test when appropriate.
Resuits
Incidence ofnonrandom X-inactivation.
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DNA samples of 142 of the 177 (80.2%) mother-neonates pairs were both heterozygous at the HUMARA
locus. The allelic ratio between the two X-linked alleles at the HUMARA iocus were detennined for cadi
individual. Tic overail incidence ofskewing (CR 3:!) in the maternai population was 25.4% (36/142).
These frmales were aged from 16 to 40 years old with a mean at 27.2 yo. The incidence of skewrng was
12.0% (17/142) in the neonate population. This increased incidence of skewhig with age was statistically
significant (p0.003$, L= 8.37).
Concordance in nonrandom X-inactivation between neonates and their mothers.
Allelic ratios for the neonate population were scored into two categories: skewed (n17) or non-skewed
(n=125). For the 17 skewed neoiates, 10 (58.8%) had mothers that were also skcwed. In contrast, ofthe
125 non-skewed neonates, only 26 (20.8%) had mothers that were skewed (fig 1). Statisticaliy, the
incidence of skewing in the mothers of skewed neonates was significantly different from that of non-skewed
neonates (p=0.00 1$, fisher’s exact test, 2-tau), figure 2 shows some examples cf skewed mother-daughter
pairs. Tic mean age of mothers of skewed neonates was 26.53 years old, which was not significantly
different from mothers ofnon-skewed neonates: 26.99 years old.
Parental origin ofthe inactive X chromosome in skewed neonates.
0f the 17 neonates found skewed (CR LI 3:1) by J-IU!vIARA analysis, $ had the patemal X skewed
(preferentialiy inactive), arid 9 had the maternai X skewed (data flot shown).
Concordance ofactivation states in skewed mother-neonate pairs
Analysis cf the activation status cf the transmitted X chromosome from parent to daughter is limited to the
analysis of maternai X’s. Ten of 17 skewed neonates had skewed mothers, thereby aliowing this aiialysis.
In 7 pairs the activation state was retained: the transmifted X was inactive in the mother and inactive in the
daughter (fig 2A), or the transmitted X was active and remained active in the daughter (fig 28). The
activity state was discordant in 3 pairs: the inactive X was transmitted but became preferentialiy active in
the daughter (fig 2C), or the active X was transmifted and became preferenfially inactive in the daughter
(fig 2D).
PGK-PCR clonality analysis.
0f the 17 neonates skewed by FIUMARA analysis, 7 were informative (heterozygous) for PGK anaiysis. Ail
7 were also skewed by PGK analysis (data not shown). Similariy, of tic 36 mothers skewed by 1-IUMARA
analysis, 15 were informative and skewed at the PGK iocus. The 7 non-skewed mothers of skewed neonates
were also tested, 3 were PGK informative and exhibited a random X-inactivation paftem. Lastly, 26 non
skewed daughters of skewed mothers were tested. Seven were PGK informative: 6 exhibited random X
inactivation pallems whiie one had a skewed paftern of X inactivation. Therefore, 31 of 32 (96.9%) had
concordant resuits at both bd.
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Xist minimalpromoter mutation.
A C-to-G mutation at position 43 in the minimal promoter ofthe Xist gene creates a novel flha I restriction
enzyme site. M internai Hha I site serves as an internai control. 0f the 17 mother-neonate pairs analyzed,
none exhibited the Xist promoter mutation (data not shown).
Discussion
In this study we have documented, for the first time, a highly significant correlation between the degree of
nonrandom X-inactivation in female neonates and their mothers. We found that a neonate with nonrandom
X-inactivation lias a 59% chance of having a mother exhibiting the same phenomenon. Only 20% of
neonates with random X-inactivation had a mother with a skewed pattem of inactivation. It bas been
possible to document convincingly the hentability ofnonrandom X-inactivation on account ofthe HUMARA
assay’s highly informative polymorphism. More than $0% ofmother-neonate pairs were heterozygous, thus
evaluable for concordance. In comparison, the analysis of other loci, sucli as PGK, would have aliowed the
analysis of only 10 % of mother-daughter pairs, which may have lead to an acertainement bias.
Furthermore, the skewing documented in the neonate population may correspond to primary nonrandom X
inactivation since their blood celis have flot been subjected to selective pressure or enviromnental factors to
the same extent as in older femaies. The presence ofphenocopies, as documented by the increase ofskewing
with age, would have obscured the heritability ofthe trait if older subjects were analyzed.
The aggregation ofskewing in mother-daughter pairs suggests that nonrandom X-inactivation is a heritable
trait in humans. IfX-inactivation was purely stochastic and nonrandom X-inactivation was a rare statistical
event where most colis have inactivated the same X only by chance, no concordance between the mother and
daughter would have been expected. However, heritabiÏity of skewing, as for any case of fiimiliality, could
be caused by shared environment or by genetic fiictors, either autosomal, mitochondrial or X-linked.. The
analysis of this observation is difficuit since nom-andom X-inactivation may be caused by several different
mechanisms occurring at different times in the development of the embryo (Table 1). Several of these
mechanisms may be heritaNe.
The possibility that heritability of skewing in humans is causcd by a cis-acting element that biases the choice
of the X to be inactivated has to be thoughtftuiiy considered. The evolutionary conservation of severaÏ
mechanisms and sequences responsible for X-inactivation in eutherians reinforces the possibility that the
mouse Xce may have an human equivaient. In fàct, the data obtained in the mother-daughter pairs does not
exciude an XCE model in humans. Strong XCE alleles can be transmifted by either parent and concordance
of activation state between a skewed mother and daughter is expected if the XCE locus is genetically iinked
to the HUMARA locus. The discordance of activation state in 3 ofthe 10 pairs could be due to the efforts of
recombination (genetic distance) between the HUMARA locus and a putative XCE iocus, or alternatively, to
the efforts of the paternal XCE allele, whose “strength” cannot be assessed relative to the maternai allele.
Another possibility is that these three discordant mothers are phenocopies, i.e. manifest skewing for other
Xreasons. and that the father is transmitting flue strong XCE allele. Is there further evidence for an XCE
model in hurnans? The only supporting evidence would corne from a unique family reported by Namnova,37
where an inhented pattern of nonrandom X-inactivation was observed in a healtiuy fanuly. Seven daughters
wcre skewcd with the patemal X being the prefercnfially active one. if the XCE model is operational in this
familv. the phenotype may be caused by an exceptionally strong allele that can completely bias the choice of
the X to be inactivated. However. [lue occurrence of such strong alleles is probably veiy rare: we have
analyzed 69 familîes composed of 387 individuals and found no such pattera of transmission (Mio R and
Busque L, unpublished). One possible limitation in the analysis of skewing in multigenerational families is
[lie increased incidence of skewing with age. This phenomenon is particularly signilicant aller the age of
60. Sïnce the cause(s) of acquired skcwing are flot known. several of these skcwed females may represent
phenocopies and obscure the evidence for specific genetic transmission of the skewing trait. This acquired
skewing phenomenon was evidcnt in [lie rnothcr-daughters pairs since the incidence of nonrandom X
inactivation was 12% in the neonates and 25.4% in the mothers (pO.OO3$). However, the mother’s age had
no effect on the incidence of skewing in [lue neonates since the mean age of mothers of skewed neonates was
the sarne as mothers ofnon-skewed neonates.
Mutations in the Xist promoter have also been implicatcd as a heritable cause of skewing. However. the
mutation was not detectabie in our 17 mother-skewed neonate pairs. furthermore, In [lue study by Plenge et
al., of 1166 independent X chromosomes analyzcd, only one was found to harbor the mutation, Titis
suggests it is a rare mutation and does not explain [lie majorfty of skewed individuals in the population.
Camer state for mutant X-hnked alictes is also associated with heritable skewing of the X chromosome,
siiuce celis witl; the active X carrving the deleterious gene are selected against. However, if the ;nother is
transmitting thc mutant allele. it is expccted fluai the maternai allele will be inactive in tue daughter. Thus
ail daugh[ers of skewed females will have [lie patemal X in the active state. This uvas not the case for 4 of
the 10 daughters of skewed mothers. Furthennore, the mutant allele model would imply that at least 12% of
flue normal female population carry deletenous genes on the X chromosome. There is no evidence for such a
higlt incïdence of X-linked diseases in the normal population.
Another theoretical rnechanism possibly associated with heritabilitv of skewing is the presence of a trans
acting factor [bat may influence the choice of the X to be inactivated. This factor could be X-linked.
autosomal. or even mitochondrial. The analysis of the mode of transmission has shown that a potential
skewing gene may be transrnitted by either parent. Titis would be Iess compatible wi[h mitochondrial
iniieritance but would favor autosomai or X-tinkcd inhentance. However. [hem is no definite documentation
ofa trans-acting factor [hat regulates X-inactivation. Mthough we have mainly considered genetîc factors so
far, several otlier rncchanisms may be tieritable. Even a pure stochastic model of X-inactivation may show
heritabilitv if the number of celis present at the time of X-inactivation varies in families. For exampie, if X
inactivation occurs when flue number of embrvoblasts is consistently lower in certain families. [bis will lead
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to an increased incidence of nonrandom X-inactivation in these farnilies. even in the absence of influence on
die choice of the X to be inactivated.
The documentation of hcritabïhlv. ii-respective of its cause. may force recvaluatïon of certain assertions made
in the past. For example, the incidence of nonrandom X-inactivation in normal females has been used to
evaluate [lie number of embiyological celis contributing to die hcmatopoïetic stem ceti pool, assuming a pure
stochastical model of X-inacfivation. The number of contnbuting celis estimated by this rnethod is relatively
low: 5y$19,22,4144 However, if other causes ofskewing such as a gendic predïsposïtion. as suggested hi
heritabilily of the trait. accounts for a significant proportion of skewed females. the estimation of the
primordial pool size has been underestimated.
The documentation of heritabititv of nonrandom X-inactivation justifies [lie efforts of mapping and
identifying die skewing gene(s). This wiII gain insight in the mechanism of X-inactivation and die
interactions between genetic factors and nonrandom X-inactivation. However, due to n multipiicity of causes
giving rise to skewed patterns of X-ïnacfivation, mapping of die skewing gene(s) may be a difficuit task.
Mapping strategies should focus on identifving n population with low phenocopies. The better
understanding of primarv nonrandom X-inactivation will help characterize the etiology of acquired skewing
documented in aging normal females. Titis may lead to a better understanding of [lie biology of
hematopoiesis with age.
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Footnotes
1. AbhreWations used in this paper: CR. corrected ratio: HUMARA. hurnan androgen-receptor gene; PGK.
phosphoglycerate kinase: Xa, active X chromosome: Xi. inactive X chromosome: Xm. maternai X
chromosome; Xp, patemal X chromosome: XCE. X chromosome controlling etement: MC. X-inactivation
center: )UST, X-inactivation spedilic transcript.
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Figure 1. Concordance of skewing in mother-daughter pairs. Neonates were categorized according to the
allelic ratios obtained at the HUMARA locus: skewed (ratio 3.0) or non-skewed (ratio < 3.0). The
incidence of skewing in respective mothers was 58.8 % (10/17) for skewed neonates and 20.8% (10/17) for
non-skewed neonates (p=O.00l$).
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Figure 2. Representative resuits of the HUTvIARA clonality assay in mother-daughter pair analysis. 0f
seventeen skewed neonates, ten had mothers that were also skewed - four pairs are shown above (samples A-
D). For the remaining seven neonates, mothers exhibited random X inactivation paftems (data flot shown).
Lane I (-) contains the auto-control, lane 2 (+) the ffpatI digested sample. Samples A and B, the status of
the matemally derived X is retained in the daughter. Samples C and D, the activation state ofthe maternally
derived X is flot retained in the daughter. Resuits are expressed as corrected ratios (C.R.). Ratios greater
than or equal to 3 represent nonrandom X-inactivation pattern. M, mother; D, daughter (neonate).
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Annex 2
SKEWED Xi AND LYMPHOCYTE CLONAHTY
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SKEWED Xi AN]) LYMPHOCYTE CLONALITY
C .Smce the frequency of clonai populations of lymphocytes increases with age (Posneft et al., 1994),
we set ont to determine whether lymphocyte clonality was contributing to the AS trait. In particular,
the clonai status of T and B lymphocytes (as determined by TCR-y and IgH gene rearrangements)
was analyzed as a function of the Xi phenotype (skewed versus non-skewed). For T lymphocyte
cionaiity, T-ceil receptor gene rearrangements at the (TCR)-y chain iocus were analyzed (Short et
al., 1996). for B lymphocyte clonality, rearrangements of immunogiobulin heavy chain (1gB) genes
were analyzed (Achulie et aI., 1995). Methods: For TCR-y and IgH gene rearrangements, DNA ftom
23 Xi-skewed (6Oyo) and 25 non-skewed (6Oyo) femaies were investigated (Xi skewing status
was determined by HUMARA analysis ofPMN celis). The criterion to delineate a clonai population
was the visuai assessment of a single or two predominant amplification products (bands). Resuits:
TCR-y gene rearrangement anatysis. As shown in Figure Annex 2-1 a) and b) (page xx), versus
the positive controls (Figure Annex 2-1 c) (page xx), clonai populations of T lymphocytes were
equaliy observed in both Xi-skewed and non-skewed females, suggesting T lymphocyte clonality
does not contribute to skewed Xi pattems. IgH gene rearrangement analysis. As shown in Figure
Annex 2-2 a) and b) (page xxi), die majority of females do not support clonai populations of B
lymphocytes. Further, the ftequency of B lymphocyte clonality was equally distributed among Xi
skewed and non-skewed femaies, suggesting B lymphocyte clonality does flot contribute to skewed
Xi patterns. Conclusions: lymphocyte clonality (determined gene rearrangements) does not appear
to contribute to a skewed Xi pattern when PMN celis are analyzed. Nonetheiess, as the criterion for
skewed Xi was based on PMN analysis, a more insighffui study may be to analyze lymphocyte
cionaiity in femaies whom demonstrate a skewed Xi pattera in lymphocytes.
xx
Figure Annex 2-1. T lymphocyte clonality assessed by TCR-y gaie rearrangements.
a) skewed females (60 yo) (n=23)
‘j
b) non-skewed females (60 yo) (n=25)
e
P1?_#I41iI1e:
e
c) positive controls (Iymphoma) (nz2)
1
xxi
figure Annex 2-2. B lymphocyte clonality assessed by immunoglobulin heavy chain gene
rearrangements.
a) skewed females (60 yo) (n23)
e
c) positive controls (B celi Iymphoma) (n2)
e.
b) non-skewed females (60 yo) (n25)
‘ê
—
*
e
* —ê -
*
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Annex 3
EVIDENCE 0f A HSC ORIGIN 0F SKEWING IN HUMANS
xxiii
Hematopoietic stem ccii ongin of skewing in humans
To determine the celi origin of Xi skewïng in hematopoietic lineages, the )UR of progenitor ceils
was compared to that of more differentiated ceil types. Methods: With informed consent, PB
samples of eligible female BM donors were evaluated for Xi status. Based on a skewed Xi pattern,
three healthy female volunteers were selected for analyses. A small aliquot of BM aspirate was
dedicated for study analysis. Pure populations of committed progenitor celis (CD34+ 3$+), less
commifted progenitor celis (CD34+ 38-), and differentiated ce!! populations: T ceils (CD3+), NK
ceils (CD56+), B celis (CD2O+) and monocytes (CDI4+) were obtained by florescent activated celi
sorting (FACS). The Xi pattem was determined by the ITUMARA clonality assay. Resulis and
Conclusion: based on visual examination, )URs of individual lineages within each individual were
highly concordant, consistent with derivation from a common progenitor, evidence in favor of a
HSC origin of AS. However, since only blood ceils were analyzed, a limitation to the study was
whether Xi skewing was primary or secondary/acqufred in origin.
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Annex 4
Q PILOT STUDY: EVIDENCE FOR TWO Xi TRAITS IN ELDERLY HUMÀN
FEMALES
xxv
EVIDENCE FOR TWO Xi TRAITS IN ELDERLY HUMAN FEMALES
b derive preliminary evidence in favor of two Xi traits in human females, the incidence of skewed
Xi and concordance for a skewed Xi pattera among various tissues was analyzed. Methods: A
small cohort of elderly females entering the arnbulatory center for complete blood counts were
accrued for study enroliment. To obtain females demonstrating the AS trait. elderly females (based
on visual appearance) were primarily setected. With written mfonned consent (page xxviii), two
biological samples were obtained from volunteering females (n=52): P3 and buccal ceils (BC). P3
was separated into polymorphonuclear (PMN) and mononuclear (MLL) layers by cellular
fractionation (see Chapter 2.5 and 2.6 for biological and cellular fractionation procedures). DNA
was isolated and the Xi pattern determined by the HUMARA clonality assay (Chapter 2.9 for
methods). Seven subjects were removed from analyses due to non-informativeness (homozygosity
for the F{UMARA locus), 2 additional samples were excluded due to poor PCR resuits, rendering a
total of 43 informative females. Mean age of participants was 50,7 yo. Resuils and Conclusions:
34.9% of females had a skewed Xi pattern in PMN ceils and 20,9% in BC samples (see Table
Annex 4, page xxvii) for individual subject resuits). This difference was significantly different
(pO,O5). The higher incidence of Xi-skewing in PMN is consistent with the AS trait. A skewed Xi
pattern in BC was highly concordant with a skewed Xi pattera in leukocytes (7/9 or 78%),
consistent with the properties of the prirnary Xi trait. In contrast, Xi-skewing in blood (n=15) was
Iess ftequently concordant with skewing in BC (7/15 or 47%) (see Figtire Annex 4 (page xxvi) for
sample resuits), stiggesting that the AS trait is unrelated to the primary Xi trait.
xxvi
figure Annex 4. Intraindividual concordance of Xi patterns. a) Random Xi in both PMN and BC,
illustrative of a primary Xi pattern. b) Skewed Xi pattern in both PMN and BC, consistent with the
properties of a skewed primaly Xi pattern. c) Skewed Xi pattern in PMN but random Xi in BC,
consistent with the properties ofthe AS trait.
a) Concordant for random X inactivation
PMN BC
+ - +
q-
(R) (R)
b) Concordant for skewed X inactivation: body-wide skewing
PMN BC
-
+ - +
w.
(S) (S)
e) Discordant for X inactivation paftems: AS
PMN BC
-
+ - +
t
(S) (R)
Abbreviations: -. mock digest; + Hpa II digest; R. random X inactivation;
S. skewed X inactivation.
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Table Annex 4. Xi pattems in polymorphonuclear ceils (PMN) versus buccal ceils.
Identifier code X inactivation phenotype Age
PMN Buccal cells
591 R R 62
592 R R 2$
594 R R 49
597 R R 52
59$ R R 49
600 R R 4$
602 R R 67
607 R R 39
610 R R 46
612 R R 50
614 R R 31
616 R R 77
61$ R R 22
619 R R 36
620 R R 24
62$ R R 4$
629 R R 41
647 R R 34
651 R R 56
653 R R 55
655 R R 7$
659 R R 5$
663 R R 79
67$ R R 72
680 R R $5
2650A R R 31
587 S R 79
595 S R 46
599 S R 51
609 5 R 59
627 S R 44
656 5 R 63
719 5 R 20
$0$A S R 39
601 R S 43
624 R S 45
58$ S S 79
605 5 S 65
60$ S S 46
611 S 5 49
617 S S 47
621 S S 59
625 S S 27
Abbreviations: PMN, polymorphonuclear cells, R, random X inactivation, S skewed X inactivation
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O fORMULAIRE DE CONSENTEMENT
Dons de sang de sujets normaux
• Nous sommes à la recherche d’échantillons de sang provenant de sujets
normatix pour étudier les cellules sanguines. De cette façon, nous croyons
pouvoir améliorer notre compréhension sur les leucémies et lyrephomes.
Seulement des prises de sang sont nécessaires.
• Les leucémies et les tymphomes Sont des cancers impliquant des cellules du
sang. Nous avons développé des.thôdes-d’analyse-zenaçants 1sque
nous croyons impliqués dans le développement de ces cancers. Cependant, noor
ignorons si la présence de ces gènes est directement reliée à la maladie ou:s’i!
s’agit, parfois, d’une observation de laboratoire sana con.équcnce. Pour. éclaircir
ce point, nous voulons déterminer si ces gènes sont présents chez les individus
normaux, et ce en fonction de leur âge. En somme, nos recberches -visent à
mieux comprendre ces maladies, leur apparition et leur développement
• En participant à ces études, vous contribuerez à l’avancement des connaissances
sur les maladies sanguines telles que les leucémies et les lymphomes.
POUR ÊTRE ADMISSIBLE, IL FAUT:
N’avoir aucune maladie du sang
Q Ne pas avoir ou avoir eu un cancer.EFFET SECONDAIRE
Les effets secondaires sont ceux reliés à la prise de sang. II y aura de la
douleur au moment de la prise de sang à cause de la piqûre. Rarement, il
peut y avoir une ecchymose (bleu) au site de la ponction, plus rarement
encore, il peut y avoir un hématome ou une infection au site de ponction.
TYPES D’ANALYSES
Nous utiliserons les cellules du sang, leur ADN et dérivés afin:
De caractériser des molécules associées à certains cancers (bel-2, bcr-abl,
ras, c-fins, p53, etc.).
D’étudier la structure et le comportement des chromosomes (polymorphisme,
inactivation du chromosome X, mutation, etc.). -
(J • D’isoler et étudier des cellules actives du sang face à certains cancers
(lymphocytes, cellules NK, etc.).
Bien qu’il n’y aura pas de commercialisation directe ou indirecte des spécimens ou
des données génétiques, il est possible que les connaissances acquises lors de ces
études puissent éventuellement donner lieu à des applications diagnostiques ou
thérapeutiques lesquelles pourraient être commercialisées.
CONFIDENTIALITÉ
Toutes les mesures seront prises pour que les résultats soient gardés
confidentiels. Si ces données étaient publiées, l’anonymat seia conseriL
Cependant, vous pourrez être informés des résultats d’analyses. De plus, si vous
acceptez, il nous sera possible de communiquer avec vous afin d’effectuer des
analyses sanguines supplémentaires.
Voici votre choix de type de participation (cocher une case seulement):
D J’accepte de donner un échantillon de mon sang pour cette étude. De
plus, j’accepte d’être éventuellement contacté et pourrai être informé des..
résultats par lettre confidentielle.
D J’accepte de donner de façon confidentielle un échantillon de mon sang,
mais je ne veux pas être contacté et ne serai pas informé des résultats de
mes analyses.
D Je refuse de participer à cette recherche
Signature du sujet NOM (Caractères d’imprimerie)(No. téléphone) DATE
Signature du témoin NOM (Caractères dimprÏmerie) DATE
Pour de plus amples informations, vous pouvez contacter les docteurs Dems
Claude Roy ou Lambert Busque responsables de ces études, Département
d’Hématologie-Immunologie, Hôpital Maisonneuve-Rosemont, au 252-3495.
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Annex 5
FORMULAIRE DE CONSENTEMENT
oodi
Hôpital Maisonneuve-Rosemont Mresse PoStale: 5415, boul. de l’Assomplion
Centre affilié à l’Université de Montréal Montréal (Québec) HiT 2M4
L FORMULAIRE DE CONSENTEMENT
Projet:
IDENTIFICATION D’UN GÈNE CONTRÔLANT LA PRODUCTION DES CELLULES
SANGUINES, SITUÉ SUR LE CHROMOSOME X.
INTRoDuCTION:
Le laboratoire d’hématologie moléculaire du centre de recherche de l’Hôpital Maisonneuve
Rosemont se spécialise dans l’étude des maladies du sang (leucémies, lymphomes) et les
greffes de moelles osseuses à l’aide d’analyses basées sur l’inactivation du chromosome X
chez les femmes.
Nous avons récemment découvert que près de 40% des femmes normales âgées de plus de
60 ans ont une variation de la normale qui fait que un des deux chromosome X est
préférentiellement inactivé au niveau des cellules de la moelle osseuse fhématopoïèse
clonale, skewing). Le projet de recherche vise à mieux comprendre ce phénomène et
potentiellement à identifier un gène important pour la production des cellules du sang situé
sur le chromosome X.
Ce projet nous permettra de mieux comprendre le vieillissement de la moelle osseuse et
possiblement les causes des cancers de la moelle osseuse. De plus, il est possible que nous
identifions un ou des gènes importants pour la production des cellules sanguines, ce qui
pourrait un jour favoriser le développement de nouveaux médicaments.
REcRUTEMENT DE FAMILLES (4 soeurs ou plus, dont l’une âgée de 60 ans ou plus).
Afin de poursuivre nos recherches, nous devons recruter des familles n’ayant pas de
maladies du sang. Nous avons besoin de familles où il y a up minimum de 4 soeurs, et dont
au moins une des soeurs est âgée de 60 ans ou plus.
POURQUOI SOMMES-NOUS INTÉRESSÉS PAR LES FEMMES?
Nous utilisons un test basé sur la présence de 2 chromosomes X, c’est pourquoi seulement
les femmes peuvent participer à notre étude.
POURQUOI RECRUTER DES FAMILLES?
Car il est plus facile de suivre la transmission des gènes dans une famille afin d’identifier un
ou des gène (s) responsablefs) de l’anomalie des cellules du sang.
COMMENT PARTICIPER À L’ÉTUDE?
• Être en bonne santé et ne pas avoir de maladie du sang;
• Ne pas avoir de cancer actif;
• Avoir 3 soeurs ou plus, dont l’une est âgée de 60 ans ou plus;
• Demander vous-même à vos soeurs si elles veulent participer à l’étude;
• Consentir à une prise de sang;
• Consentir à un frottis buccal (se faire gratter doucement l’intérieur de la joue avec une
petite brosse);
Pavillon Maisonneuve Pavillon Rosemont Pavillon Rachel4bungny PaviHon pédiatnque Centre d’accueil
5415. bout, de l’Assomption 5689. boul. Rosemont 5305. boul. de l’Assomption Thérèse’de1fturratde Judith-Jasmin
Montréal HIT 2M4 Montréat HiT 2H1 Montréal HiT 2M4 6900, 42e Avenue 8850. rue B,saillon
Tél. (514) 252-3400 Tél. (514) 252-3400 Tél.: (514) 252-3400 Montréal HiT 2t2 Montréat H1K 4N2
Tél.: (514) 374-7940 Té!. (514) 354-5990
xxxiii
Une infirmière clinicienne prendra rendez-vous avec vous. Elle fera le prélèvement à votre
domicile au moment où vous serez disponible. Ce n’est pas un problème si vos soeurs
n’habitent pas la même région que vous, notre infirmière se déplacera pour faire les
prélèvements.
RISQUES
Les seuls risques sont ceux d’une prise de sang. Il y aura de la douleur au moment de la
prise de sang à cause de la piqûre. Rarement, il peut y avoir une ecchymose (bleu) au site
de la ponction, plus rarement encore, il peut y avoir un hématome ou une infection au site de
ponction.
TYPES D’ANALYSES:
Nous utiliserons les cellules du sang, leur ADN (acide déoxyribonudéique) et dérivés afin:
• De trouver la cause de l’anomalie de clonalité (skewing) des cellules sanguines chez les
personnes de plus de 60 ans en étudiant la stwcture et le comportement des
chromosomes (înactivatïon du chromosome X, polymorphisme, mutation, etc.).
• De faire des analyses connexes permettant de mieux comprendre les maladies du sang.
CoNsERvATIoN DES ÉcHANTILLONS ET DES DONNÉES SCIENTIFIQUES
Les spécimens et les données seront détruits après 50 ans ou plus tôt selon les directives du
sujet. La conservation de l’ADN est sujette aux cas fortuits et à la force majeure.
C0NFJDENTIALrrÈ:
Toutes les mesures seront prises pour que les résultats demeurent confidentiels et soient
gardés au laboratoire de recherche.
Les résultats de cette étude seront éventuellement publiés dans une revue spécialisée de
médecine. Toutefois, il n’y aura aucune mention de l’identité des sujets analysés
(confidentialité). De plus vous avez le droit de vous retirer de l’étude en tout temps en
communicant avec le responsable de l’étude, le Docteur Lambert Busque MD FRCPC au
service d’hématologie de l’Hôpital Maisonneuve-Rosemont (252-3400 poste 3741).
Je comprends que je ne recevrai pas d’information médicale provenant de ce projet de
recherche.
u J’accepte d’être recontactée si le projet requiert d’autres spécimens, pour répondre
aux questions d’ordre médical ou encore pour de nouvelles études.
Je comprends qu’il est de ma responsabilité d’informer le responsable de l’étude de
tout changement d’adresse.
fl Je refuse d’être recontactée si le projet requiert d’autres spécimens, pour répondre
aux questions d’ordre médical ou encore pour de nouvelles études.
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Commercialisation
Il n’y aura pas de commercialisation directe ou indirecte des spécimens ou des données
génétiques. Ceux-ci demeureront la propriété de l’Hôpital Maisonneuve-Rosemont.
Toutefois, il est possible que les connaissances acquises lors de ces études donnent lieu
éventuellement à des applications diagnostiques ou thérapeutiques lesquelles pourraient être
commercialisées. Il n’y aura aucune retombée économique pour les participants à l’étude.
Une compagnie, dont le Docteur Lambert Busque est actionnaire minoritaire, détiendra toute
propriété intellectuelle éventuelle qui pourrait résulter du présent projet.
ÉVALUATION ÈTHIQUE
Le Comité d’éthique de la recherche de l’Hôpital Maisonneuve-Rosemont a approuvé le
présent projet.
L Ayant été informée et ayant eu l’occasion de poser mes questions, j’accepte de
donner un échantillon de sang pour l’étude de l’inactivation du chromosome X et pour
des analyses connexes permettant de mieux comprendre l’inactivation du
chromosome X.
L Je refuse de participer à cette recherche
Signature du chercheur
Pour de plus amples informations, vous pouvez contacter le Dr Lambert Busque MD FRCPC
responsable de l’étude au service d’hématologie, Hôpital Maisonneuve-Rosemont ((514) 252-
3400 poste 3741) ou Linda Lizoffe au (514) 252-3400 poste 4685 (ou au 1-800-726-3403).
Advenant un problème avec le déroulement de celle étude vous pouvez joindre une
personne indépendante de l’équipe de recherche. La représentante du comité d’éthique est
le Dr. Yvette Bonny (514-252-3400).
Signature du sujet Date
Nom (caractères d’imprimerie)
Adresse
(no téléphone)
Signature du témoin Nom (caractères d’imprimerie) Date
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Annex 6
O QUESTIONNAIRE MÉDICAL
o
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OUEST ION N AIRE
1. DATE DE NAISSANCE:____________________
2. VOTRE MÈRE EST-ELLE VIVANTE? Q OUI Q NON
3. VOTRE PÈRE EST-IL VIVANT? D OUI Q NON
4. COMBIEN DE SOEURS AVEZ-VOUS?_________
5. COMBIEN DE FRÈRES AVEZ-VOUS?
_________
6. COMBIEN DE FILLES AVEZ-VOUS?
____
7. COMBIEN DE FILS AVEZ-VOUS?
8. AVEZ-VOUS FAIT DES FAUSSES COUCHES? Q OUI Q NON
COMBIEN?
__________
9. FAITES-VOUS DE LANÉMIE? Q OUI Q NONO 7O.AVEZ-VOUS DÉJÀ EU UN CANCER? O OUI D NON
11.PRENEZ-VOUS DES HORMONES? Q OUI Q NON
12. ÊTES-VOUS FUMEUSE? Q OUI Q NON
xxxvii
C
Famille:
_______
_______
_______
_______
_______
lnUMUu:
_______
_
_______
Paroisse mariage des grands-parents paternels:
Paroisse mariage des grands-parents maternels:_______________________________
Cause de décs:
Pète
__
Frète
___
___
_
FïIs
___
___
___
___
___
_
Mère_______________ Soeur Fille_______________
Cancer
Quand:
Type:
Traitement: radiothérapie E]
__
_______
_______
_______
__
Chimiothérapie D
__
Si fumeuse (au moment de la prise de sang)
Nb d’année
Nb de paquet par jour (au moment de la prise de sang)
Si non-fumeuse:
A déjà fumée? OulE] NonE]
Si oui Combien de temps?
Combien de paquetjour
Arrêt depuis quand?
Fumée secondaire: Oui D Non D
Si oui
Combien de temps?
Arrêt depuis quand?
___
___
Personne fume combien de paquet par jour en sa présence?____________
Souffrez-vous de maladies tel que:
Asthme: Q
Lupus: Q
Arthrite rhumatoïde : D (Attention gonflement des articulations et non
arthrose)
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Liste de tous les médicaments et produits naturels pris au moment de la prise de sang
(vitamines, aspirine, pression etc.)
Hormonothérapie:
Commentaire:
